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ABSTRACT OF THE DISSERTATION 
FUNCTIONALIZED APTAMERS FOR DETECTION  
OF SMALL-MOLECULE TARGETS 
by 
Haixiang Yu 
Florida International University, 2019 
Miami, Florida 
Professor Yi Xiao, Major Professor 
Aptamers have recently gained considerable attention for small-molecule detection in 
diverse applications such as drug identification, medical diagnostics, and environmental 
monitoring. However, the performance of aptamer-based sensors has been greatly limited 
by the low target affinity and responsiveness of small-molecule binding aptamers. This 
dissertation describes several novel aptamer engineering and isolation strategies to 
remedy this problem. Specifically, we first develop a generally applicable strategy to 
engineer split aptamers containing two binding domains termed cooperative-binding split 
aptamers (CBSAs). CBSAs exhibit higher target binding affinity and are far more 
responsive in terms of target-induced split aptamer assembly compared to single-domain 
parent split aptamers from which they are derived. Using a cocaine-binding CBSA, we 
achieve specific fluorescence detection of as low as 50 nM cocaine in 10% saliva within 
15 minutes. We then develop a general approach for creating rapid and sensitive CBSA-
based enzyme-assisted target recycling (EATR)-amplified small-molecule sensors for 
sensitive target detection. Using this strategy, we develop a fluorescence assay for 
dehydroisoandrosterone-3-sulfate which achieves 100-fold enhanced target sensitivity 
ix 
 
relative to a non-EATR-based assay, and a colorimetric assay for visual detection of low-
micromolar concentrations of cocaine. To simplify the sensor development process, we 
establish a novel and simple SELEX strategy for directly isolating aptamers with intrinsic 
dye-displacement functionality which transduce target-binding events into a change of 
dye absorbance. As a demonstration, we isolate an aptamer against the synthetic 
cathinone 3,4-methylenedioxypyrovalerone (MDPV) that can detect MDPV at 
concentrations as low as 300 nM in a label-free, rapid, and simple dye-displacement 
assay. To further control the target-binding spectra of aptamers, we employ a novel 
parallel-and-serial SELEX strategy to isolate an aptamer binding 12 synthetic cathinones 
with nanomolar affinity but not 11 non-target compounds that are closely related in 
structure. Using this aptamer, instantaneous visual detection of synthetic cathinones at 
nanomolar concentrations in biological samples is achieved. In summary, this work 
demonstrates the great potential of novel aptamer engineering and isolation strategies in 
generating functional signal-reporting aptamers for sensitive small molecule detection. 
Importantly, the strategies described here are generalizable and can be used to develop 
aptamer-based assays for virtually any small-molecule targets. 
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 CHAPTER 1: Introduction 
1.1. Overview 
Aptamers are single-stranded oligonucleotide-based bioaffinity elements isolated in 
vitro via a technology termed “systematic evolution of ligands by exponential 
enrichment” (SELEX). Since 1990, hundreds of aptamers have been isolated for various 
targets including proteins, small molecules, metal ions, and whole cells. More recently, 
the analytical power of aptamers in biosensors has been demonstrated, particularly for the 
detection of small-molecule targets such as illicit drugs, environmental toxins, antibiotics, 
and biomarkers. Compared with antibodies, the dominant class of biorecognition 
elements used in current biosensors, aptamers have several remarkable advantages. First, 
unlike antibodies, which are isolated in vivo via immunization of animals, the aptamer 
isolation process is entirely in vitro. Thus, aptamers can easily be isolated even for non-
immunogenic and toxic small-molecule targets. Moreover, aptamer properties such as 
target-binding affinity and specificity can be controlled during the SELEX process by 
adopting different selection strategies and manipulating the selection conditions. In 
contrast, the in vivo nature of antibody generation forbids such control over antibody 
binding properties. Second, isolated aptamers can be chemically synthesized at low cost 
and with minimum batch-to-batch variation, overcoming two major drawbacks of 
antibody production. Third, compared to peptide-based antibodies, which suffer from 
irreversible degradation and denaturation under harsh conditions (e.g., high temperature), 
aptamers (particularly DNA-based aptamers) have higher chemical and thermal stability, 
conferring a much longer shelf life than antibodies—even at room temperature. Finally, 
post-SELEX sequence engineering and chemical modification of aptamers can be 
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routinely performed via chemical synthesis, which allows facile incorporation of different 
sensing functionalities into aptamers for target detection. However, engineering of 
antibodies is typically challenging and often limits their sensing utility. As a result, 
numerous aptamers have been isolated for small molecules and adopted into various 
sensing platforms for diverse applications such as drug detection, environmental 
monitoring, food safety, and clinical diagnostic.  
Newly-isolated aptamers usually have a fully-folded structure. Although they may 
possess high target-binding affinity, these aptamers generally lack signal-reporting 
functionality for target detection. A few assays based on fully-folded aptamers have been 
reported; however, they are usually limited to specific aptamers or require specific 
instruments, and there is currently no generalizable method to isolate fully-folded 
aptamers with innate signal-reporting functionality. To incorporate such functionality, 
aptamers are routinely cleaved to derive structure-switching aptamers or split aptamers. 
These engineered aptamers have lower thermal stability compared with their fully-folded 
parent aptamers, and predominately display a single-stranded conformation with 
disrupted target binding domains in the absence of target. Nevertheless, these aptamer 
fragments maintain target-binding affinity and can fold or assemble into a duplexed 
structure similar to their parent aptamer upon addition of target molecules. When 
modified with a fluorescent, electrochemical, or enzymatic label, such target-induced 
conformational changes can be readily transduced into a measurable signal for target 
detection. Unfortunately, the low thermal stability of structure-switching or split aptamers 
inevitably leads to reduced target-binding affinity compared with their parent aptamers, 
which results in poor assay sensitivity. This is particularly troublesome for small-
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molecule binding aptamers, which often have relatively low target-binding affinity, with 
dissociation constants (KD) ranging from high nanomolar to low micromolar. Therefore, 
general approaches for the development of highly sensitive aptamer-based sensors for 
small-molecule targets would be highly valuable.  
1.2. Motivation and goals 
The primary research objective in this dissertation was to develop new general 
strategies to isolate and engineer functionalized aptamers for sensitive detection of small-
molecule targets. To achieve this goal, we implemented four innovative approaches: 1) 
engineering new aptamer constructs that have both high target-binding affinity and 
sensitive target response, 2) developing an efficient signal amplification strategy to 
increase the sensitivity of current aptamer-based sensors, 3) developing a generalizable 
sensing platform utilizing fully-folded aptamers, and 4) establishing a novel selection 
strategy to isolate class-specific small-molecule-binding aptamers.  
First, we developed a general aptamer engineering strategy in which we incorporated 
cooperative-binding functionality into split aptamers to enhance their target response for 
more sensitive small-molecule detection (see Chapter 3). Conventional split aptamers 
containing one target-binding domain typically possess low target affinity and weak 
target response, resulting in low sensitivity when employed in biosensors. To overcome 
this challenge, we engineered novel cooperative-binding split aptamer (CBSA) 
constructs, which incorporate two cooperative binding domains such that target binding 
at one domain greatly increases the affinity of the second domain. The cooperative-
binding functionality of CBSAs allows them to achieve higher target-binding affinity and 
more sensitive target-induced aptamer assembly compared to their parent split aptamer 
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with a single binding domain. This means that rapid ultrasensitive detection of small-
molecule targets can be readily achieved using a CBSA modified with a fluorophore-
quencher pair. Importantly, the strategy of CBSA engineering is straightforward and can 
be generalized to any aptamer with a three-way junction (TWJ) secondary structure. 
Given the fact that many TWJ-structured aptamers have been isolated for various small 
molecules, CBSA-based sensors can be readily developed for the detection of various 
small-molecule targets, such as illicit drugs, biomarkers, toxins, and therapeutics. 
Upon successful engineering of CBSAs, we further developed a generalizable 
enzyme-assisted target recycling (EATR) approach to enhance the analytical power of 
CBSAs (see Chapter 4). Specifically, we introduced a C3 spacer abasic site between the 
two target-binding domains of the CBSA. When the CBSA assembles upon target 
binding, the C3 spacer in the CBSA duplex offers a substrate that can be efficiently 
cleaved by Exo III. This cleavage event releases target molecules into solution, which 
then mediates more cycles of target-induced CBSA assembly and enzyme cleavage until 
all CBSAs are degraded. In the absence of target, the CBSA fragments remain separated, 
forming no duplexed abasic site, and are thus spared from Exo III digestion. Our EATR 
strategy serves two purposes. First, since a small amount of target can result in cleavage 
of far large numbers of CBSAs, EATR can be used as an efficient signal amplification 
mechanism to increase the sensitivity of CBSA-based sensors. Alternatively, EATR-
mediated aggregation of CBSA-modified gold nanoparticles (AuNPs) can be employed to 
develop an instrument-free colorimetric assay. Given the generality of our CBSA 
engineering strategy and the versatility of the EATR approach, such assays should 
provide a valuable means for small-molecule detection in various fields. 
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We have further developed a general strategy to isolate fully-folded aptamers with 
intrinsic dye-displacement functionality for sensitive colorimetric detection of small 
molecules (see Chapter 5). Previous studies have shown that dye-displacement assays 
have several exceptional advantages, being rapid, highly sensitive, and label-free. 
However, the implementation of such methods has been limited, since finding a signal-
reporting small-molecule dye for a specific aptamer is difficult. To solve this problem, 
we first determined that the dye diethylthiatricarbocyanine (Cy7) can stack into DNA 
TWJs in a sequence-independent fashion, producing a dramatic color change. We then 
designed a SELEX strategy utilizing a structured library containing a TWJ target-binding 
domain to isolate small-molecule binding aptamers. Aptamers isolated through this 
library intrinsically bind to Cy7, and thus can be directly incorporated into a Cy7-
displacement assay for rapid, sensitive, and colorimetric target detection. Given the high 
generality of our SELEX strategy and the excellent performance of the dye-displacement 
platform, we foresee that our approaches can be used for sensitive colorimetric detection 
of various small-molecule targets in diverse applications. 
We finally developed a novel ‘parallel-and-serial’ selection strategy for isolating 
class-specific oligonucleotide-based aptamers in vitro (see Chapter 6). This strategy first 
entails parallel selection to selectively enrich cross-reactive binding sequences, followed 
by serial selection that enriches aptamers binding to a designated target family. As a 
demonstration, we isolated a class-specific DNA aptamer against a family of designer 
drugs known as synthetic cathinones. The aptamer binds to 12 diverse synthetic 
cathinones with nanomolar affinity and does not respond to 11 structurally similar non-
target compounds, some of which differ from the cathinone targets by a single atom. This 
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is the first account of an aptamer exhibiting a combination of broad target cross-
reactivity, high affinity and remarkable specificity. Leveraging the qualities of this 
aptamer, instantaneous colorimetric detection of synthetic cathinones at nanomolar 
concentrations in biological samples was achieved. Our findings significantly expand the 
binding capabilities of aptamers as class-specific bioreceptors and further demonstrate the 
power of rationally designed selection strategies for isolating customized aptamers with 
desired binding profiles. We believe that our aptamer isolation approach can be broadly 
applied to isolate class-specific aptamers for various small molecule families. 
1.3. Scope of the dissertation 
Chapter 2 provides a general literature review of the historical background of 
aptamers, SELEX, aptamer-based sensors for small molecule detection, AuNPs and their 
use in aptamer-based sensors, EATR, and the small-molecule targets used in the work. 
Chapter 3 details a strategy for engineering highly target-responsive CBSA for sensitive 
detection of small molecules and demonstrates the application of CBSAs for rapid 
fluorescent detection of cocaine in saliva samples. Chapter 4 further describes a 
generalizable EATR approach both as a signal amplification method to increase the 
sensitivity of the CBSA-based fluorescence assay and a signal reporting strategy for 
colorimetric detection of small molecules. Chapter 5 describes a new SELEX strategy to 
isolate fully-folded aptamers with intrinsic dye-displacement functionality for rapid, 
sensitive, and colorimetric detection of any small-molecule targets. Chapter 6 describes a 
generally applicable selection strategy to isolate class-specific aptamers as well as a rapid 
sensitive assay for visual detection of a family of synthetic cathinones. Chapter 7 
provides a summary of the dissertation and proposes future research directions. 
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CHAPTER 2: Background and Literature Review 
2.1. Aptamers and their use as affinity reagents for small-molecule targets 
Aptamers are single-stranded DNA- and RNA-based bioaffinity elements isolated in 
vitro from randomized libraries via a procedure called SELEX.1 The term ‘aptamer’ was 
derived from the Greek word aptus, or “to fit”.2 These oligonucleotides typically are 
short in length, ranging from 20- to 80-nt, but often possess target-binding specificity that 
rivals antibodies.3 Similar to antibodies, ligand recognition by aptamers is based on non-
covalent interactions such as electrostatic interactions, hydrogen bonds, pi-pi interactions, 
and van der Waals forces.4 The first aptamers targeting protein1 and small-molecule2 
targets were isolated in 1990. Since then, hundreds of aptamers have been isolated for a 
great diversity of targets including metal ions, small molecules, proteins, and even whole 
cells.5  
Inspired by naturally-occurring functional RNAs such as ribosomes and ribozymes, 
the first aptamers were isolated from RNA-based libraries. However, RNA-based 
aptamers have low chemical stability due to the presence of a reactive 2’ hydroxyl group 
on their ribose backbone, and are prone to chemical and enzymatic hydrolysis.6 Although 
substitution of the 2’ hydroxyl group with a fluorine or amine can increase the stability of 
the aptamer, these chemical modifications significantly increase the cost of aptamer 
production and may also reduce the binding affinity of the aptamer.7 In contrast, the 
deoxyribose backbone of DNA does not have the 2’ hydroxyl group, and thus has much 
higher chemical stability and resistance to hydrolysis. In 1992, the first DNA-based 
aptamer was isolated against thrombin, with a KD of 25 nM.8 Since then, many DNA 
aptamers have been isolated with comparable performance to RNA aptamers. At present, 
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more than 50% of reported aptamers are composed of DNA due to their high stability, 
ease of handling, and commercial availability.5 
Recently, a number of groups have intensively explored the utility of aptamers as 
biorecognition elements for small-molecule detection. Sensitive and accurate detection of 
small-molecule targets is critical for diverse fields including law enforcement, 
environmental monitoring, clinical diagnostics, and medical treatment.9–11  Instrumental 
methods such as gas chromatography and mass spectroscopy have very high sensitivity 
and specificity, but these methods are expensive, time-consuming, and rely on 
cumbersome instruments and trained personnel.12 Moreover, lengthy sample preparation 
steps are required when dealing with complex sample matrices such as biofluids.12 These 
disadvantages greatly limit the utility of these methods for rapid and on-site applications. 
12,13 Biosensors employing specific binding between targets and biorecognition elements 
offer a powerful alternative for the rapid detection of small molecules. For example, 
antibodies can bind to their targets with nanomolar or lower KDs with very high 
specificity, allowing for highly sensitive detection of targets even in complex samples.14 
Antibodies can also be coated onto paper substrates to fabricate low-cost lateral-flow 
devices,14 and on-site biosensing currently relies heavily on such immunoassays.  
2.1.1 Advantages of aptamers as biorecognition elements for small molecule 
detection 
Aptamers, as newly emerged biorecognition elements, offer several exceptional 
advantages for sensors compared with antibodies (Table 2-1).15,16 The generation of 
antibodies relies on antigen-induced immune response, but small molecules have low 
molecular weight (<1,000 Da) and are typically poorly immunogenic. Therefore, small-
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molecule targets generally need to be modified with a linker and conjugated to a carrier 
protein prior to immunization.17 Such a process can be challenging due to the limited 
number of functional groups on the target for conjugation chemistry. In contrast, the in 
vitro nature of SELEX technology means that aptamers can be directly isolated for 
virtually any small molecule. Furthermore, the whole process of antibody generation, 
which includes target preparation, immunization of animals, antibody characterization, 
and antibody purification, is lengthy and labor intensive, and can take more than six 
months.18 In contrast, aptamer isolation is typically fast and only takes several weeks. 
This is critical for rapidly evolving small-molecular targets such as designer drugs, where 
the lengthy antibody-development process has become a significant barrier for forensic 
laboratories in keeping up with the diversity of new drugs on the streets.18,19 The process 
of antibody production is not only expensive, but also leads to large batch-to-batch 
variation.5,14 Moreover, it is difficult to precisely engineer and chemically modify 
antibodies for signal reporting, and such modifications can often significantly reduce 
target-binding affinity of the antibodies.20 On the other hand, aptamers can be chemically 
synthesized with low production cost and minimal batch-to-batch variation, and sequence 
engineering of aptamers is also straightforward, enabling introduction of diverse sensing 
functionalities. Indeed, various chemistries are commercially available to modify 
aptamers with different fluorescent,21 electrochemical,22 or enzymatic23 tags for signal 
reporting purposes. 
Depending on the application, it may be crucial for biosensors to either be highly 
specific to a single target (to prevent false-positive results) or broadly cross-reactive to a 
class of structurally-related targets (to detect multiple targets using one bioreceptor). 
10 
 
Because antibody generation is an in vivo process, neither affinity nor specificity of the 
antibodies can be controlled.17 As a result, current immunoassays for small-molecule 
detection routinely suffer from false-positives generated by non-specific antibody 
binding. Meanwhile, immunoassays are usually not able to detect a class of structurally-
related targets since a minor modification on a target’s core structure may completely 
impair binding.24 On the other hand, various selection strategies such as “counter-
SELEX”25 or “toggle-SELEX”26 can be employed to customize the binding-profile of 
isolated aptamers and generate highly specific or class-specific aptamers.  
Table 2-1. Comparison between aptamer and antibody in sensor development. 
Features Antibody Aptamer 
Target limitation Limited for small molecules and toxic compounds No limitation 
Production period Months to over a year Weeks 
Production cost High Low 
Batch-to-batch variation High Low 
Binding profile Uncontrollable Highly tunable 
Chemical stability Low High 
 
As proteins, antibodies are thermodynamically unstable and undergo irreversible 
denaturation under harsh conditions, such as high temperature or high-salt condition. 
Therefore, immunoassays generally need to be refrigerated and usually have a shelf life 
of less than a year.15 In contrast, aptamers—especially those based on DNA—are more 
chemically and thermally stable than antibodies, and can be kept at room temperature for 
years without losing bioactivity.5 The stability of aptamers can be further enhanced by 
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chemical modification of the ribose backbone with 2-fluorine or 2-O-methyl groups, to 
resist degradation from enzymes in the blood.5  
2.2. Isolation of small-molecule-binding aptamers via SELEX  
 
Figure 2-1. General process of SELEX. 
Aptamers are isolated from randomized DNA or RNA libraries through a multi-round 
SELEX procedure. Each round of isolation consists of three essential steps: separation of 
target-binding strands, polymerase chain reaction (PCR) amplification of the target-
binding strands, and reconstruction of the new library from the isolated sequences. 
Strands binding to the target with higher affinity are enriched more than non-binders 
during each round. Therefore, after several rounds of SELEX, strands with the highest 
target-binding affinity will dominate the library and can be identified by sequencing the 
pool. Figure 2-1 shows a schematic outline of the SELEX process. 
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2.2.1 Library design 
Libraries used for aptamer isolation typically comprise a randomized sequence flanked 
by consensus sequences at both ends that serve as primer-binding sites. The library can 
be either DNA or RNA; DNA libraries can be directly synthesized, while RNA libraries 
are generated by in vitro transcription of the DNA library. The number of nucleotides (N) 
in the random region determines the total possible sequences (4N) in the library, as each 
position has four possible nucleotides (A, T, C and G for DNA; A, U, C, and G for 
RNA). The length of the random region can range from 6 to 200 nt.27 A long random 
region has more sequence diversity, which in principle allows for the formation of more 
complicated motifs that may benefit aptamer affinity and specificity. However, not all 
possible sequences in these libraries can be practically represented during SELEX.28 In 
contrast, short random regions form simpler binding motifs but also allow for 
representation of every possible sequence. Notably, one recent study showed that the 
length of the random region has no significant correlation with the affinity of the isolated 
aptamers.27 A shorter aptamer also has advantages such as easier identification of the 
target-binding domain, easier sequence engineering to introduce signal-transducing 
functionality, and lower production costs. The most widely used small-molecule binding 
aptamers for sensor development, which include aptamers for cocaine,21 ATP,29 and 
kanamycin,30 are shorter than 40 nt. In addition to the length of the random region, one 
can incorporate different secondary structures such as G-quadruplexes,31 stem-loops,32 
and TWJs33,34 into the library to isolate more specialized aptamers with various 
functionalities. For example, we have recently designed a TWJ-structured library and 
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isolated an aptamer with intrinsic binding affinity to the small molecule dye Cy7 for 
sensitive detection MDPV using a colorimetric dye-displacement assays.34 
 
Figure 2-2. Common strategies to separate target-binding and non-binding strands. These 
strategies include (A) target-immobilized SELEX, (B) library-immobilized SELEX, and (C) 
homogeneous SELEX. 
2.2.2 Strand separation strategies for SELEX 
The success of SELEX greatly depends on the separation of target-binding strands 
from non-target-bound library strands. This can be achieved through either heterogeneous 
or homogeneous techniques. Heterogeneous (bead-based) SELEX methods have been 
widely utilized to isolate hundreds of aptamers for small-molecule targets such as 
steroids,33 nucleotides,29,35 and antibiotics,30,36–39 achieving micromolar binding affinities 
after 10–20 rounds of selection.40 These methods require immobilization of either the 
target or library strands. For target-immobilized SELEX (Figure 2-2A), a small-molecule 
target is covalently conjugated on a solid-phase carrier (e.g., magnetic microbeads) via a 
linker. When the target-conjugated carrier is incubated with the nucleotide library, 
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strands binding to the target strongly adhere to the solid phase and can be collected, while 
non-target-binding strands remain in the solution and can be eluted away with the buffer. 
Since the target is covalently conjugated onto the beads in target-immobilized methods, 
highly-stringent SELEX conditions can be employed to isolate aptamers within a few 
rounds.41  
However, these methods also have several technical challenges.42,43 Since small 
molecules typically have limited functional groups, surface conjugation of these targets 
can be challenging. Functional groups occupied by the linker may not be accessible to 
aptamer binding, making isolation of high-affinity aptamers difficult. In addition, both 
the bead surface and the linker are susceptible to non-specific recognition by library 
molecules, reducing separation efficiency and requiring additional negative SELEX 
processes to remove these non-specific binders.43 For small molecules that are not 
suitable for surface immobilization, library-immobilized SELEX is often used (Figure 
2-2B). This method utilizes a short, bead-conjugated complementary DNA (cDNA) 
sequence that hybridizes to a specific region of the library strands and thereby 
immobilizes them onto the surface. Upon addition of the target, non-binding sequences 
remain on the surface, while target-binding strands undergo a conformational change that 
detaches them from the cDNA and releases them into solution, so that they can be 
collected for further enrichment. Since small-molecule targets are free in solution, non-
specific enrichment of carrier/linker binding sequences can be avoided. However, 
because the binding between library and capture strand is non-covalent and prone to 
spontaneous dissociation during target elution,44 the separation efficiency of these 
methods is low and requires more rounds of selection. Moreover, both target-
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immobilization and library-immobilization create steric hindrance to interactions between 
library and target, resulting in the isolation of aptamers with low target-binding affinity.  
Alternatively, several homogeneous methods (Figure 2-2C) have been recently 
developed to overcome the limitations of heterogeneous SELEX, enabling higher 
separation efficiency and allowing for isolation of high-affinity aptamers after just a few 
rounds of selection. The first reported homogeneous SELEX technique utilized capillary 
electrophoresis separation, exploiting the differential mobility between unbound and 
target-bound library molecules under an external electrical field.45,46 However, this 
method offers limited utility for small-molecule targets, because the mobility of target-
aptamer complexes is very similar to that of unbound oligonucleotides, resulting in poor 
separation resolution.47 Alternatively, graphene oxide has been used to remove non-
target-bound molecules during the separation step, as this material binds more strongly to 
single-stranded DNA than to folded, target-bound DNA structures.48 This technique has 
produced DNA aptamers for three pesticides and two toxins, with KD ranging from 1–100 
nM after 5-10 rounds.49–51 However, this technique is not compatible with targets that 
have strong π-π interaction with graphene oxide, such as doxorubicin.52 So far, there is no 
generally applicable homogeneous SELEX technique for isolating small-molecule-
binding aptamers. 
2.2.3 Aptamer enrichment by PCR and regeneration of single-stranded libraries 
There are a few examples of aptamers isolated through a single-round selection 
process53,54 or a multi-round selection process without PCR amplification.55 However, 
none of these methods has been successfully applied to small-molecule targets, and 
SELEX is almost always a multi-round process. Since target-bound strands usually 
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comprise a minimal fraction of the library pool, especially in the earlier rounds, the 
separated target-binding strands need to be amplified by PCR to regenerate the new 
library for the next round of selection. For RNA-based libraries, in vitro reverse 
transcription is required before PCR amplification. During PCR, single-stranded library 
strands are converted into double-stranded products, and it is therefore necessary to 
remove antisense strands to regenerate the single-stranded new library for the next round 
of selection. Methods routinely used for library regeneration include physical 
separation,56 enzymatic digestion57,58, and asymmetric PCR59. In the physical separation 
method, a biotinylated reverse primer is used during PCR to generate a biotin-labeled 
antisense strand. The double-stranded PCR products are then captured by streptavidin-
coated microbeads and incubated with NaOH, denaturing the double-stranded DNA and 
releasing the sense strands into solution. These strands are then collected and used as a 
new single-stranded library. Alternatively, modified primers can be used to enable 
enzymatic removal of antisense strands from the PCR products. For example, if PCR 
amplification is performed using a 5’-phosphorothioate-labeled forward primer, the 
antisense strands can be digested using T7 exonuclease, while the sense strands are 
protected by the 5’-phosphorothioate label and remain intact.57  Similarly, if PCR 
amplification is performed using a 5’-phosphorylated reverse primer, lambda exonuclease 
can be used to specifically remove the phosphorylated antisense strands while sparing the 
non-modified sense strands.58 As an alternative, asymmetric PCR allows for direct 
generation of single-stranded libraries by adding an excess of forward primer relative to 
the reverse primer. During PCR, the reverse primer is rapidly depleted so that ultimately, 
only the sense strand can be effectively amplified with the forward primer, producing 
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single-stranded products.59 These different methods for library regeneration have been 
found to vary moderately in terms of cost and efficacy,60 and our work has generally 
employed physical separation with streptavidin-coated agarose resin.34,61 
 
Figure 2-3. Common SELEX strategies for control aptamer specificity. 
2.2.4 Common selection strategies for control affinity and specificity of aptamers  
One of the major advantages of aptamers compared with antibodies is that their 
affinity and specificity can be fine-tuned during SELEX by using different selection 
strategies. Control of aptamer affinity is usually achieved by manipulating SELEX 
stringency. Under low-stringency conditions, even aptamers with low target-binding 
affinity can be retained in the enriched pool. However, under highly stringent conditions, 
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only aptamers with the highest target affinity can survive.62–64 Common ways of 
modulating selection stringency include altering target concentration, target incubation 
time, temperature, and buffer ionic strength.27,62,63 High selection stringency results in 
higher aptamer affinity. However, high stringency also increases the risk of losing target-
binding sequences, especially during earlier rounds where the copy number of each 
sequence is low. Therefore, SELEX is usually performed with relatively lower stringency 
in earlier rounds to retain all possible target-binding sequences. The stringency is then 
gradually increased in later rounds to enrich high-affinity aptamers.65 Some mathematical 
models have been established to guide selection stringency during the SELEX process, 
62–64 but in most cases the change in stringency between rounds is highly empirical.61  
Some selection strategies have also been developed to control the binding specificity 
of the aptamers. One disadvantage of target-immobilized SELEX is the evolution of 
bead-binding aptamers. Negative-SELEX strategies can overcome this problem (Figure 
2-3, left).66 Here, the library is first incubated with non-modified beads, so that bead-
binding strands are adsorbed onto the beads. These beads are then removed, and the 
remaining library strands are then incubated with target-immobilized beads for regular 
SELEX. A similar strategy, termed counter-SELEX, was developed to prevent isolated 
aptamers from binding to possible interferents (Figure 2-3, left). In 1994, using a very 
stringent counter-SELEX regime, Polisky et al. isolated a theophylline-binding aptamer 
that has a 10,000-fold higher affinity for this target compared to caffeine, which only 
differs from the target by a methyl group.25 After incubating theophylline-immobilized 
beads with the library, they used a high concentration of caffeine to elute and thereby 
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eliminate library strands recognizing this molecule. Multiple rounds of counter-SELEX 
can be used to further fine-tune the specificity of the resulting aptamers.  
The specificity of aptamers can also be tailored to recognize a whole family of targets 
sharing the same core structure. Such ‘class-specific’ aptamers can be used in many 
sensing applications, including detection of illicit drugs and their metabolites for forensic 
investigations, antibiotics for food safety, or pesticides for environmental monitoring.67–69 
In order to generate class-specific aptamers, Sullenger et al. developed a toggle-SELEX 
strategy (Figure 2-3, right) in 2001, yielding an aptamer that cross-reacted to both human 
and porcine thrombin.26 The initial library was incubated with a mixture of both targets to 
enrich all potential aptamers, after which human and porcine thrombin were used as 
alternating selection targets every round. Consequently, only library strands that bind to 
epitopes present on both targets can be enriched in every round, while aptamers specific 
to one species were removed. The final aptamer bound to human and porcine thrombin 
with a KD of 2.8 and 0.1 nM, respectively. In comparison, an aptamer isolated using only 
porcine thrombin demonstrated >10,000-fold higher specificity for this protein relative to 
human thrombin.26 Toggle-SELEX has been employed to isolate several class-specific 
aptamers, mostly for protein and cell targets.70–72 In some cases, toggle-SELEX was also 
performed with more than two targets to achieve broader binding spectra.71,72 A similar 
toggle strategy can also be applied to isolate class-specific aptamers for small-molecule 
targets.36,39,73 However, this is more challenging than for protein and cell targets due to 
lack of epitopes on small-molecule targets. For example, one study used toggle SELEX 
with four different target pairs to isolate class-specific aminoglycoside-binding aptamers. 
However, only one out of the 80 aptamers demonstrated cross-reactivity to all eight 
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aminoglycoside targets.36 To overcome such limitations, we have recently developed new 
parallel-and-serial selection strategies to increase target cross-reactivity and the success 
rate of class-specific aptamer isolation.74 As a demonstration, we have isolated a class-
specific aptamer that binds to more than 12 synthetic cathinones sharing the same core-
structure with nanomolar affinity. 
 
Figure 2-4. Different strategies to develop aptamer-based sensors. Sensors can be developed 
from (A) a fully folded aptamer via (B) aptamer truncation, (C) splitting, (D) introducing a 
competitive strand, or (E), a dye binding to target-binding domain of the aptamer. 
2.3. Aptamer-based sensors for small molecule detection 
As target affinity is typically the only selection pressure applied during SELEX, 
isolated aptamers usually lack innate signal transducing functionality and cannot be 
directly used for biosensing. Many strategies have been developed to introduce different 
signal transducing functionalities into aptamers to achieve optical, electrochemical, or 
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electrical detection of small-molecule targets (Figure 2-4).75 Most aptamer-based sensors 
for small-molecule detection rely on a conformational change of the aptamer upon target 
binding—functionality that are typically be introduced into the aptamer via a multi-stage 
process of sequence analysis, truncation and chemical modification.75–77 Nevertheless, 
several sensor platforms are available that employ fully-folded aptamers without 
requiring target-induced conformational change.  
2.3.1 Sensors based on target-induced conformational changes  
Small-molecule-binding aptamers are usually fully folded upon isolation, with stable 
secondary structures (Figure 2-4A), such that target binding does not significantly alter 
their structure. The functionality of binding-induced conformational change is therefore 
introduced into the aptamer via post-SELEX. An aptamer comprises a target-binding 
domain and several scaffold regions. Small-molecule-binding aptamers usually have 
small target-binding domains, since the small surface area of the target can interact with a 
limited number of nucleotides simultaneously. The nucleotides in the scaffold regions do 
not directly interact with the target, but help to stabilize the structure of the aptamer and 
thereby ensure proper formation of the target-binding domain. When scaffold regions are 
disrupted, the aptamer will lose its secondary structure and become single-stranded. 
However, the disrupted sequences may retain their capacity for target recognition and to 
reassemble into the original secondary structure in the presence of the target. This target-
induced aptamer conformational change can then be employed for signal transduction. 
Aptamer truncation, splitting, and strand-displacement are the three general strategies to 
introduce target-induced conformational change functionality. 
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2.3.1.1 Sensors based on truncated structure-switching aptamer  
The most intuitive way of introducing structure-switching functionality is to truncate 
the aptamer (Figure 2-4B). Aptamers usually have double-stranded stems contributing to 
the scaffold region. Shortening these stems reduces the melting temperature of the 
aptamer, shifting their equilibrium to favor a single-stranded structure that can still be 
refolded upon target binding. For example, the well-characterized cocaine-binding aptamer 
MNS-4.1 (KD ∼5 μM) is structurally stable and forms a TWJ even before binding 
cocaine.78 Stojanovic et al. subsequently truncated one of the three stems to destabilize the 
aptamer, and attached a fluorophore-quencher pair to the ends of the truncated stem for signal 
reporting.78 The resulting aptamer exists in an equilibrium state consisting of both folded and 
unfolded structures in the absence of the target, in which the fluorophore cannot be efficiently 
quenched and thus emits strong fluorescence. The aptamer refolds in the presence of cocaine, 
bringing the quencher into proximity of the fluorophore and resulting in a signal reduction. 
The method demonstrated a limit of detection (LOD) of 10 μM.78 The same aptamer sequence 
has also been modified with electroactive methylene blue for electrochemical detection of 
cocaine even in the most challenging sample matrix, whole blood.79 So far, many structure-
switching aptamers have been engineered by truncation for folding-based sensor 
development.80  
Traditionally, engineering of structure-switching aptamers with sensitive target 
response is a laborious multistep process. First, the secondary structure of the fully-folded 
aptamer must be predicted by software such as mfold or NUPACK.81,82 Different 
domains of the aptamer are then truncated or mutated to identify the target-binding 
domain and scaffold regions. Finally, multiple truncated aptamers with different portions 
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of the scaffold regions removed are synthesized and tested for validating structure-
switching functionality, and the optimized aptamer is used for downstream sensor 
developments.83–85 This process is not only labor-intensive but also greatly relies on trial 
and error. For example,  Neves et al. identified the target-binding domain and secondary 
structure requirements of MNS-4.1 by interrogating 24 truncated/mutated aptamers using 
isothermal titration calorimetry (ITC),86 followed by testing the parent aptamer with three 
truncated/mutated variants using nuclear magnetic resonance (NMR) to identify the 
optimized structure-switching aptamer.87 To expedite the aptamer engineering process, 
we have recently developed a one-step nuclease-directed truncation method to generate 
structure-switching small-molecule-binding aptamers.88 Specifically, we found that Exo 
III digestion of aptamers can be strongly inhibited a few nucleotides prior to their target-
binding domain. The resulting digestion product not only retains substantial target-
binding affinity but also exhibits structure-switching functionality, enabling rapid 
development of aptamer-based sensors for small-molecule detection. 
Since small-molecule-binding aptamers usually have relatively high dissociation 
constants (∼μM KD),40 a substantial scaffold region is required to stabilize the aptamer 
structure and maintain target-binding affinity, which promotes problematic background 
folding. For example, the optimized structure-switching cocaine-binding aptamer 
described above are partially folded in the absence of target, resulting in high background 
that greatly limited sensor sensitivity.78,89 However, further truncation of this aptamer 
results in the complete loss of target affinity.86 
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2.3.1.2 Sensors based on split aptamers  
An alternative way to generate target-induced conformational change is to split the 
fully folded aptamer into two21 or three90 fragments, which destabilizes the aptamer such 
that the fragments are unable to assemble in the absence of target. However, the 
fragments retain their capacity for target recognition and can successfully reassemble into 
a complex secondary structure in the presence of target (Figure 2-4C).91 As with 
truncation, splitting of the aptamer also requires knowledge of its target-binding domain 
and scaffold regions. Splitting is often performed at non-binding loop regions of the 
aptamer. Recently, Heemstra et al. reported a general approach for engineering small-
molecule-binding DNA split aptamers with TWJ target-binding domains.92 Splitting of 
aptamers with other secondary structures can be challenging, especially for those lacking 
apparent non-binding loop regions, thus requiring considerable trial-and-error.  
Splitting is a more aggressive method that results in reduced background signal 
compared with truncated aptamers. However, aptamer splitting also results in notably 
reduced target affinity for the same reason.21 Thus, this approach still compromises the 
sensitivity of the resulting sensors. To improve sensor sensitivity, Zhang et al. reported an 
amplified assay based on an enzyme-linked split aptamer to perform colorimetric cocaine 
detection.23 One fragment was conjugated to a plastic surface; in the presence of cocaine, this 
fragment formed a complex with the second fragment, which was modified with biotin in 
order to bind streptavidin-linked horseradish peroxidase for signal amplification. However, 
washing caused the dissociation of a subset of the assembled tripartite complexes, resulting in 
a LOD of just 2.8 μM. To address this, Heemstra et al. incorporated a proximity ligation 
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strategy into this assay.93 Here, cocaine binding facilitated the assembly of the azide- and 
cyclooctyne-modified split fragments, bringing these two chemical groups into close 
proximity to form covalent bonds. This prevented dissociation of the assembled target–
aptamer complex during washing and improved the sensor's detection performance. Although 
the signal was then amplified by the enzyme, the sensitivity remained limited to 0.1 μM94 due 
to the low binding affinity of the split aptamer (KD = ∼200 μM).21 Target affinity can be 
improved by engineering split aptamers with longer complementary stems, but the 
majority of thermostable split aptamers undergo some degree of pre-assembly in the 
absence of target, producing high background signal.95 
To overcome this limitation, we have developed a general approach to incorporate 
cooperative binding-functionality into split aptamers to achieve more sensitive detection 
of small molecules.95,96 The new aptamer construct termed cooperative binding split 
aptamer (CBSA) contains two tandem target-binding domains, where the initial target-
binding event stabilizes the structure of the split aptamer and facilitates subsequent 
target-binding at the second binding domain. Compared with split aptamers with a single 
target-binding domain, CBSAs exhibit higher target affinity and far more responsive 
target-induced aptamer assembly, enabling sensitive target detection. For example, we 
have developed a CBSA-based fluorescence assay that can detect cocaine with a LOD of 
50 nM in 10% saliva within 15 min, which could not be achieved with any conventional 
split-aptamer-based sensors.95  
2.3.1.3 Sensors based on strand displacement  
Both truncated aptamers and split aptamers require sequence engineering to disrupt the 
isolated aptamer, but strand-displacement strategies allow for the generation of structure-
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switching aptamers without sequence engineering (Figure 2-4D).97 This strategy employs 
a short competitive strand complementary to the aptamer. In the absence of the target, the 
competitive strand hybridizes with the aptamer and disrupts its folded structure. The 
aptamer undergoes a conformational change upon target binding, refolding into its 
original structure and thus dissociating with the competitive strand. This target-induced 
structure-switching event can be readily transduced into an optical97 or electrochemical22 
signal. For example, Li et al. attached a fluorophore to an ATP-binding aptamer and a 
quencher onto the competitive strand. In the absence of the target, the hybridization of 
aptamer and the competitive strand brings the fluorophore into proximity with the 
quencher, yielding low fluorescence. Upon addition of the target, the competitive strand 
is displaced, resulting in a high fluorescent signal.97 Since no sequence engineering is 
required in the strand-displacement approach, less knowledge is required about the 
aptamer structure. Moreover, library-immobilized SELEX methods have been developed 
that make it possible to isolate aptamers with inherent structure-switching 
functionality,32,98 which further simplify sensor development. Nevertheless, since 
competitive strands have high binding affinity for the aptamer, they inadvertently inhibit 
target binding and consequently reduce the sensitivity of strand-displacement assays. 
This is particularly problematic for the detection of small-molecule targets, which have 
relatively low target-binding affinity. As such, the LOD of strand-displacement assays for 
small molecules is usually comparable to or even higher than the KD of the aptamer being 
employed.32,33,97,99,100 Moreover, unlike truncated aptamer or split-aptamer-based assays, 
strand-displacement assays require a heating-and-cooling process lasting ≥ 30 min to 
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ensure complete hybridization between the complementary strand and aptamer to achieve 
low background. This greatly hinders the use of these assays for rapid on-site detection.  
2.3.2 Sensors that do not require target-induced conformational change  
Recently, several methods have been developed that can generate a readout of target 
binding without utilizing a structure-switching aptamer. These typically employ a fully-
folded aptamer in combination with a second probe such as a dye molecule, exonuclease, 
or even the target itself to report target-binding events. This eliminates the need for 
laborious sequence engineering but also yields high sensitivity due to the high target-
binding affinity of fully-folded aptamers. The need for specific signaling probes is the 
major drawback of these methods, which has limited their application to only a few 
targets. Nevertheless, several new strategies have been developed to improve the 
generality of these methods. 
2.3.2.1 Dye-displacement assays  
Dye-displacement assays34,74,101–104 rely on small-molecule dyes that can initially be 
associated with the aptamer-binding domain (Figure 2-4E). The target displaces the dye 
from the binding domain, resulting in a change in the absorbance or fluorescence of the 
dye. These assays do not require any additional labeling or chemical modification of the 
aptamer. Since the aptamers typically bind to these small-molecule targets and dyes with 
similar affinities, target-induced dye-displacement is more thermodynamically feasible 
than the displacement of a tightly-bound complementary strand in strand-displacement 
assays. As a result, dye-displacement assays can achieve a LOD which is 10-fold lower 
than the KD of the aptamer being used.34,74,101–104 However, this assay strategy has not 
been generalized, as there are currently no sequence engineering strategies or SELEX 
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techniques that can directly isolate aptamers with dye-displacement functionality. To 
remedy this problem, we recently developed a simple strategy for directly isolating 
signal-reporting aptamers that have intrinsic dye-displacement functionality from a TWJ 
structured DNA library.34 As a demonstration, we isolated an aptamer against a synthetic 
cathinone, 3,4-methylenedioxypyrovalerone (MDPV). The aptamer intrinsically binds the 
small-molecule dye Cy7 within its TWJ domain, while MDPV efficiently displaces the 
dye, resulting in a change in absorbance within seconds. The assay also showed high 
sensitivity, achieving a LOD of 300 nM in 50% urine or saliva.34 
2.3.2.2 Aptamer-modified field-effect transistors  
Receptor-modified field-effect transistors (FETs) have recently gained attention in the 
biosensing field.105 The conductivity of the semiconductor channel in FETs is extremely 
sensitive to changes in the local electric field. When the surface of a FET is modified 
with a specific bioreceptor such as an aptamer, binding of charged target molecules at the 
surface is sufficient to generate an electric signal.105 FET-based sensors can achieve ultra-
high sensitivity, partially because of the nonlinear behavior of the semiconductor 
channel. Since the charge on the targets is being employed for signal transduction, high-
affinity fully-folded aptamers can be directly employed in the sensor platform. Moreover, 
FET offers a broad dynamic range spanning several orders of magnitude, which cannot 
be achieved in most sensing platforms.106 For example, Weiss et al. demonstrated 
detection of positively-charged dopamine using an aptamer-modified FET with a LOD of 
10 pM and a dynamic range from 10 pM to 1 µM.107 Aptamer-modified FETs do have 
some significant limitations, however. First, small-molecule targets with no charge have 
minimal effect on the semiconductor, and thus cannot be effectively measured.108 Second, 
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semiconductor transconductance is only sensitive to variations in charge density within 
the electrical double layer, but the thickness of this layer dramatically decreases as 
solution ionic strength increases—dropping below 1 nm in physiological fluids, which 
makes target detection challenging in these conditions.109 Recent work has shown the 
possibility of remedying both limitations, based on the determination that small-molecule 
binding can introduce a ternary structure change in fully-folded aptamers modified onto 
the FET surface. This rearrangement of negatively-charged aptamer phosphodiester 
backbones near the semiconductor surface can then be detected by FET even if the 
binding event itself occurs outside the electrical double layer. Using this strategy, 
Andrews et al. demonstrated sensitive detection of both charged and non-charged small 
molecules in biological samples.110 The generalizability of this strategy for other small-
molecule-binding aptamers needs to be assessed in the future, however. This will not be 
easy due to the need for specialized equipment and techniques for fabrication of aptamer-
modified FETs, which are not accessible for most labs. 
2.3.2.3 Exonuclease-inhibition assay 
We have recently discovered that binding of small-molecules to aptamers can strongly 
affect their digestion by the exonucleases Exonuclease III (Exo III) and Exonuclease I 
(Exo I).88,111 Exo III and Exo I respectively digest double- and single-stranded DNA from 
the 3’ terminus. In the absence of target, aptamers can be completely digested by this 
nuclease mixture. However, upon binding of the target, digestion by both enzymes is 
strongly inhibited at a position 3-4 nucleotides prior to the target-binding domain, 
yielding a truncated aptamer. Such drastic differences in digestion profiles can be utilized 
to determine the presence of the target using a DNA-binding dye such as SYBR gold or a 
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fluorophore-quencher-modified molecular beacon. This exonuclease-based assay allows 
for the use of high-affinity fully-folded aptamers without any sequence engineering or 
modification, achieving much higher sensitivity compared with sensors based on 
structure-switching aptamers. We have demonstrated the generality of this method using 
different aptamers with both TWJ and stem-loop secondary structures, with low 
nanomolar detection limits in biological matrices.111 Since each aptamer has a unique 
sequence, multiplex detection can also be achieved in a single-pot reaction using specific 
molecular beacons (Figure 2-5).  
 
Figure 2-5. Working principle of exonuclease-inhibition assay for small molecule detection.111 
2.4. Gold nanoparticles (AuNPs) and their use in aptamer-based sensors  
AuNPs are gold particles with diameters ranging from 1–100 nm, and are widely used 
for biosensor development due to their distinctive optical properties. The color of an 
AuNP solution is determined by their localized surface plasmon resonance (LSPR) and 
can thus change according to their size, shape, and distance from each other. For 
example, 13-nm spherical citrate-capped AuNPs have strong absorbance at 520 nm and 
present a red color. Particles with smaller sizes have higher LSPR frequency, resulting in 
a blue-shift of their absorbance spectra that produces an orange-red color, whereas larger 
particles absorb at longer wavelengths and thus produce a purple color. When AuNPs 
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aggregate upon addition of salt, the absorbance peak shifts to 650 nm and the solution 
color changes to blue. The color changes that occur upon dissolution, enlargement, 
assembly, dissociation, or aggregation of AuNPs have been extensively utilized for signal 
transduction in different sensors for the instrument-free, naked-eye detection of various 
targets. In addition, nucleic acids can be easily modified onto AuNPs through gold-thiol 
chemistry. For these reasons, AuNPs have been widely used as a sensing element for 
colorimetric detection of targets including metal ions, small molecules, DNA, and 
proteins.112 
 
Figure 2-6. Synthesis AuNPs by citrate reduction. 
2.4.1 Synthesis and characterization of citrate-capped AuNPs 
Various techniques have been developed for the synthesis of AuNPs with different 
sizes and shapes.113–117 The most commonly used technique is the Turkevitch method, 
which uses citrate to reduce HAuCl4 into spherical AuNPs in aqueous solution (Figure 
2-6).113 HAuCl4 solution is mixed with trisodium citrate; Au3+ ions in the solution are first 
reduced to Au+ ions, and then to Au0 species through disproportionation. This Au0 
species is thermodynamically unstable and rapidly becomes a nucleation center for other 
newly-reduced Au0 species. These nucleation centers therefore slowly grow into well-
dispersed AuNPs. Excessive citrate anion acts as a capping reagent that adsorbs onto the 
surface of the AuNPs and renders them negatively-charged. These AuNPs therefore repel 
each other and are stable for a long period of time without aggregation. The size of the 
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AuNPs can be easily fine-tuned by adjusting the HAuCl4:citrate ratio, temperature, or 
solution pH.113  
After synthesis of AuNPs, the size, shape, concentration, and dispersity of the 
nanoparticles can be characterized by various methods (Figure 2-7). Given the color 
change associated with these particles (Figure 2-7A), one can easily determine their size 
and concentration based on UV-vis absorbance (Figure 2-7B). The surface plasmon peak 
wavelengths and extinction coefficients for different sizes of AuNP have been well 
studied,118 and UV-vis spectrometry offers a rapid, facile, and non-destructive way to 
characterize the size and concentration of synthesized AuNPs. The accuracy of this 
method is relatively low, however – especially for size determination. This is because the 
surface plasmon peak wavelength of AuNPs with sizes ranging from 1 to 100 nm only 
varies between 520 and 580 nm,118 and the local environment and different surface 
modifications have been known to further affect their UV-vis absorbance.119 UV-vis 
spectrometry is also inaccurate for poly-disperse AuNPs due to the overlapping surface 
plasmon peaks from particles of different sizes. Dynamic light scattering (DLS) is 
another analytical method routinely used to characterize the size and dispersity of AuNP 
solutions (Figure 2-7C).119 Nanoparticles in the solution scatter light upon illumination, 
and the intensity of scattered light rapidly fluctuates over time due to Brownian motion of 
the particles. Smaller particles have faster Brownian motion, which results in more rapid 
DLS fluctuation, thus allowing accurate measurement of particle size. DLS measurement 
also provides information about particle dispersity, which is important for assessing the 
quality of AuNPs.119  Notably, DLS measures the hydrodynamic size of particles, which 
includes the protectant (such as citrate) and surface modification (such as DNA) instead 
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of just the size of the gold core. This unique feature of DLS allows the study of 
bioconjugation processes on AuNPs.120 Finally, transmission electron microscopy (TEM) 
is a powerful tool for AuNP characterization (Figure 2-7D). Although it requires much 
more expensive instruments and more complicated sample preparation, the size of 
individual AuNPs can be accurately determined without the interference of solvent 
conditions or surface protectants/modifications. Moreover, TEM also gives direct 
information on particle shape that cannot be obtained using other methods.  
 
Figure 2-7. Methods for AuNP characterization. (A) color, (B) UV-vis spectrum, (C) DLS 
measurement, and (D) TEM picture of 13 nm AuNPs. 
2.4.2 DNA functionalized AuNPs 
DNA-modified AuNPs can specifically recognize a variety of targets, including 
nucleic acids, proteins, peptides, small molecules, and metal ions.112 Accordingly, such 
particles have proven extraordinarily useful for bioimaging, bioseparation, diagnostic 
assays, drug targeting, nanotherapeutics, and nanomaterial assembly.10,121,122 DNA can be 
conjugated onto AuNPs by several chemistries,123–126 where alkane-thiol adsorption is the 
most common approach (Figure 2-8).125,127 In this method, an excessive amount of 
thiolated DNA is mixed with AuNPs for several hours to allow gold-thiol interaction. The 
DNA surface coverage on AuNPs is controlled by the DNA:AuNP ratio employed for 
modification. Next, salt aging is performed, in which the salt concentration of the AuNP-
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DNA solution is gradually increased. Citrate-capped AuNPs without DNA attached are 
not stable at elevated ionic strength and aggregate from the solution, while conjugation of 
highly negatively charged-DNA allows modified AuNPs to tolerate even 1 M salt 
concentrations.128 Finally, the DNA-modified AuNPs are washed with buffer by 
ultrafiltration or ultracentrifugation to remove salt and unconjugated DNA. The resulted 
DNA-modified AuNPs can then be characterized using different methods and can be 
stored refrigerated for several months.  
The extent of DNA surface coverage can profoundly influence DNA hybridization 
efficiency, enzyme activity, and assay sensitivity employing DNA-modified AuNPs.129–
135 High surface coverage is associated with steric hindrance, electrostatic repulsive 
interactions, and elevated surface salt concentration, whereas low surface coverage can 
result in nonspecific binding of oligonucleotides to the particle surface. Both scenarios 
can greatly reduce DNA hybridization efficiency and enzyme activity for surface-bound 
DNA probes,136,137 resulting in low sensitivity of DNA-modified AuNP-based assays. 
Therefore, strategies for accurately quantifying the degree of surface coverage are critical 
for research applications based on DNA-conjugated particles. 
DNA surface coverage on AuNPs under different modification conditions is typically 
quantified using thiolated DNA with a fluorophore label. Fluorophore-labeled DNA is 
strongly quenched when bound to AuNPs, but this fluorescence is fully recovered once 
the DNA is detached from the surface. Therefore, the surface coverage of thiolated-DNA-
modified AuNPs can be determined by measuring the fluorescence of oligonucleotides 
liberated via ligand displacement with dithiothreitol (DTT), which can effectively bind 
AuNPs via two thiol groups.138,139 The standard DTT displacement protocol usually 
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requires overnight incubation of DNA-modified AuNPs with high concentrations (∼0.5 
M) of DTT at room temperature.128 Although time-consuming, the DTT displacement-
based assay is recognized as a reliable “gold standard” for quantifying surface coverage 
on AuNPs irrespective of DNA length or sequence. Recently, several label-free methods 
utilizing PCR, OliGreen, and unimolecular beacon have been developed to characterize 
DNA surface coverage.140–142  
 
Figure 2-8. Synthesis of DNA-modified AuNPs.121 
We have recently developed a simple and broadly applicable Exo III digestion assay 
based on the cleavage of phosphodiester bonds—a universal feature of DNA-modified 
particles—to accurately quantify DNA probe surface coverage on AuNPs and other 
commonly used particles of different compositions, conjugation chemistries, and sizes.143 
Our assay utilizes particle-conjugated, fluorophore-labeled probes that incorporate two 
abasic sites. These probes are hybridized to a cDNA strand, and quantitation is achieved 
via cleavage and digestion of surface-bound probe DNA via Exo III’s apurinic 
endonucleolytic and exonucleolytic activities. The presence of the two abasic sites in the 
probe greatly speeds up the enzymatic reaction without altering the packing density of the 
probes on the particles. Probe digestion releases a signal-generating fluorophore and 
liberates the intact cDNA strand to start a new cycle of hybridization and digestion until 
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all fluorophore tags have been released. After digestion, DNA surface coverage can be 
determined accurately based on the complete release of fluorophores. Our method 
delivers accurate, rapid, and reproducible quantitation of thiolated DNA on the surface of 
gold nanoparticles, and also performs equally well with other conjugation chemistries, 
substrates, and particle sizes, and thus offers a broadly useful assay for quantitation of 
DNA surface coverage. 
2.4.3 Aptamer-based assays employing AuNPs for small molecule detection  
Both unmodified and aptamer-modified AuNPs have been widely employed as 
colorimetric signal reporters in aptamer-based assays for naked-eye small-molecule 
detection.96,144–146 Unmodified citrate-capped AuNPs strongly adsorb single-stranded 
DNA through interaction with exposed nitrogenous bases, but have low binding affinity 
to double-stranded DNA.147 Meanwhile the binding of negatively-charged single-
stranded DNA to AuNPs significantly stabilizes AuNPs against salt-induced 
aggregation.148 Basing on this feature, Fan et al. developed a simple split-aptamer-based 
assay for rapid visual detection of cocaine (Figure 2-9A).145 A cocaine-binding split DNA 
aptamer was incubated with 13-nm citrate-coated AuNPs, followed by addition of the 
analyte and a salt solution. In the absence of target, both split aptamer fragments are in a 
single-stranded conformation and adsorb onto the AuNPs. The DNA-protected AuNPs 
are stable with the addition of salt solution, and thus the sample maintains the red color of 
the original AuNP mixture. In the presence of target, however, the split-aptamer 
fragments assemble, forming a duplexed complex that detaches from the particle surface. 
When a salt solution is added into the sample, the unprotected AuNPs rapidly aggregate 
and produce a clearly visible red-to-blue color change. Using this method, cocaine was 
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visually detected within 10 min at concentrations as low as 20 µM. Similar methods have 
been developed for the detection of other targets such as ATP145 and aminoglycosides36. 
Recently, the same method has also been successfully applied to a truncated structure-
switching aptamer for detection of cocaine.149 Unfortunately, these assays are not very 
specific, as unmodified AuNPs are not stable and can undergo non-specific aggregation 
under high salt or target concentration, even in the presence of single-stranded DNA.128  
 
Figure 2-9. Examples of aptamer-based colorimetric assays employing AuNPs for small 
molecule detection. (A) Assay based on unmodified AuNPs. (B) Assay based on DNA- modified 
AuNPs employing a “assembly-to-dissociation” strategy. (C) Assay based on CBSA- modified 
AuNPs employing a “dissociation-to-aggregation” strategy. 
On the other hand, DNA-modified AuNPs are stable in high-salt buffers because of 
repulsion by the negatively-charged DNA strands tethered to the particle surface.128 They 
can also undergo programmable dissociation or aggregation upon specific target-binding, 
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yielding a colorimetric readout for sensitive target detection. For example, Li et al. 
discovered that adenosine-binding aptamers conjugated onto 13-nm AuNPs with low 
surface density collapse onto the surface in the absence of the target, but fold into a rigid 
duplexed structure that lifts up from the surface upon target binding. Such a target-
induced conformational change alters the inter-particle steric hindrance and prevents 
AuNPs from aggregating under high ionic strength.150 Using this method, adenosine was 
detected at concentrations as low as 20 µM. It is also well known that two sets of AuNPs 
modified with different DNA probes can assemble into lattice-like nano- and micro-
structures in the presence of a cross-linking strand that is complementary to both surface-
modified probes, producing a blue color.125,151 This process is reversible at elevated 
temperatures when the linker strand dissociates from the surface-modified DNA, 
producing a blue-to-red color change. If the cross-linking strand is replaced with a 
structure-switching aptamer, AuNP assembly and dissociation can be mediated by target 
concentration (Figure 2-9B). Specifically, in the absence of target, the aptamer unfolds 
and links two sets of DNA-modified AuNPs together, forming blue aggregates. In the 
presence of target, the aptamer folds into a duplexed structure and dissociates from the 
surface-immobilized probes, resulting in dissociation of the aggregates and producing a 
blue-to-red color change. Using this “assembly-to-dissociation”  method, Lu et al. 
demonstrated aptamer-based visual detection of cocaine and adenosine.144  
Another commonly-employed strategy known as “dissociation-to-aggregation” utilizes 
an target-triggered enzymatic cleavage reaction to remove surface-bound DNA strands, 
which destabilizes the AuNPs and causes them to aggregate, producing a red-to-blue 
color change (Figure 2-9C).96,152–155 For example, we recently demonstrated the use of 
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CBSAs for sensitive colorimetric detection of cocaine based on the aggregation of 
AuNPs via enzyme-assisted target recycling (EATR).96,155 We coupled one the two 
CBSA fragments to AuNPs while the other remained free in solution. In the absence of 
target, the fragments remain separate, and the AuNP-conjugated fragment is resistant to 
digestion by Exo III. When the target is present, the CBSA fragments assemble, forming 
a substrate that can be cleaved by Exo III. This digestion shears all surface-bound DNA, 
resulting in aggregation of AuNPs and a red-to-blue color change. This method allowed 
for visual detection of cocaine at concentrations as low as 10 µM within 30 minutes.96  
2.5. EATR-based signal amplification   
In conventional bioassays, assay sensitivity is limited by the the target affinity of the 
bioreceptor, as the signal intensity is proportional to the number of receptor-bound target 
molecules.156 To overcome this limit, many amplification approaches have been 
developed that enable detection of targets at very low concentrations157,158. EATR159 
relies on selective, nuclease-mediated degradation of the probe strand of a target-probe 
duplex that only forms in the presence of target. This liberates the target, which is then 
‘recycled’ for use in further digestion reactions. In this scenario, each target molecule can 
generate multiple signals, achieving much higher sensitivity compared with assays 
without amplification. So far, many EATR-based assays have been developed for the 
detection of DNA as well as small molecules.96,159,160 
2.5.1 EATR assays for DNA detection 
EATR was first used with molecular beacon probes for DNA detection (Figure 
2-10).158 The molecular beacon probe contains a loop sequence complementary to the 
target DNA, with a fluorophore-quencher pair attached to the stem of the beacon as a 
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signal-reporting element. When the molecular beacon probe binds the target DNA, it 
switches from a stem-loop structure into a probe-target duplex that contains a specific 
sequence that can be recognized by a nicking enzyme. This enzyme then catalyzes 
cleavage of the beacon probe, liberating the fluorophore and releasing the target, which 
can then be recycled to hybridize with other molecular beacon probes. Thus, an 
amplifiedfluorescent signal can be generated by a single copy of the target though EATR, 
greatly decreasing the LOD. Using this EATR method, termed nicking enzyme signal 
amplification (NESA), Xie et al. demonstrated more than 100-fold signal amplification 
and achieved a LOD of 6.2 pM for a DNA target.158 Without the assistance of the 
enzyme, the assay remained insensitive to target concentrations as high as 2 nM. Given 
that DNA can be easily modified with various signaling reporters154,158,161,162 and 
different nucleases can be utilized to process target-probe duplexes,158,161,163,164 many 
EATR-based assays have been developed for DNA detection with ultra-high 
sensitivity.159 For example, Plaxco et al. improved the NESA assay by replacing the 
nicking enzyme with a structure-specific nuclease, Exo III. This method does not require 
a specific enzyme-recognition sequence in the target, and thus can be generalized for 
detection of virtually any sequence.164 More recently, we have successfully demonstrated 
EATR on the surface of AuNPs and achieved ultra-sensitive visual detection of DNA 
targets.154 The assay utilizes particle-conjugated DNA probes that incorporate two abasic 
sites. The single-stranded probe is inert to Exo III, rendering the AuNPs stable in solution 
and producing a red color. Target DNA can hybridize to the AuNP-conjugated probes 
forming a stable duplex, and these duplexes can then be rapidly digested by Exo III.  
Probe digestion releases the target strand to start new cycles of hybridization and 
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digestion until all surface-tethered probes are sheared. The AuNPs then aggregate, 
yielding a red-to-blue color change. This color change is easily observed by the naked 
eye within 15 min, and as little as 2 nM of target can be detected using this method. 
Importantly, even a single-base target mismatch adjacent to the abasic sites impairs Exo 
III activity on the probe, making this assay suitable for single nucleotide polymorphism 
detection.  
 
Figure 2-10. Working principle of an EATR assay for detection of DNA.158 
2.5.2 Aptamer-based EATR assays for small-molecular detection 
In principle, the target-induced assembly of split aptamers should be compatible with 
EATR-mediated signal amplification, since this process largely resembles hybridization 
between target and probe strands in DNA-based EATR assays. However, such an 
approach has been historically challenging due to the low target affinity and insensitive 
target-induced aptamer assembly of small-molecule-binding aptamers. We have recently 
overcome these limitations by incorporating highly target-responsive CBSAs into EATR-
amplified biosensors. Specifically, we have developed an EATR-amplified fluorescence 
assay for the detection of dehydroepiandrosterone sulfate (DIS) using a fluorophore-
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quencher-labeled CBSA and Exo III, and have demonstrated that this assay exhibits 100-
fold enhanced sensitivity relative to the CBSA alone without EATR signal amplification. 
Importantly, this assay also proved highly sensitive when used in urine samples, allowing 
us to detect DIS at concentrations as low as 1 μM in 50% urine within 30 minutes. 
Moreover, using CBSA fragment-modified AuNPs as signal reporters, naked-eye 
detection of low micromolar concentrations of cocaine was achieved within 20 minutes.  
2.6. Small molecule targets used in this work 
2.6.1 Cocaine 
Cocaine (Figure 2-11A) is a strong and highly addictive central nervous system 
stimulant extracted from the coca plant. Cocaine is currently a schedule II-controlled 
substance regulated by the Drug Enforcement Agency, and has been approved for limited 
medical uses. Recreational abuse of cocaine can have severe negative health 
consequences, such as nausea, hyperthermia, hypertension, cardiac arrest, and even 
death.165 Cocaine is the second most abused and third most frequently seized illicit drug 
in the United States.166 The National Survey on Drug Use and Health estimated that in 
2016, about 1.9 million people aged 12 or older were current users of cocaine.167 
2.6.2 DIS 
DIS (Figure 2-11B), also known as dehydroepiandrosterone sulfate (DHEA-S) sulfate 
is a conjugated metabolite of DHEA, which is the precursor of many other androgens and 
estrogens.168 DIS is one of the most abundant steroid hormones in both blood and urine. 
DIS itself has no hormonal activity; however, it can be converted into hormonally-active 
DHEA by steroid sulfatase. Upon secretion by adrenal cortex into the circulation, DIS is 
mostly bound to serum albumin, and thus has a long biological half-life of 14 hours.168 
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DIS is eventually excreted into the urine through the kidney. DIS concentration in blood 
and urine reflects adrenal gland function. Levels are low during childhood, rapidly 
increase during sexual maturation, and peak around the age of 20 to 30 years and 
gradually decrease afterward.169 Urinary concentration of DIS in healthy adults typically 
ranges from 1–20 μM 170,171 but can climb to the sub-millimolar range in patients with 
adrenal dysfunction and adrenal tumors.172 
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Figure 2-11. Chemical structure of small molecule targets. Structures of (A) cocaine, (B) DIS, 
and (C) core structure of synthetic cathinones are shown. R1-R4 represent substituent sites. 
2.6.3 Synthetic cathinones 
Synthetic cathinones (Figure 2-11C), known popularly as ‘bath salts’, are a family of 
novel psychoactive substances that share the same beta-keto phenethylamine chemical 
core structure. They are highly addictive central nervous system stimulants,173 and are 
associated with many negative health consequences, such as agitation, seizures, cardiac 
arrest, and even death.174,175 Synthetic cathinones are sold on the Internet and in head 
shops as “legal” alternatives to amphetamines and ecstasy.19 Evidence from poison 
control centers suggests that synthetic cathinones are primarily used by youths and young 
adults.176 So far, 14 synthetic cathinones have been scheduled as controlled substances by 
the Drug Enforcement Agency.177 However, in attempts to circumvent existing drug laws, 
drug designers continually add new substituents to existing synthetic cathinones, giving 
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rise to several hundred novel synthetic cathinone derivatives that are potentially even 
more potent and dangerous.19 Synthetic cathinones thus pose a major risk to public health 
and safety due to their severe and unpredictable toxicity, the difficulty of achieving 
effective surveillance, and their increasingly broad availability.  
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CHAPTER 3: A Cooperative-Binding Split Aptamer Assay for Rapid, Specific and 
Ultra-Sensitive Fluorescence Detection of Cocaine in Saliva 
3.1. Introduction 
Aptamers are single-stranded oligonucleotides isolated via in vitro SELEX,1,2 which 
can specifically bind to a wide range of targets including proteins, small molecules and 
metal ions.3 Aptamers offer several advantages as recognition elements for biosensors 
relative to antibodies. First, aptamers can be chemically synthesized with high 
reproducibility at relatively low cost.5 Second, the high chemical stability of DNA 
aptamers means that they can be used under harsher conditions and stored with a longer 
shelf life.5 Finally, it is possible to generate unstructured aptamers that form specific 
secondary structures such as three-way junctions33,78 or tertiary folds such as G-
quadruplex structures8,29 upon target binding. Such target-induced conformational 
changes can be readily exploited for specific target detection in a variety of applications, 
including medical diagnostics, environmental monitoring and drug screening.9–11 
However, target-induced conformational change is hard to control, especially for 
small-molecule-binding aptamers that have relatively high dissociation constants (~μM 
KD).40 For example, the well-characterized cocaine-binding aptamer MNS-4.1 (KD ~ 5 
μM) is structurally stable and forms a three-way junction even before binding cocaine.101 
To achieve an effective target-induced conformational change, the aptamer can be split 
into two21 or three90 fragments. This destabilizes the aptamer such that the fragments are 
unable to assemble without target, while the fragments retain their capacity for target 
recognition and can successfully reassemble into a complex secondary structure in the 
presence of target. Such target-induced assembly of the split aptamers can accordingly be 
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employed for signal transduction. However, aptamer splitting results in notably reduced 
target affinity.21 Thus, this approach still compromises the sensitivity of split aptamer-
based sensors, even with various amplification strategies applied.23,93 
To overcome the limitation of split aptamers, we have developed a cooperative 
binding-based approach to generate split aptamers that retain high target affinity. 
Cooperative binding behavior is commonly observed in ligand-binding proteins that are 
highly responsive to ligand concentration, such as hemoglobin,178 ion channels179 and 
transcription factors.180 Those proteins generally have more than one ligand-binding site, 
where binding at one site increases the affinity of the other sites, resulting in a ‘switch-
like’ binding curve.181 Breaker et al. initially found that some tandem riboswitches182,183 
naturally employ such cooperative binding182 to control gene expression in response to 
subtle changes in ligand concentration. This cooperative behavior was further extended 
into artificial biosystems such as ribozymes,184 molecular beacons185 and DNA 
aptamers186. Specifically, Plaxco et al. introduced the disorder into the parent aptamer to 
achieve cooperative binding, and focused on the demonstration of the “switch-like” 
response behavior of cooperative binding that occurred when ligand concentration 
approaches K1/2 (K1/2 represents the ligand concentration at which half of the binding 
domains are occupied). These engineered cooperative DNA aptamers could not employ 
for practical sensor platform because the introduction of cooperativity unavoidably 
reduced the target-binding affinity of the resulting cooperative aptamer (K1/2 = ~3 
mM).186  
We have for the first time successfully incorporated two tandem target-binding 
domains into a split aptamer (termed cooperative binding split aptamer, CBSA) to 
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achieve more sensitive detection of cocaine, even in complex biological samples. The 
initial cocaine-binding event stabilizes the structure of the split aptamer and facilitates 
subsequent target-binding at the second binding domain. Our CBSA exhibits higher 
target affinity and far more responsive target-induced aptamer assembly compared to the 
single-domain parent split aptamer (PSA) from which it was derived. Using a 
fluorophore/quencher pair, we have demonstrated that a CBSA-based fluorescence assay 
can achieve sensitive and reproducible cocaine detection in biofluid specimens, with a 
LOD of 50 nM in 10% saliva within 15 min. Given the simplicity of splitting and 
engineering a CBSA from an isolated aptamer and the excellent performance of the 
CBSA-based assay in biofluid samples, it should be straightforward to develop other 
CBSA-based assays from existing or future aptamers for rapid, sensitive and specific 
detection of various targets in clinical or field settings in a simple, low-cost assay format.  
3.2. Experimental section 
3.2.1 Materials 
2-amino-5,6,7-trimethyl-1,8-naphthyridine (ATMND) was purchased from Ryan 
Scientific and dissolved in dimethyl sulfoxide (DMSO) as a stock solution (50 μM). 
Cocaine hydrochloride was purchased from Sigma-Aldrich. Benzoylecgonine 
tetrahydrate, (-)-nicotine, anhydroecgonine methyl ester and cocaethylene were 
purchased from Cerilliant Corporation and prepared as 50 mM stock solutions in 
deionized water and stored at 4°C. Saliva samples were collected from eight healthy and 
drug-free volunteers (four males and four females) and centrifuged at 20,000 rcf for 15 
min, with supernatants stored at 4°C before use. The pooled saliva matrices were 
prepared by mixing 1 mL of saliva supernatant from each donor. All DNA molecules 
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were ordered from Integrated DNA Technologies and purified with HPLC and the 
sequences are listed in Table 3-1. DNA was dissolved in PCR grade water and DNA 
concentrations were measured with a NanoDrop 2000 (Thermo Scientific).  
Table 3-1. Sequence ID and DNA sequences used in Chapter 3. 
 
3.2.2 Characterization of split aptamer assembly using ATMND  
For each ATMND-binding assay, we mixed 10 μL of 10× binding buffer (100 mM 
Tris, 1 mM MgCl2, pH 7.4), 85 μL of deionized water, 1 μL of each split aptamer 
fragment (final concentration 1 μM), 1 μL ATMND solution (final concentration 200 
Sequence ID Sequence (5’ – 3’) 
L-PSA CTCCTTCAACGAAGTGGGTTCC 
S-PSA GG/iSpC3/ACAAGGAG 
L-LSA CTCCTTCAACGAAGTGGGTTCCTTGTCTC 
L-5325 CTCCTTCAACGAAGTGGGTTCCTTCAACGAAGTGGGTCTC 
S-5325 GAGACAAGG/iSpC3/ACAAGGAG3’ 
S-5325-Cy5 /5IAbRQ/ GAGACAAGG/iSpC3/ACAAGGAGT/3Cy5Sp/ 
L-CBSA-M1 CTCCTTCAACGAAGTGGGTTCCTTCGACGAAGTGGGTCTC 
L-CBSA-M2 CTCCTTCGACGAAGTGGGTTCCTTCAACGAAGTGGGTCTC 
L-5335 CTCCTTCAACGAAGTGGGTCTCCTTCAACGAAGTGGGTCTC 
S-5335 GAGACAAGG/iSpC3/GACAAGGAG 
S-5335-Cy5 /5IAbRQ/ GAGACAAGG/iSpC3/GACAAGGAGT/3Cy5Sp/ 
L-5335-GT CTCCTTCAATGAAGTGGGTCTCCTTCAACGAAGTGGGTCTC 
L-5435 CTCCTTCAACGAAGTGGGTCTTCCTTCAACGAAGTGGGTCTC 
S-5435 GAGACAAGGA/iSpC3/GACAAGGAG 
L-5445 CTCCTTCAACGAAGTGGGTTCTTCCTTCAACGAAGTGGGTCTC 
S-5445 GAGACAAGGA/iSpC3/GAACAAGGAG 
38-GC GGGAGACAAGGAAAATCCTTCAACGAAGTGGGTCTCCC 
38-GC-20A GGGAGACAAGGAAAATCCTACAACGAAGTGGGTCTCCC 
38-GC-20C GGGAGACAAGGAAAATCCTCCAACGAAGTGGGTCTCCC 
38-GC-21T GGGAGACAAGGAAAATCCTTTAACGAAGTGGGTCTCCC 
38-GC-22T GGGAGACAAGGAAAATCCTTCTACGAAGTGGGTCTCCC 
38-GC-22G GGGAGACAAGGAAAATCCTTCGACGAAGTGGGTCTCCC 
/5IAbRQ/ represents Iowa Black RQ               b.  /iSpC3/ represents internal C3 spacer  
c. S-5325 served as short fragment for CBSA-5325, LSA, CBSA-M1 and CBSA-M2  
d.  /3Cy5Sp/ represents Cy5                             e. Mutations are marked in red               
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nM) and 2 μL of cocaine at different concentrations into wells of a 96-well plate. 
Fluorescence intensity was measured using Tecan M1000Pro with excitation at 358 nm 
and emission at 405 nm at a 2-minute time interval until the fluorescence intensity was 
stable. Each sample was analyzed in triplicate, and the means and standard deviations 
were plotted. Quenching was calculated by (FA-F)/FA×100%, where FA is the 
fluorescence of 200 nM ATMND in 1× binding buffer alone and F is the fluorescence of 
the ATMND-CBSA mixture with or without cocaine. Error bars show standard 
deviations obtained from three measurements. 
3.2.3 Isothermal titration calorimetry (ITC) experiments 
 ITC experiments were performed with a MicroCal ITC200 (GE Healthcare). Cocaine 
and split aptamers were prepared with 1×binding buffer. The sample cell was initially 
loaded with 20 μM of CBSA-5335 or PSA. 4 mM of cocaine titrant was loaded into the 
syringe. Each experiment typically consisted of 39 successive 1 μL injections after a 0.4 
μL purge injection with spacing of 210 seconds to a final molar ratio of 43:1 
(cocaine:aptamer). Split-aptamer experiments were performed at 20 °C. The raw data 
were first corrected based on the heat of dilution of cocaine, and then analyzed with the 
MicroCal analysis kit integrated into Origin 7 software. The titration curve of PSA was 
fitted with a single-site binding model and the titration curve of CBSA-5335 was fitted 
with independent-sites and cooperative-sites models with two binding sites. 
3.2.4 Fluorophore/quencher-modified CBSA-5325, -5335, or -5335-GT for 
detection of cocaine 
 For each fluorophore/quencher-modified CBSA-based assay, we mixed 10 μL of 10× 
binding buffer, 83 μL of deionized water, 1 μL of the CBSA long fragment and 1 μL of 
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the fluorophore/quencher-modified CBSA short fragment (final concentration 1 μM 
each), and 5 μL of cocaine at different concentrations into wells of a 96-well plate. We 
measured the fluorescence intensity with a Tecan M1000Pro with excitation at 648 nm 
and emission at 668 nm at room temperature after 15 minutes of incubation. Each sample 
was analyzed in triplicate, and the means and standard deviations were plotted. The data 
were fitted with the Hill equation using Origin 9 software to calculate Hill coefficient 
(nH) and cocaine concentration producing half occupancy (K1/2). The signal gain was 
calculated by (F-F0)/F0×100%, where F0 is the fluorescence of the CBSA mixture without 
cocaine and F is the fluorescence of CBSA mixtures with different concentrations of 
cocaine. Error bars show standard deviation of signal gains from three individual 
measurements at each cocaine concentration. 
3.2.5 Assessing saliva matrix and dilution effects on the CBSA-5335-based 
fluorophore/quencher assay  
Cocaine was first spiked into the pooled saliva (FIU IRB: IRB-13-0320) to create 
artificial samples with concentrations ranging from 0.25 to 500 μM. Each sample was 
prepared by mixing 10 μL of 10× binding buffer, 1 μL of CBSA long fragment and 1 μL 
of fluorophore/quencher-modified CBSA short fragment (final concentration 1 μM each) 
into wells of a 96-well plate. 10 or 50 μL of sample for each cocaine concentration was 
added into the well to analyze the 10% or 50% saliva matrices and deionized water was 
added to bring each well’s volume to 100 μL. Fluorescence intensity with excitation at 
648 nm and emission from 655-850 nm was scanned with a Tecan M1000Pro at room 
temperature after 15 minutes of incubation. Each sample was analyzed in triplicate, and 
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the mean and standard deviation of the signal gain at different cocaine concentrations 
were plotted.  
3.2.6 Determining the sensitivity and dynamic range of CBSA-5335-based 
fluorophore/quencher assay in saliva  
For cocaine detection in 10% saliva, we combined 5 μL of cocaine in solutions of 
concentrations ranging from 0.001 to 10 μM with 10 μL of pooled saliva, 10 μL of 10× 
binding buffer, 1 μL of CBSA long fragment, 1 μL of fluorophore/quencher-modified 
CBSA short fragment (final concentration 1 μM each), and 73 μL of deionized water into 
wells of a 96-well plate. Fluorescence intensity with excitation at 648 nm and emission at 
668 nm was measured with Tecan M1000Pro at room temperature after 15 minutes of 
incubation. Each sample was analyzed in triplicate, and the mean and standard deviation 
of the signal gain at different cocaine concentrations were plotted. A control calibration 
curve in buffer was also generated with cocaine concentrations ranging from 0.001 to 10 
μM as described above. The signal gain was calculated by (F-F0)/F0×100%, where F0 is 
the fluorescence without cocaine and F is the fluorescence with different concentrations 
of cocaine. Error bars show standard deviations from three measurements. The 
measurable LOD was determined using the lowest non-zero calibrator concentration 
according to the Scientific Working Group for Forensic Toxicology Standard Practices 
for Method Validation in Forensic Toxicology.187 In all cases, the calibrators (cocaine 
standard concentration) were analyzed over three runs, and the lowest concentration 
achieving mean signal gain higher than 3.3 times the standard deviation was defined as 
the measurable LOD. 
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3.2.7  Determining the target specificity of CBSA-5335-based 
fluorophore/quencher assay in saliva  
The CBSA-5335 fluorophore/quencher assay was performed as described above with 
cocaine, cocaethylene, benzoylecgonine, anhydroecgonine methyl ester or nicotine at 
concentrations of 5 or 50 μM in 10% saliva. Each sample was analyzed in triplicate and 
the mean and standard deviation of the signal gain at different cocaine concentrations 
were plotted. The cross-reactivity of each analyte at each concentration was calculated as 
a percentage based on SigANA/SigCOC × 100%, where SigANA is the signal gain achieved 
by a given interferent and SigCOC is the signal gain achieved by cocaine at the same 
concentration.  
3.2.8 Determining the precision and bias of CBSA-5335-based 
fluorophore/quencher assay in saliva  
The CBSA-5335 fluorophore/quencher assay was performed as described above in 
10% diluted saliva matrices collected from eight different donors, 10% diluted pooled 
saliva matrices and binding buffer. We performed six measurements of samples 
containing final cocaine concentrations of 0, 1, 5 and 10 μM, and plotted the mean and 
standard deviation of the signal gain at different cocaine concentrations. The bias of each 
cocaine concentration was calculated as (Meansam - Meanpool)/ Meanpool × 100%, where 
Meansam is the mean signal gain obtained in 10% saliva matrices collected from different 
donors, and Meanpool is the mean signal gain obtained in the 10% pooled saliva matrix. 
The precision within samples or between runs at different cocaine concentrations was 
calculated by performing a one-way ANOVA test with the measurement number (6) as 
the grouping variable. Within-sample precision at each cocaine level was calculated 
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as , where MSwg is the within-group mean square obtained 
from the ANOVA table, and Meansam is the mean of signal gains obtained in 10% saliva 
matrices collected from different donors. Between-run precision at each cocaine level 
was calculated as , where MSbg is the between-
group mean square obtained from the ANOVA table, and n is the total number of 
measurements (n = 6).  
3.3. Results and discussion 
3.3.1 Design of the cocaine-binding CBSA  
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Figure 3-1. The design of our cocaine-binding CBSA. Two split aptamer pairs were derived from 
38-GC. Stem 1 of one split aptamer (A) was merged with stem 2 of the other split aptamer (B) to 
form an engineered CBSA (C) comprising a short fragment (SF) and a long fragment (LF). 
Cooperative target binding of split aptamers requires the incorporation of at least two 
binding domains into a single pair of fragments. We previously reported a cocaine-
binding aptamer (38-GC)102 that exhibits 2.5-fold higher cocaine affinity than the MNS-
4.1 aptamer from which it was derived. 38-GC contains a three-way junction with the 
target-binding domain located at its center, surrounded by three double-stranded stems 
(stems 1, 2 and 3) and two loops (GAA and AAA loops). We have determined that stem 
54 
 
3 is essential for cocaine binding, while both stem 1 and stem 2 contribute to the stability 
of the three-way junction structure that forms upon target binding.102 We derived two 
different pairs of split aptamer fragments from 38-GC (Figure 3-1, A and B), in which 
stem 3 remained intact but the 3’-end of stems 1 and 2 were truncated and the AAA loop 
of stem 2 was eliminated. We subsequently produced a construct from these two sets of 
split aptamers, in which stem 1 from one set was linked to stem 2 from the second set 
(Figure 3-1C). The resulting CBSA consists of a short fragment (SF) and a long 
fragment (LF).  
3.3.2 Characterizing cocaine-induced CBSA assembly  
We anticipated that the CBSA fragments would remain separated in the absence of 
target, but would form two tandem cocaine-binding domains when fully assembled with 
cocaine. To confirm effective target-induced CBSA assembly, we developed a binding 
assay based on the fluorescent molecule ATMND. It has been reported that ATMND can 
strongly bind to a thymine situated opposite a C3 spacer abasic site (AP site) within a 
DNA duplex (KD = 111 nM) via three-point hydrogen bonding.188 Although ATMND 
fluoresces brightly when free in solution, this fluorescence is greatly quenched when 
ATMND is bound to a DNA duplex in this fashion.189 We therefore replaced the 
adenosine (at position 10 from 5’) between the two binding domains of the short 
fragment with a C3 spacer to form an AP site with a thymine in the opposite position 
within the long fragment upon cocaine binding (Figure 3-2A). In the absence of cocaine, 
the long and short fragments remain separated, with strong fluorescence produced by the 
free ATMND molecules (Figure 3-2B, left). Upon addition of cocaine, the CBSA 
fragments undergo cooperative target-induced assembly and form a duplexed AP site that 
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binds ATMND and quenches its fluorescence (Figure 3-2B, right). The resulting CBSA-
5325/cocaine complex contains four base-paired segments (Figure 3-2A, right; segments 
labeled A–D) and a dinucleotide bulge formed within each three-way junction.86  
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Figure 3-2. ATMND as a fluorescence reporter of target-induced CBSA assembly. (A) We 
modified the core CBSA sequence (left) by replacing the adenosine (at position 10 from 5’) 
between the two binding domains of the short fragment with a C3 spacer abasic site (marked as 
X) to yield the final CBSA construct (middle). Upon binding cocaine, the CBSA undergoes 
target-induced assembly, forming a dinucleotide bulge within each three-way junction (right). 
The cocaine-CBSA-5325 complex features four complementary double-stranded regions (A–D) 
and a duplexed AP site. (B) In the absence of cocaine, LF and SF remain separated and the 
unbound ATMND in solution generates a strong fluorescent signal. Cocaine induces CBSA 
assembly, forming the duplexed AP site that binds ATMND and thereby quenches its 
fluorescence. (C) Time-course of ATMND quenching by cocaine-induced split aptamer 
assembly. (D) Sequence of the parent split aptamer (PSA) with incorporated AP site. 
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3.3.3 Importance of dual-binding domain of CBSA for target-induced assembly 
We subsequently confirmed the cocaine-induced assembly of CBSA experimentally. 
When we mixed 1 μM each of the long and short fragments with 200 nM ATMND in 1× 
binding buffer (10 mM Tris-HCl, 100 μM MgCl2, pH 7.4 ), we observed 10% 
background quenching (Figure 3-2C, before cocaine addition). This quenching is most 
likely attributable to low levels of non-specific quench and non-target assembly of the 
CBSA. Upon addition of 250 μM cocaine, 72% of the ATMND fluorescence was 
quenched within 15 min, indicating rapid target-induced CBSA assembly (Figure 3-2C, 
after cocaine addition). We also tested the performance of the AP-incorporating parent 
split aptamer (PSA) from which the CBSA was initially derived (Figure 3-2D, PSA), 
which features only a single cocaine-binding domain, in our ATMND-binding assay. In 
the absence of cocaine, the PSA quenched 6% of ATMND fluorescence (Figure 3-2C, 
before cocaine addition), and no measureable signal change was observed upon addition 
of 250 μM cocaine (Figure 3-2C, after cocaine addition). This indicates that no cocaine-
induced assembly is taking place, presumably because the shortening of stem 1 to four 
base-pairs with an abasic site in the middle results in poor thermodynamic stability of the 
cocaine-PSA complex at room temperature. We therefore conclude that the quenching 
observed most likely arises through nonspecific interactions between PSA and ATMND.  
Aptamer binding affinity78,190 and DNA hybridization efficiency191 are both strongly 
affected by magnesium concentration. We therefore used our ATMND-binding assay to 
optimize cocaine-induced CBSA assembly by varying the Mg2+ concentration from 0 to 
1000 μM, and observed that maximum cocaine-induced ATMND quenching occurred in 
the presence of 100 μM Mg2+ (Figure 3-3A). In the absence of cocaine, we observed 9% 
57 
 
quenching without Mg2+, which we attributed to nonspecific CBSA assembly (Figure 
3-3A, no cocaine). The presence of cocaine only generated an additional 7% quenching 
due to the absence of the Mg2+ counterion, resulting in strong repulsion between the 
CBSA fragments (Figure 3-3A, cocaine). At high concentration of Mg2+ (1000 μM), 
extensive CBSA assembly occurred in the absence of cocaine, producing 38% ATMND 
quenching, while also reducing the binding affinity of CBSA to cocaine, which only 
produced an additional 17% quenching upon addition of 250 μM cocaine (Figure 3-3A). 
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Figure 3-3. Optimization of Mg2+ and ATMND concentrations for our CBSA-based ATMND-
binding assay. (A) ATMND (200 nM) quenching by target-induced CBSA assembly upon 
addition of 250 μM cocaine in the presence of 0-1000 μM Mg2+ in 1× binding buffer. Quenching 
was calculated by (FA-F)/FA×100%, where FA is the fluorescence of 200 nM ATMND in 1× 
binding buffer alone and F is the fluorescence of the ATMND-CBSA mixture with 250 μM 
cocaine (red curve) or without cocaine (black curve), respectively. (B) Quenching analysis with 
ATMND concentrations ranging from 50-1000 nM in 1× binding buffer containing 100 μM Mg2+. 
Quenching was calculated by (F0-F)/F0×100%, where F0 and F are the fluorescence of the 
ATMND-CBSA in the absence and presence of cocaine, respectively. 
We also varied the ATMND concentration from 50 to 1000 nM, and found that 200 
nM ATMND produced low background and high target-induced signal change (Figure 
3-3B). Under these optimized conditions (200 nM ATMND and 100 μM Mg2+), we 
examined the extent of target-induced CBSA assembly at different cocaine 
concentrations. We found a strong correlation between ATMND quenching from CBSA 
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assembly and cocaine concentration in the range of 0 to 250 μM (Figure 3-4). We 
characterized the binding affinity of the assembled-CBSA for ATMND by titrating 
different concentrations (0-20 μM) of CBSA into 200 nM ATMND in the presence of 1 
mM cocaine (Figure 3-5). The calculated KD was 365 nM, which is consistent with the 
reported value for ATMND binding to AP sites.188 We subsequently demonstrated that 
the presence of two binding sites makes CBSA-5325 far more responsive to the presence 
of cocaine than split aptamers containing a single binding domain. We produced a long 
split aptamer (LSA) from CBSA, in which we replaced one of the binding domains with 
fully complementary sequences (Figure 3-6A, LSA). The LSA fragments quenched 75% 
of ATMND fluorescence in the absence of cocaine. Addition of 250 μM cocaine only 
induced an additional 10% signal change, indicating that most LSA fragments were 
stably pre-assembled even without target (Figure 3-6B). In contrast, CBSA-5325 
generated a large signal change (72%) upon addition of 250 μM cocaine because of its 
dual target binding domains, with far weaker background signal (9%) without cocaine. 
 
Figure 3-4. ATMND-reported calibration curve for CBSA-5325 at varying cocaine 
concentrations. Error bars show standard deviations from three measurements. Quenching was 
calculated by (F0-F)/F0×100%, where F0 and F are the fluorescence of the ATMND-CBSA in the 
absence and presence of cocaine, respectively.  
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Figure 3-5. ATMND binding affinity for cocaine-assembled CBSA-5325. ATMND (200 nM) 
fluorescence was quenched with increasing concentrations of CBSA-5325 in the presence of 1 
mM cocaine. Inset: Scatchard plot of the fluorescence data. The KD was determined based on the 
negative reciprocal of the slope.  
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Figure 3-6. Analyzing the dual binding domains of CBSA for target-induced assembly. (A) We 
generated multiple derivatives of CBSA-5325, including split aptamers with a single binding 
pocket (LSA) and a pair of point-mutants (CBSA-M1 and CBSA-M2) with sequence alterations 
that disrupt either of the two binding domains (pink circle). (B) ATMND quenching in the 
presence or absence of 250 μM cocaine. Quenching was calculated by (FA-F)/FA×100%, where 
FA is the fluorescence of 200 nM ATMND in 1× binding buffer alone and F is the fluorescence of 
the ATMND-CBSA mixture with 250 μM cocaine or without cocaine, respectively. 
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Figure 3-7. KD of 38-GC and different 38-GC mutants for cocaine as characterized by ITC. The 
sample cell was initially loaded with 20 μM of aptamers. 500 μM of cocaine titrant was loaded 
into the syringe. Each experiment typically consisted of 19 successive 2 μL injections after a 0.4 
μL purge injection with spacing of 150 seconds to a final molar ratio of 5.5:1 (cocaine:aptamer). 
The experiments were performed at 25 °C. The raw data were first corrected based on the heat of 
dilution of cocaine, and then analyzed with the MicroCal analysis kit integrated into Origin 7 
software with a single-site binding model. 
Specific target binding at both domains is required for target-CBSA assembly. We 
tested the binding affinity of 38-GC and several point-mutated derivatives using ITC 
(Figure 3-7). We found that replacing an adenosine at position 22 with guanine 
completely impaired cocaine binding (Figure 3-7, 38-GC-22G). Based on this finding, we 
created two CBSA mutants (CBSA-M1 and CBSA-M2) in which either of the two 
binding domains was disrupted by this single-nucleotide mutation, leaving only a single 
binding domain capable of binding cocaine (Figure 3-6A). CBSA-M1 and CBSA-M2 
were mutated at the 3’- and 5’-binding domain of the long fragment, respectively. We 
tested these mutants using the same ATMND-binding assay, and found that neither 
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CBSA-M1 nor CBSA-M2 was capable of cocaine-induced aptamer assembly, with no 
significant ATMND quenching observed upon addition of cocaine (Figure 3-6B). These 
results confirmed that both target-binding domains of the CBSA were required for target-
induced aptamer assembly, and thus provide strong support for a cooperative-binding-
based assembly mechanism.  
3.3.4 Confirmation of cooperative target binding of CBSA and fabricating an 
ultra-sensitive CBSA-based fluorophore/quencher assay  
We hypothesized that the binding affinity of the CBSA might be enhanced by further 
stabilizing the target/aptamer complex with additional base-pairs, based on prior findings 
that longer complementary stems surrounding the three-way junction increased the 
aptamer’s target-binding affinity.87 Thus, we increased the total number of base-pairs 
between the two binding domains of CBSA-5325 by adding an additional one, two or 
three base-pairs to generate CBSA-5335, -5435 and -5445 (Figure 3-8A) and examined 
the extent of target-induced CBSA assembly at different cocaine concentrations (0 - 50 
µM). Our results demonstrated that the number of additional base-pairs greatly affects 
both binding affinity and target-induced assembly. In the absence of cocaine, the 
quenching of ATMND fluorescence increased as the number of base-pairs between the 
two CBSA binding domains increased from 5- to 8-bp (Figure 3-8B). This is probably 
due to the increased thermo-stability of CBSA assembly, even without target. Upon 
addition of cocaine, we found a strong correlation between ATMND quenching from 
CBSA assembly and cocaine concentration in the range of 0 to 50 μM (Figure 3-8C). 
Compared to CBSA-5325, quenching saturation occurred at lower target concentrations 
for the other CBSAs, in keeping with the assumption that the CBSA binding affinity can 
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be enhanced with additional base-pairs. However, considerable background assembly 
was observed for CBSA-5435 and CBSA-5445 in the absence of cocaine, reducing their 
target-induced signal gain. We thus found that CBSA-5335 is most responsive and 
exhibited the most extensive target-induced CBSA assembly, and we therefore used this 
construct for subsequent sensor development.  
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Figure 3-8. Stem length effects on cocaine-induced CBSA assembly. (A) Sequences of CBSA-
5325, -5335, -5435 and -5445. (B) ATMND (200 nM) fluorescence upon addition of 1 µM 
CBSA-5325, -5335, -5435 or -5445 at various cocaine concentrations (0 - 50 µM). (C) ATMND-
reported calibration curve for these CBSA variants at varying cocaine concentrations. Quenching 
was calculated by (F0-F)/F0×100%, where F0 and F are the fluorescence of the ATMND-CBSA in 
the absence and presence of cocaine, respectively. 
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Figure 3-9. Effect of target-binding affinity (K1/2) on CBSA cooperativity. (A) The working 
principle of the CBSA-based fluorophore/quencher assay. (B) Calibration curves for the assay at 
cocaine concentrations ranging from 0 to 2500 μM (left). Right panel shows a linear response at 
0-10 μM. Reactions were performed with 1μM CBSA long fragment, 1 μM 
fluorophore/quencher-modified CBSA short fragment, and different concentrations of cocaine in 
10 mM Tris-HCl, 0.1 mM MgCl2 (pH 7.4) at room temperature.  
 
 
Figure 3-10. Spectra of CBSA-5335-based fluorescent detection of cocaine in 1× binding buffer. 
In the absence of cocaine, we observed negligible emission from 655 to 850 nm when excited at 
648 nm. The fluorescence peak at 668 nm increased with increasing cocaine concentration. 
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We then produced fluorophore/quencher-modified derivatives of CBSA-5325 and 
CBSA-5335 to achieve sensitive detection of cocaine. The short fragment was modified 
with an IowaBlack RQ quencher at its 5’ terminus and a Cy5 fluorophore at its 3’ 
terminus. In the absence of cocaine, the two CBSA fragments remain separate, and the 
flexibility of the unbound short fragment routinely brings the fluorophore into close 
proximity with the quencher, resulting in very low fluorescence (Figure 3-9A, left). In the 
presence of cocaine, the two fragments assemble to form a rigid target/aptamer structure 
that separates the fluorophore/quencher pair, producing increased fluorescence (Figure 
3-9A, right). We used these two fluorophore/quencher-modified CBSAs to generate 
calibration curves for cocaine concentrations ranging from 0-1000 μM (Figure 3-9B; 
spectra of CBSA-5335 shown in Figure 3-10) and used the Hill equation (Equation 3-1) 
to fit the binding curve to calculate K1/2 and Hill coefficient (nH):186,192  
                   (Equation 3-1) 
We determined a K1/2 of 106 μM with an nH of 1.1 for CBSA-5325 and a K1/2 of 36 
μM with an nH of 1.5 for CBSA-5335 (where K1/2 represents the cocaine concentration at 
which half of the binding domains are occupied and nH describes the order of binding 
cooperativity).192 An nH of 1.5 clearly indicates higher cooperativity between the two 
binding domains of CBSA-5335. We found that the measurable LOD was 500 nM (4.5 ± 
0.8%) and 50 nM (4.3 ± 0.9%) for CBSA-5325 and CBSA-5335, respectively (Figure 
3-9B). Clearly, the target-binding affinity of CBSA can be affected by the cooperativity 
of the two binding domains. Note that CBSA-5335 has the highest cocaine affinity of any 
split aptamer described to date, and the LOD of CBSA-5335 is more than 200-fold lower 
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than that of a previously-described single-domain, split aptamer-based cocaine assay 
using a similar sensing platform (LOD = 10 μM).21  
CBSA-5335A B PSA
 
Figure 3-11. Characterization of cocaine binding affinity of CBSA-5335 and PSA using ITC. 
Top panels present raw data showing the heat generated from each titration of cocaine for (A) 
CBSA-5335 (black broken line represented independent-sites model and red solid line 
represented cooperative-sites model) and (B) PSA. Bottom panels show the integrated heat of 
each titration after correcting for dilution heat of the titrant.  
We subsequently used ITC to characterize the binding mechanism and affinity of 
CBSA-5335 for its target at both sites. Recognizing that the KD of the aptamers was in 
the μM range, we set up a titration with a high cocaine:aptamer ratio to obtain accurate 
KD values for each binding scenario (the adjacent binding pocket empty, or occupied by 
cocaine), where KD represents the ligand concentration at which half of the receptor sites 
are occupied at equilibrium.193 The resulting two-phase titration curve confirmed the 
interaction of cocaine with the two binding domains of CBSA-5335 (Figure 3-11A). The 
binding stoichiometry between cocaine and CBSA was manually set as two, because 
previous studies have demonstrated that one cocaine-binding aptamer binds a single 
molecule of cocaine.102 ITC data of CBSA-5335 were then fitted with both independent-
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sites and cooperative-sites models194 with two binding sites (Figure 3-11A, black broken 
line represented independent-sites model and red solid line represented cooperative-sites 
model). We observed better fitting using the cooperative-sites model, and determined that 
the KD for the initial and secondary cocaine-binding events were 116 and 36 μM, 
respectively (Figure 3-11A). Based on these KDs, we calculated a K1/2 of 65 μM and a nH 
of 1.3 for CBSA-5335,195 which is comparable with the results obtained via the CBSA-
5335-based fluorophore/quencher assay (K1/2 = 36 μM and nH =1.5). Notably, the low 
K1/2 of CBSA-5335 represents a 56-fold higher target binding affinity relative to its 
single-domain PSA (KD = 2 mM, Figure 3-11B).  
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Figure 3-12. Effect of the intrinsic affinity of the PSA on CBSA target-binding affinity (K1/2). 
(A) We generated CBSA-5335-GT by replacing a G-C base-pair (highlighted) in the 5’ binding 
domain of CBSA-5335 with a G-T wobble pair. (B) Calibration curves for the assay at cocaine 
concentrations ranging from 0 to 1000 μM after a 15-minunte incubation (left), with a linear 
response at 0-10 μM (right). Experiments were performed with 1μM CBSA long fragment, 1 μM 
fluorophore/quencher-modified CBSA short fragment, and different concentrations of cocaine in 
10 mM Tris-HCl, 0.1 mM MgCl2 (pH 7.4) at room temperature. 
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We believed that the target-binding affinity of CBSA could be affected by the intrinsic 
binding affinity of its parent split aptamer. To address this point, we replaced a G-C pair 
in the 5’ binding domain of CBSA-5335 with a wobble G-T pair to form CBSA-5335-
GT. This alteration in stem 3 of the cocaine-binding aptamer reduces its binding affinity 
to cocaine102 (Figure 3-12A), but we expected the resulting CBSA to still retain its 
cooperativity. Indeed, our fluorescence results demonstrated that both CBSAs have 
identical cooperativity (nH = 1.5) (Figure 3-12B). However, since the intrinsic affinity of 
38-GC is 4-fold higher than the parent split aptamer variant used for CBSA-5335-GT, 
CBSA-5335 yields a lower K1/2 (33 µM) and better sensitivity (LOD = 50 nM in buffer) 
than CBSA-5335-GT (K1/2 = 125 µM and LOD = 500 nM in buffer) (Figure 3-12B). 
3.3.5 Validation of the CBSA-5335-based fluorophore/quencher assay for cocaine 
detection in saliva samples  
We subsequently confirmed that our CBSA-5335-based fluorophore/quencher assay is 
capable of equally sensitive cocaine detection in saliva samples. The excitation 
wavelength for Cy5 (648 nm) does not induce auto-fluorescence in the saliva matrix, and 
thus produces minimal background fluorescence (Figure 3-13). Additionally, the high 
quenching efficiency of the IowaBlack RQ quencher196 allowed robust detection of 
cocaine at very low concentrations. To ensure that our CBSA-5335-based 
fluorophore/quencher assay can be reliably used in real-world (i.e., clinical or field) 
settings, we evaluated the assay’s performance according to Scientific Working Group 
for Forensic Toxicology Standard Practices.187 To this end, we performed detailed 
experiments to investigate matrix effects, reaction time, limit of detection, interference 
effects and bias and precision in saliva samples.  
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Figure 3-13. Fluorescent detection of cocaine in saliva with our fluorophore/quencher modified 
CBSA-5335. 10% saliva (blue) exhibited no emission from 655 to 850 nm when excited at 648 
nm. CBSA-5335 alone (black) yielded only slight fluorescence background when excited at 648 
nm, but we observed a significant increase in fluorescence at 668 nm with the addition of 50 μM 
cocaine (red). 
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Figure 3-14. Successful detection of cocaine in saliva samples with fluorophore/quencher-
modified CBSA-5335. (A) Dilution effects on cocaine detection in saliva. Saliva samples spiked 
with cocaine were tested with CBSA-5335 at 50% or 10% dilutions. Calibration curves were 
constructed based on signal gain at each concentration of cocaine in the pre-dilution sampler. (B) 
Time course of CBSA-5335 in the presence of 1, 5 and 10 μM cocaine in 10% pooled samples.  
To test the matrix effects on assay performance, we mixed eight different saliva 
samples collected from healthy and drug-free donors of diverse gender and ethnic 
backgrounds as a pooled matrix. The pooled matrix was then spiked with different 
concentrations of cocaine (0 to 500 µM) and diluted with binding buffer 1:1 (50%) or 1:9 
(10%) before being applied to the CBSA-5335-based fluorophore/quencher assay. Our 
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results showed that the 10% dilution resulted in a higher signal gain with a broader 
dynamic range (0-100 µM in the initial saliva sample) compared to the 50% dilution (0-
25 µM in the initial sample) (Figure 3-14A). Additionally, the 10% dilution compensates 
for variations (such as salt concentration and pH) in individual saliva samples, and we 
therefore used 10% dilutions for subsequent experiments.  
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Figure 3-15. High sensitivity and specificity of our CBSA-5335-based fluorophore/quencher 
assay for cocaine detection in saliva. (A) Calibration curve for the assay in buffer and 10% saliva. 
(B) Signal gains from the CBSA assay in the presence of 50 μM (left) and 5 μM (right) cocaine 
(COC) or potential interferents including cocaethylene (EC), benzoylecgonine (BZE), 
anhydroecgonine methyl ester (MEG) and nicotine (NIC) in 10% saliva. Inset shows the 
interferent structures. Error bars show standard deviation of signal gain from three measurements 
at each concentration. 
 
Figure 3-16.Calibration curve of our CBSA-5335-based fluorophore/quencher assay in 1× 
binding buffer and 10% saliva at cocaine concentrations ranging from 0 to 10 μM. The signal 
gain was calculated by (F-F0)/F0×100%, where F0 is the fluorescence without cocaine and F is the 
fluorescence with different concentrations of cocaine. Error bars show standard deviation of 
signal gain from three measurements at each concentration.  
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We also monitored the time course of our CBSA-5335-based fluorophore/quencher 
assay in 10% pooled saliva matrix. We found that the fluorescence signal greatly 
increased with the increase of reaction time upon the addition of 1, 5 or 10 μM cocaine 
and 85% of the maximum signal was obtained after 15 minutes (Figure 3-14B). Clearly, 
the fast reaction time of our assay is suitable for on-site detection due to the rapid 
assembly of cocaine-CBSA complex in saliva samples.  
CBSA-5335-based fluorophore/quencher assay also demonstrates excellent 
performance on target detection in complex samples. Studies have shown that cocaine 
concentrations are generally higher in saliva than serum within the first few hours of 
administration,197,198 and the European Union’s Driving Under the Influence of Drugs, 
Alcohol and Medicines (DRUID) program identified 510 nM as the recommended cut-off 
sensitivity for road-side screening of cocaine in undiluted saliva.197 To determine the 
sensitivity of our assay, we generated a calibration curve in 10% saliva samples, 
obtaining a linear range from 0 to 10 µM and a measurable LOD of 50 nM (signal gain 
3.3±0.8%, Figure 3-15A and Figure 3-16). This suggests that, accounting for the ten-fold 
sample dilution, our assay can meet the recommendations established by DRUID for on-
site detection of cocaine, with a detectable LOD equivalent to 500 nM in undiluted saliva. 
In contrast, split aptamers containing a single binding domain have previously achieved 
LODs of 30 nM in 0.5% saliva,199 5 μM200 and 3.8 μM201 in 25% saliva. Two factors 
contribute to the high sensitivity of our CBSA assay. First, the low thermo-stability of the 
split aptamer greatly suppresses non-specific assembly of the CBSA fragments. Second, 
the cooperative binding from the two target-binding domains significantly increases the 
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CBSA’s affinity, resulting in a 56-fold reduction in KD (36 μM) relative to its single-
domain PSA (2 mM). 
We then investigated the specificity of the CBSA-5335-based fluorophore/quencher 
assay for cocaine versus structurally-similar and -dissimilar interferents in saliva. 
Benzoylecgonine (BZE), anhydroecgonine methyl ester (MEG), and cocaethylene (EC) 
are major structurally-similar metabolites of cocaine that are secreted into oral fluids.202 
We tested our CBSA-5335-based assay with high concentrations of these metabolites as 
well as nicotine (NIC), since tobacco is widely used among cocaine users. We found that 
our CBSA assay showed excellent cocaine specificity: our results demonstrated no 
measurable signal from 50 μM of BZE, MEG, or NIC and only 19% and 3% cross-
reactivity to 50 μM and 5 μM EC, respectively, in 10% saliva (Figure 3-15B). The results 
are consistent with previously reported assays21,93 based on single-domain cocaine-
binding split aptamers, demonstrating that CBSA retains excellent specificity for its 
target molecule in saliva. Finally, we tested the bias and precision of our CBSA assay by 
spiking cocaine at low, medium, and high concentrations into 10% saliva samples (final 
concentration of 1, 5 or 10 μM) from eight different individuals (Figure 3-17A). Using 
the pooled saliva as a standard, the average bias of signal gain obtained in these 
individual samples was 12.7%, -0.4% and -5.8% for 1, 5 and 10 μM cocaine, 
respectively. At 1, 5 and 10 μM, the coefficients of variation (CV) within samples were 
7.1%, 5.2% and 9.0%, respectively, and the CV between runs were 7.3%, 5.1% and 
8.5%, respectively (Figure 3-17B). Thus, the bias and CV were consistently below the 
acceptable cut-off (20%) for drug-screening methods,187 further demonstrating the 
immediate feasibility of our CBSA-based assay for on-site drug screening.  
72 
 
Cocaine     Signal gain (%)          Bias                         Precision
Conc.        Mean          Mean        Bias           CV (%)                CV (%) (µM)       (samples)    (pool)        (%)        within-sample    between-run
1                 20              18           12.7              7.1                        7.3
5               105             106          -0.4               5.2                        5.1
10             212              225         -5.8               9.0                        8.5
A
B
 
Figure 3-17. Bias and precision of the CBSA-5335-based fluorophore/quencher assay. (A) Signal 
gain obtained from various cocaine concentrations in buffer, 10% saliva collected from different 
donors (Sample I-VIII) and 10% pooled saliva. Signal gain was calculated by (F-F0)/F0×100%, 
where F0 is the fluorescence of the CBSA without cocaine and F is the fluorescence of the CBSA 
with cocaine. Error bars show standard deviations from six measurements. (B) Bias at each 
cocaine concentration was calculated from the mean signal gain obtained with samples I-VIII and 
the pooled sample. Within-sample and between-run precision at each cocaine concentration was 
calculated by one-way ANOVA. 
 
3.4. Conclusions 
We have demonstrated greatly improved split-aptamer-based sensing of cocaine in 
both buffer and saliva with a CBSA that incorporates two tandem target-binding domains 
into a single split aptamer. The CBSA fragments remain separate in the absence of target 
but specifically assemble upon addition of cocaine, and show high sensitivity to target 
concentration as a result of increased binding affinity caused by cooperative binding 
behavior. We achieved rapid, one-step detection of cocaine by simply mixing our CBSA 
components, which consist of a fluorophore/quencher-modified short fragment and an 
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unmodified long fragment, with a cocaine-containing sample at room temperature. A 
measurable LOD of 50 nM in buffer was achieved within 15 minutes without any signal 
amplification. The sensor’s performance was also very robust in saliva, achieving a LOD 
of 50 nM cocaine in 10% diluted saliva. Our assay also demonstrates very high target 
specificity, as evidenced by acceptably low cross-reactivity to common interferents, 
strong reproducibility, as well as a cost of $1.28 per test, confirming the potential value 
of our CBSA-based assay for on-site detection of cocaine. 
Our CBSA-based assay can be generalized in terms of both targets and sensor 
platforms. Stojanovic et al. recently isolated new aptamers for four different steroids via 
heterogeneous SELEX using partially randomized DNA libraries with a pre-designed, 
three-way-junction binding domain.33 We believe that such a selection strategy could 
similarly be applied for the isolation of aptamers for other drugs of abuse as well as 
clinically relevant targets such as small-molecule biomarkers, toxins and therapeutics. 
Based on Heemstra’s general approach to split three-way-junction structured aptamers92 
and the simplicity of engineering a CBSA from a split aptamer, it should be 
straightforward to develop other CBSA-based assays from the isolated aptamers for 
which the target-binding domain has been identified. Since many optical and 
electrochemical sensing strategies have been developed that employ target-induced split 
aptamer assembly,94,160,203–205 it should be feasible to integrate our CBSA into these 
platforms. We also foresee the potential to improve the performance of our CBSA-based 
assay by employing signal amplification techniques160,204–207 that could further enhance 
its sensitivity.  
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CHAPTER 4: Rapid and Sensitive Detection of Small-Molecule Targets Using 
Cooperative Binding Split Aptamers and Enzyme-Assisted Target Recycling 
4.1. Introduction 
The biosensor field is on a continuous quest for ever-greater sensitivity. In 
conventional bioassays, where the signal is directly proportional to the target 
concentration, the sensitivity is determined by the intrinsic target affinity of the 
bioreceptor being used for detection.156 In this scenario, it would be difficult to generate a 
measurable signal at target concentrations more than 100-fold lower than the KD of the 
bioreceptor. Accordingly, many amplification approaches have been developed in which 
one binding event can generate multiple signals,157,158 allowing detection of targets at 
very low concentrations. Enzyme-assisted target recycling (EATR) has proven to be an 
especially effective way to amplify signals generated from target-binding events.159 This 
approach relies on selective, nuclease-mediated degradation of the probe strand of a 
target-probe duplex that only forms in the presence of target; this liberates the target, 
which is ‘recycled’ for use in additional digestion reactions. For example, EATR has 
been used with molecular beacon probes for DNA detection.158 The molecular beacon 
probe contains a loop sequence complementary to the target DNA, with a fluorophore-
quencher pair attached to the stem of the beacon as a signal-reporting element. When the 
molecular beacon probe binds the target DNA, it switches from a stem-loop structure into 
a probe-target duplex that contains a structural164 or sequence158 recognition site for a 
nuclease. This enzyme then catalyzes the digestion or cleavage of the beacon probe, 
liberating the fluorophore and releasing the target, which can then hybridize with another 
molecular beacon probe. Thus, a substantial fluorescent signal can be generated by a 
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single copy of the target though EATR, greatly decreasing the limit of detection.158,164 
Given that DNA can be easily modified with various signaling reporters154,158,161,162 and 
that different nucleases can be utilized to process the target-probe duplex,158,161,163,164 
many EATR-based assays have been developed for DNA detection with ultra-high 
sensitivity.159  
Aptamers are nucleic acid-based bio-recognition elements that are isolated in vitro 
through SELEX processes.1 Aptamers can bind to a wide variety of targets, including 
proteins, metal ions, small molecules, and even whole cells,3 and aptamer-based 
biosensors have been developed for environmental monitoring, drug detection, and 
medical diagnostics.9–11 Aptamer-based sensors have many advantages compared to other 
state-of-the-art methods for the detection of small-molecule targets. Instrumental 
methods, such as gas or liquid chromatography/mass spectrometry, are sensitive and 
specific. However, these methods require laborious sample preparation and instruments 
that are cumbersome and sophisticated, limiting their use for on-site and high-throughput 
detection.12 Antibody-based immunoassays, such as ELISA, are highly sensitive and 
offer high target specificity. However, the in vivo processes for antibody generation are 
tedious, costly, and challenging for non-immunogenic small molecules.16 On the other 
hand, aptamers can be isolated rapidly with controllable affinity and specificity, and are 
produced without batch-to-batch variation.16 Many strategies have been employed into 
aptamer-based assays to achieve target detection in an instrument-free manner.208 In 
particular, aptamers can be split into two or three fragments that remain separate in the 
absence of target but assemble upon target binding,21,90 and such split-aptamer based 
sensors have gained popularity as a potential strategy for effective signal reporting.91 In 
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principle, the target-induced assembly of split aptamers should be compatible with 
EATR-mediated signal amplification. Ideally, the split fragments should be highly 
responsive to target-induced assembly and only the target-aptamer complex should be 
specifically recognized and digested by the enzyme. However, it is difficult to achieve 
sensitive target-induced aptamer assembly with conventional split aptamers with a single 
binding-domain. Small-molecule-binding split aptamers usually have equilibrium 
dissociation constants (KD) in the high micromolar range, such that no measurable target-
induced aptamer assembly can be observed even with a high concentration of targets.92,95 
Although target affinity can be improved by engineering split aptamers with longer 
complementary stems, the majority of thermo-stable split aptamers undergo some degree 
of pre-assembly in the absence of target,95 producing high background signal. Second, in 
contrast to DNA-based EATR assays, in which target-binding always converts a stem-
loop probe structure into a probe-target duplex, aptamer-target binding often gives rise to 
complex tertiary structures that are non-ideal substrates for nucleases. For example, 
three-way junctions and G-quadruplexes have been shown to inhibit exonuclease I,209 
flap endonuclease I,210 and polymerases.211 Additionally, target binding within the 
aptamer can interfere with enzyme binding and activity; for example, some small-
molecule DNA-intercalating agents and DNA adducts can inhibit nucleases, especially 
exonucleases.210,212,213 
To overcome these limitations, we have developed a strategy for generating CBSAs 
for use in EATR-amplified biosensors. CBSAs are engineered from parent split aptamers 
with a single target-binding domain, and consist of a short fragment and a long fragment 
that contain two target-binding domains. The first binding event partially stabilizes the 
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CBSA structure such that the second binding event can occur. This cooperative assembly 
can reduce the concentration change required to assemble the CBSA several-fold, 
resulting in far greater specificity and sensitivity relative to the parent split aptamer.95,186 
For example, our group has previously demonstrated the successful engineering of a 
highly target-responsive CBSA for cocaine, which enables specific, ultra-sensitive, one-
step fluorescence detection of cocaine within 15 minutes in 10% saliva.95 Here, we have 
developed a CBSA-based EATR-amplified fluorescence assay for the detection of 
dehydroisoandrosterone-3-sulfate (DIS) in urine samples. We modified our short 
fragment to incorporate a C3 spacer abasic site;214 when the CBSA assembles, the 
resulting duplex at the abasic site is recognized and cleaved  by exonuclease III (Exo III). 
This results in recycling of the long fragment and DIS molecules for further rounds of 
digestion, while releasing a fluorescent signal for each digestion event. We demonstrated 
that this assay exhibits 100-fold enhanced sensitivity relative to the CBSA alone without 
EATR signal amplification. Importantly, this assay also proved highly sensitive when 
used in urine samples, allowing us to detect DIS in 50% urine within 30 minutes at 
concentrations as low as 1 μM. To demonstrate the generality of our approach for the 
detection of other small-molecule targets, we also developed an assay that utilizes EATR-
mediated aggregation of CBSA fragment-modified gold nanoparticles (AuNPs) for 
colorimetric detection of cocaine. This assay was able to successfully achieve naked-eye 
detection of low micromolar concentrations of cocaine within 20 minutes. We believe 
that our approach should offer a general strategy for the development of other CBSA-
based, EATR-amplified assays for the rapid, sensitive, and specific detection of various 
small-molecule targets in complex samples in both clinical and field settings.  
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4.2. Experimental section 
4.2.1 Materials  
Table 4-1. The sequences of the oligonucleotide strands employed in Chapter 4. 
 
a. /iSpC3/ represents internal C3 spacer modification  
b. /5IAbRQ/ represents Iowa Black RQ quencher modification  
c. /iCy5/ represents Cy5 fluorophore modification 
 
All DNA strands used in this work were synthesized by Integrated DNA Technologies 
and purified with HPLC. DNA was dissolved in PCR grade water and DNA 
concentrations were measured with a NanoDrop 2000 (Thermo Scientific). The 
sequences of the oligonucleotide strands are listed in Table 4-1. 
Tris(hydroxymethyl)aminomethane (Tris), hydrochloric acid, sodium chloride, 
magnesium chloride, bovine serine albumin (BSA), 1,4-dithiothreitol (DTT), gold (III) 
chloride trihydrate, cocaine hydrochloride, and DIS were purchased from Sigma-Aldrich. 
Exo III was purchased from New England Biolabs. OliGreen and SYBR gold were 
Sequence ID Sequence (5’ – 3’) 
COC-LF 
CTCCTTCAACGAAGTGGGTCTCCTTCAACGAAGTGGGTCT 
CAAAAA  
COC-SF GAGACAAGG/iSpC3/GACAAGGAG  
COC-SF-5’A AAAAAGAGACAAGG/iSpC3/GACAAGGAG 
COC-SF-3’A  GAGACAAGG/iSpC3/GACAAGGAGAAAAA 
COC-SF-T  AAAAAGAGACAAGGTGACAAGGAG  
SH-COC-SF-1X HS-(CH2)6-TTTTTTGAGACAAGG/iSpC3/GACAAGGAG 
SH-COC-SF-2X 
HS-(CH2)6-/TTTTTTGAGACAAGG/iSpC3/GACAAGGAGTTTTT 
TGAGACAAGG/iSpC3/GACAAGGAG 
DIS-LF GTCCGCATACGAAGTTGTCTTCCGCATACGAAGTTGTCCAAAAA 
DIS-SF GGACGTGGA/iSpC3/GACGTGGACAAAAA 
FQ-DIS-SF /5IAbRQ/GGACGTGGA/iSpC3/GACG TGGAC/iCy5/AAAAA 
DIS-LF-536 GTCCGCATACGAAGTTGTCTTCCGCAAAAA 
FQ-DIS-SF-536 /5IAbRQ/GTGGA/iSpC3/GACGTGGAC/iCy5/AAAAA 
DIS-LF-36 GTCCGCATACGAAGTTGTCAAAAA 
FQ-DIS-SF-36 /5IAbRQ/GACGTGGAC/iCy5/AAAAA  
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purchased from Thermo Fisher Scientific. Urine samples used in this work were collected 
from healthy and consenting adult donors.  
4.2.2 Isothermal titration calorimetry (ITC)  
ITC experiment was performed with a MicroCal ITC200 (Malvern). 0.2 mM DIS was 
titrated into 10 µM DISS.1-AT, with both diluted in DIS binding buffer (10 mM Tris-
HCl, 0.5 mM MgCl2, pH 7.4). The experiment consisted of 19 successive 2 μL injections 
after a 0.4 μL purge injection with spacing of 180 seconds at 23 °C. The injection heat 
was analyzed with the MicroCal analysis kit integrated into Origin 7 software, and the 
titration curve was fitted with a single-site binding model. 
4.2.3 Determining binding affinity of DIS-CBSA-4536, DIS-SA-536 and DIS-SA-36  
The binding affinities of the split aptamers were determined fluorescently as reported 
previously95 with some modifications. 1 μL of 100 μM DIS long fragment (DIS-LF, DIS-
LF-536 or DIS-LF-36), 1 μL of 100 μM respective fluorophore/quencher-modified DIS 
short fragment (FQ-DIS-SF, FQ-DIS-SF-536 or FQ-DIS-SF-36), and 93 μL of DIS 
binding buffer were mixed with 5 μL of solution containing various concentrations of 
DIS. 80 μL of each sample was then transferred into wells of a 96-well plate. After a 30-
minute incubation at room temperature, the fluorescence was measured using a TECAN 
M1000 Pro (λex/em = 648/668 nm). Each sample was analyzed in triplicate, and the 
means and standard deviations were plotted. The data were fitted with the Hill equation 
using OriginLab 9 to calculate Hill coefficient (nH) and K1/2 (DIS concentration 
producing half occupancy) of each split aptamer. 
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4.2.4 Exo III digestion and gel electrophoresis analysis 
All digestion experiments were performed as followed unless specified otherwise. 1 
µL each of 50 µM short and long CBSA fragments were added into 43 µL of reaction 
buffer to yield a final DIS and cocaine concentrations of 250 µM and 500 µM, 
respectively. The buffer composition varied for each aptamer/target composition, with 
final concentrations for each reaction as follows:  DIS (10 mM Tris, 0.5 mM MgCl2, 0.1 
mg/mL BSA, pH 7.4) and cocaine (10 mM Tris, 0.1 mM MgCl2, 0.1 mg/mL BSA, pH 
7.4). After incubation at 23 °C for 30 minutes, 5 µL of 0.01 U/μL Exo III was added. 
After 5, 10, 15, 30 and 60 minutes of digestion, 5 µL of each sample was collected and 
immediately mixed with 10 µL of loading buffer (71.25% formamide, 10% glycerol, 
0.125% SDS, 25 mM EDTA, and 0.15% (w/v) xylene cyanol) to inactivate Exo III. 
Control samples were prepared similarly, but with 5 µL reaction buffer instead of Exo III. 
The digestion products were characterized via denaturing polyacrylamide gel 
electrophoresis (PAGE), with 3 µL of each sample loaded into each well. Separation was 
carried out at 20 V/cm for 3 hours in 0.5× TBE running buffer. The gel was stained with 
1× SYBR Gold for 25 minutes and imaged using a ChemiDoc MP imaging system (Bio-
Rad). The percent of digestion was calculated based on band intensity relative to the 
control sample. 
4.2.5 CBSA-based, EATR-amplified fluorescence assay for detection of DIS 
2 μL of 100 μM DIS-LF or DIS-LF-536, 1 μL of 100 μM FQ-DIS-SF or FQ-DIS-SF-
536, and 92 μL of DIS binding buffer (10 mM Tris-HCl, 0.5 mM MgCl2, pH 7.4) or 50% 
urine diluted with the binding buffer were mixed with 5 μL of solution containing various 
concentrations of DIS in the wells of a 96-well plate. The fluorescence of each sample 
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was first measured (λex/em = 648/668 nm) after a 30-minute incubation at room 
temperature. Then, 5 μL of 0.2 U/μL Exo III was added into each well to initiate EATR. 
After a 30-minute digestion at room temperature, the fluorescence of each sample was 
measured again. The signal gain was calculated by (F-F0)/F0 ×100%, where F0 is the 
fluorescence of the split aptamer mixtures without DIS and F is the fluorescence of split 
aptamer mixtures with different concentrations of DIS. Error bars were calculated from 
standard deviation of signal gains from three individual measurements at each DIS 
concentration. 
4.2.6 Synthesis of gold nanoparticles (AuNPs) modified with cocaine-binding 
CBSA short fragment 
The modification of the thiolated short fragment onto 13-nm AuNPs was performed 
using a previously published protocol,143 at a 300:1 molar ratio of thiolated short 
fragment:AuNP. The modified AuNPs were then treated with DTT to regulate surface 
coverage. Specifically, 50 μL of 5 nM modified AuNPs were mixed with 20 μL of 
solution containing different concentrations of DTT in 10 mM Tris-HCl (pH 7.4). After a 
30-minute incubation, the solution was centrifuged at 28,000× rcf for 10 minutes. The 
supernatant was discarded to remove the excess DTT and displaced DNA strands, and the 
precipitated AuNPs were resuspended in 10 mM Tris-HCl (pH 7.4). This step was 
repeated twice. Finally, the modified AuNPs were resuspended in 5 μL of the same buffer 
to obtain a particle concentration of 50 nM. 
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4.2.7 Quantitation of the surface coverage of CBSA short fragments on AuNPs via 
DTT displacement  
We measured surface coverage of the modified AuNPs using a standard DTT 
displacement assay.141 The AuNPs were diluted to a final volume of 55 µL in Tris buffer 
(10 mM Tris-HCl, pH 7.4). 50 µL of AuNP solution was loaded into a well of a 384-well 
plate and the absorbance was measured using a TECAN M1000 Pro. The concentration 
of AuNPs was calculated using Beer’s law (ε=2.7× 108 mol-1·cm-1). 50 µL of the 
modified AuNP solution was collected and mixed with 50 µL of 1.0 M DTT solution. 
After an overnight incubation at room temperature, the solution was centrifuged at 
25,000× rcf for 10 minutes to remove the AuNP precipitate. 20 µL of the supernatant was 
then mixed with 80 µL of 0.625× OliGreen solution to obtain a 0.5× Oligreen 
concentration. 100 µL of supernatant-Oligreen mixture was loaded into a well of a 384-
well microplate and fluorescence was measured using a TECAN M1000 Pro (λex/em = 
500/525 nm). DTT-displaced oligonucleotides were quantified using an established 
calibration curve derived from CBSA short fragments that had been subjected to the same 
DTT treatment.  
4.2.8 CBSA-based, colorimetric EATR assay for detection of cocaine 
2.5 μL of short-fragment-modified AuNPs (50 nM), 1 μL of 2.5 μM long fragment 
(COC-LF), 2 μL of a solution with different cocaine concentrations or different cutting 
agents with final concentration of 50 μM, and 15.5 μL reaction buffer (final 
concentrations: 10 mM Tris-HCl, 100 mM NaCl, 0.75 mM MgCl2, 0.1 mg/mL BSA, pH 
7.4) were mixed in wells of a 384-well plate. After 30 minutes, 4 μL of 1.25 U/μL Exo III 
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was added into each well. Absorbance spectra from 400–800 nm were recorded every 5 
minutes, with pictures taken by Nikon D800 after 20 minutes of Exo III digestion. 
4.3. Results and discussion  
4.3.1 Engineering of DIS-binding CBSA  
Stojanovic and colleagues recently isolated aptamers for various steroids, including 
DIS, using a library-immobilized SELEX approach.33 DIS is one of the most abundant 
steroid hormones in urine. The concentration of DIS in healthy adults typically ranges 
from 1–20 µM,170,171 but can climb to the sub-millimolar range in patients with adrenal 
tumors.172 The isolated DIS-binding aptamer (DISS.1-AT) demonstrated a KD of 0.44 μM 
(Figure 4-1), and we used DISS.1-AT as a starting point for our CBSA engineering 
strategy that we have described previously.95 First, we generated parent split aptamers by 
removing the poly(T)3 loop region from DISS.1-AT and reducing the number of base 
pairs in stem 1 (Figure 4-2A). We then fabricated a DIS-binding CBSA by fusing two 
sets of these parent split aptamers as shown in Figure 4-2B. The engineered CBSA 
consists of a short fragment and a long fragment. To facilitate EATR, we replaced the 
adenosine at position 9 from the 5’ end of the short fragment with a C3 spacer abasic site 
(labeled as X in Figure 4-2C). In the presence of DIS, these two fragments assemble to 
form DIS-CBSA-4536 complex (Figure 4-2D), where the C3 spacer abasic site is 
opposite a thymine within the long fragment. Exo III can cleave the short fragment at this 
duplexed abasic site using its apurinic endonuclease activity,214 releasing the intact long 
fragment and DIS molecules.   
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Figure 4-1. Characterization of DIS binding affinity of DISS.1-AT using ITC. Top panel presents 
raw data showing the heat generated from each titration of DIS for DISS.1-AT. Bottom panel 
shows the integrated heat of each titration after correcting for dilution heat of the titrant.  
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Figure 4-2. Design of DIS-binding CBSA. (A) The single-stranded DIS binding aptamer 
(DISS.1-AT) was truncated at Stem 1 and Stem 2 to generate the parent split aptamers. (B) Two 
sets of parent split aptamers were (C) merged and modified to incorporate (D) a C3 spacer abasic 
site (denoted by X) that resides opposite a thymine nucleotide when the CBSA duplex is 
assembled. A fluorophore (Cy5) and a quencher (Iowa Black RQ) were respectively modified at 
the 3’ and 5’ terminus of the short CBSA fragment. A poly(A)5 overhang was added on the 3’ 
termini of each CBSA fragment to prevent non-specific Exo III digestion.  
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4.3.2 Design of a CBSA-based EATR-amplified fluorescence assay 
To confirm binding cooperativity of DIS-CBSA-4536, we modified the short fragment 
with a Cy5 fluorophore and an Iowa Black RQ quencher at the 3’ and 5’ terminus, 
respectively (FQ-DIS-SF) (Figure 4-2D). In the absence of the target, both FQ-DIS-SF 
and the corresponding long fragment (DIS-LF) remain separate, and the fluorophore is 
quenched due to its close proximity with the quencher (Figure 4-3A). Upon the addition 
of DIS, the two fragments assemble to form a rigid CBSA-target complex, separating the 
fluorophore from the quencher and resulting in elevated fluorescence (Figure 4-3B). By 
titrating various DIS concentrations, we determined a Hill coefficient (nH)192 of 1.6 for 
DIS-CBSA-4536 (Figure 4-4A), indicating considerable positive cooperativity. This 
implies that a transition of CBSA assembly from 10% to 90% requires only a 16-fold 
increase in target concentration, compared to its parent split aptamers which require an 
81-fold increase.186 NUPACK analysis81 of the DIS-binding CBSA sequences 
demonstrated that both fragments are predominantly unassembled (99%) in the absence 
of target under our experimental conditions but DIS-SF exists primarily as a duplexed 
structure. Therefore, binding of the first target to DIS-CBSA-4536 should open up the 
DIS-SF duplex, facilitating binding of a second DIS molecule to the CBSA. This results 
in a high level of cooperativity. A K1/2192 of 491 μM was obtained, where K1/2 represents 
the DIS concentration at which half of the binding domains are occupied (Figure 4-4A).  
To demonstrate the highly sensitive target-induced assembly of the CBSA, we designed 
two sets of DIS-binding split aptamers with a single binding domain. Specifically, we 
extended Stem 1 of the DIS-binding parent split aptamer (termed DIS-SA-36) (Figure 
4-2B, right and Figure 4-4B) by one abasic site and five base pairs to form a split aptamer 
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with a longer stem (termed DIS-SA-536) (Figure 4-4C). The long fragments were 
unmodified while the short fragments were modified with a Cy5 fluorophore and an Iowa 
Black RQ quencher at the 3’ and 5’ terminus, respectively. We performed binding 
experiments with these two split aptamers along with the CBSA. DIS-CBSA-4536 
demonstrated no background assembly in the absence of the target, and progressive 
target-induced assembly with increasing concentrations of DIS. DIS-SA-536 also showed 
target-induced assembly with a moderately higher target affinity, but had high 
background assembly in the absence of DIS (Figure 4-4A). As expected, no cooperativity 
was observed (nH = 1.05) with this single-binding pocket split aptamer. The parent split 
aptamer, DIS-SA-36, was unable to assemble regardless of the presence or absence of 
target due to its thermal instability.  
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Figure 4-3. Working principle of our CBSA-based, EATR-amplified fluorescence assay. (A) FQ-
DIS-SF contains a fluorophore-quencher pair, and remains dark in the absence of target. (B) In 
the presence of target, the CBSA assembles, (C) creating a duplex that can be recognized and 
cleaved by Exo III at the abasic site (denoted by X). (D) The complex then disassembles, 
releasing the intact long fragment and target for additional rounds of complex formation and 
digestion. The fluorophore is also released and produces a signal, which (E) becomes amplified 
over the course of many rounds of EATR. 
87 
 
B
C
G
G
T
C
G
T
X
C
G
T
A
C
G
T
A
A
AA
T
T
G
CG
C
G
A
CG
T
GT
CG
GC
CG
TA
C
G
T
A
A
AA
T
T
G
CG
C
G
A
CG
T
GT
CG
GC
CG TA
3'
5'
3'
5'
A5
A5
Quencher
Cy5
DIS
X Abasic site
A C
DIS-SA-36 DIS-SA-536
A5 A5
 
Figure 4-4. Characterization of target-induced assembly of DIS-CBSA-4536, DIS-SA-36 and 
DIS-SA-536 using a fluorophore-quencher assay. (A) Binding curve of these three split aptamers 
with DIS ranging from 0 to 5000 μM. Binding affinity (K1/2) and cooperativity (nH) was 
characterized by fitting with the Hill Equation. The error bars represent the standard deviation of 
three measurements. Structures of (B) DIS-SA-36 and (C) DIS-SA-536 are given. 
The affinity of DIS-CBSA-4536 was too low for direct detection of DIS at 
physiological levels.170,171 Nevertheless, the highly target-responsive feature of the CBSA 
enables us to demonstrate its compatibility with EATR-mediated signal amplification. 
We selected Exo III for this reaction because of its potent apurinic endonuclease activity, 
along with the fact that this enzyme is inexpensive and highly active at room temperature 
in a sequence-insensitive manner.215,216 When the CBSA-DIS complex assembles in the 
presence of DIS, Exo III is able to recognize the duplexed structure and specifically 
cleaves it at the abasic site (Figure 4-3C). This cleavage results in disassembly of the 
CBSA-target complex, releasing the long fragment, DIS molecules, and the fluorophore, 
which now fluoresces due to its separation from the quencher. The released long 
fragment and target are then free to assemble with another FQ-DIS-SF (Figure 4-3D), 
starting the cycle anew. The end result is that a very small amount of target can be 
recycled for multiple rounds of assembly and cleavage, generating a substantially 
amplified fluorescence signal (Figure 4-3E).  
88 
 
 
Figure 4-5. Time-course of Exo III-mediated cleavage of DIS-CBSA-4536. (A) PAGE analysis 
of digestion products from DIS-CBSA-4536. Reactions consisted of 1 µM DIS-SF, 1 µM DIS-LF 
and 0.004 U/µL Exo III with or without 500 µM DIS after 5, 10, 15, 30, 60 and 120 minutes of 
digestion. Cleavage of short (B) and long (C) fragments was quantified by (Int0-Int)/Int0 × 100%, 
where Int is the band intensity after the addition of Exo III and Int0 is the band intensity before the 
addition of Exo III. 
4.3.3 Exo III efficiently mediates EATR of DIS-CBSA-4536 in solution 
 We then set out to demonstrate efficient Exo III digestion of abasic-site-modified 
DIS-SF. In order to prevent nonspecific digestion215 of the CBSA, we added a poly(A)5 
overhang at the 3’ terminus of both fragments. We then performed a time-course of 
digestion with Exo III using DIS-CBSA-4536 in the presence or absence of DIS. The 
digestion products were collected after 5, 10, 15, 30, 60 and 120 minutes and analyzed by 
polyacrylamide gel electrophoresis (PAGE) (Figure 4-5A). The concentration of retained 
short fragments was calculated relative to a control sample that was untreated with Exo 
III. We observed that Exo III cleavage of DIS-SF was rapid and specific, with 59% 
cleavage in the presence of 500 µM DIS after 30 minutes. In contrast, only 9% of DIS-SF 
was cleaved in the absence of the target (Figure 4-5B). After 120 minutes, DIS-SF was 
almost completely cleaved (95%) in the DIS sample, compared to only 15% cleavage in 
the absence of the target (Figure 4-5B). These results confirmed that the apurinic 
endonuclease activity of Exo III could specifically cleave the CBSA even when it is 
bound to the DIS target. Notably, we observed moderate non-specific digestion of DIS-
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LF by Exo III, resulting in partial removal of its poly(A)5 protection (Figure 4-5A).215 
The total concentration of DIS-LF and its products, calculated from the intensity of all 
bands larger than 39 nt, remained constant after a 120-minute digestion (Figure 4-5C). 
Since all digested products contained the intact recognition segments of the CBSA, we 
believe that EATR efficiency was not affected. We then demonstrated recycling of target 
and long fragment by performing an Exo III cleavage reaction with 1 μM DIS-LF and 4 
μM DIS-SF in the presence of DIS. PAGE analysis confirmed that Exo III achieved 
efficient and specific cleavage of the short fragment, with 99% of DIS-SF cleaved after 
240 minutes (Figure 4-6A). In contrast, only 11% of DIS-SF was cleaved in the absence 
of DIS (SI, Figure 4-6B). We observed that less than 15% of DIS-LF was digested 
regardless of the presence or absence of target (Figure 4-6C). Since the short fragment 
was almost completely cleaved despite being present at a concentration greatly exceeding 
that of the long fragment, it is clear that Exo III-mediated recycling of the long fragment 
and target was taking place.  
 
Figure 4-6. Digestion time-course of DIS-CBSA-4536 with excess DIS-SF. (A) PAGE analysis 
of digestion products from 4 μM DIS-SF and 1 μM DIS-LF in the presence of 0.1 U/μL Exo III 
with or without 500 μM DIS after 10, 30, 60, 120 and 240 min of digestion. Digestion of DIS-SF 
(B) and DIS-LF (C) was quantified by (Int0-Int)/Int0 × 100%, where Int is the band intensity after 
addition of Exo III and Int0 is the band intensity before addition of Exo III.  
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Figure 4-7. CBSA-based EATR-amplified fluorescence assay for sensitive detection of DIS. (A) 
Fluorescence time-course measurements after adding 0.01 U/µL of Exo III to our CBSA in the 
presence of different concentrations of DIS (0, 0.5, 1, 2, 5, 10, 20, 50, 100 and 200 µM). (B) 
Calibration curves before (black) and 30 minutes after (red) EATR signal amplification. The inset 
shows the calibration curve at low DIS concentrations. The signal gain was calculated from the 
fluorescence intensity of the samples. Error bars represent the standard deviation of three 
measurements. Limit of detection is determined using the lowest non-zero calibrator 
concentration.187  
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Figure 4-8. Demonstration of EATR-amplified signal in a fluorophore-quencher assay. Time 
course digestion of (A) DIS-SA-536 and (B) DIS-CBSA-4536 with 0, 0.5, 1, 2, 5, 10, 20, 50, 100, 
and 200 μM DIS. (C) Calibration curves of the fluorophore-quencher assay obtained with both 
split aptamers before and after 30 minutes of EATR amplification.  
4.3.4 Sensitive DIS Detection in biofluid samples using CBSA-based EATR-
amplified fluorescence assay  
Having demonstrated the feasibility of our CBSA-based EATR-amplified approach, 
we performed the fluorescence assay described in Figure 4-3 to detect DIS. As expected, 
when we incubated 1 µM FQ-DIS-SF with 2 µM DIS-LF and different concentrations of 
DIS for 30 minutes, we did not observe a significant DIS-induced fluorescence change 
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even with 100 µM DIS (Figure 4-7, A and B, 0 min), as target binding of the CBSA was 
too weak to efficiently assemble the CBSA-target complex. However, after adding 0.01 
U/µL of Exo III, we saw a steady and concentration-dependent increase in fluorescence 
(Figure 4-7A). The initial rate at which fluorescence increased was proportional to the 
DIS concentration, and we found that concentrations as low as 1 μM could be detected 
after 30 minutes of cleavage (Figure 4-7B, inset). It should be noted that the fluorescence 
of the samples without DIS also increased to some extent due to the nonspecific digestion 
of FQ-DIS-SF (Figure 4-7A, 0 μM). These results clearly demonstrated that the 
sensitivity of our CBSA binding assay was enhanced 100-fold by implementing EATR, 
producing a measurable limit of detection that is more than 500-fold lower than the K1/2 
of the CBSA. As a control experiment, we also performed our EATR-amplified 
fluorescence assay using DIS-SA-536. Although DIS-SA-536 underwent target-induced 
assembly and was efficiently cleaved by Exo III, we observed no target-induced signal 
amplification after a 30-minute digestion because of the high levels of DIS-independent 
background assembly (Figure 4-8, A and C). In contrast, DIS-CBSA-4536 exhibited clear 
target-induced signal amplification (Figure 4-8, B and C), with rapid assembly occurring 
at very low concentrations of target and minimal background assembly in the absence of 
target. Importantly, our assay performed equally well in urine samples. Different 
concentrations of DIS were spiked into 50% diluted urine and tested with our CBSA 
fluorescence assay. After a 30-minute enzyme digestion, we obtained a calibration curve 
with a linear range from 0 to 100 μM (Figure 4-9A), which covers the urinary DIS 
concentration range in normal adults (1-50 μM). In addition, we found that 
concentrations as low as 1 µM DIS spiked in 50% urine could be distinguished from the 
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background signal (Figure 4-9B). Our results clearly demonstrated the robustness and 
sensitivity of our CBSA-based EATR fluorescence assay even in complex samples. 
A B
 
Figure 4-9. CBSA-based EATR-amplified fluorescence assay for sensitive detection of DIS in 
50% urine. (A) Calibration curve after a 30-min enzyme digestion with a linear range between 0 
and 100 μM DIS (inset).  (B) Calibration curve at lower DIS concentrations. The signal gain was 
calculated from the fluorescence intensity of the samples. Error bars represent the standard 
deviation of three measurements.  
4.3.5 Design of the CBSA-based colorimetric assay employing EATR-mediated 
AuNP aggregation 
Due to the highly responsive target-induced assembly feature of CBSAs, we believe 
that a similar EATR-amplified strategy can be readily adopted into different sensing 
platforms using other small-molecule-binding CBSAs. For example, the EATR-amplified 
assay described above is instrument-dependent, making it unsuitable for instrument-free 
applications. However, the same strategy can be also used to achieve rapid colorimetric 
detection of small-molecule targets in an instrument-free fashion. As a demonstration, we 
used the cocaine-binding CBSA previously developed by our group, COC-CBSA-5335, 
which has an nH of 1.5 and a K1/2 of 36 μM,95  to develop an assay with a visual readout 
that is potentially suitable for field use. Specifically, we immobilized the short fragment 
of this CBSA (COC-SF) onto AuNPs, and then added the free long fragment (COC-LF) 
in solution (Figure 4-10A). In the presence of cocaine, the fragments assemble to form 
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CBSA-cocaine complexes on the particle surface (Figure 4-10B). Exo III specifically 
recognizes the duplexed C3 spacer abasic site between the two binding domains and 
cleaves the AuNP-conjugated short fragment (Figure 4-10C), releasing the intact long 
fragment and cocaine for another round of target assembly and Exo III cleavage (Figure 
4-10D). Once all of the short fragments have been cleaved from the particle surface 
(Figure 4-10E), the AuNPs lose their stability under the employed buffer conditions and 
rapidly aggregate, producing a visible red-to-blue color change (Figure 4-10F). The 
CBSA fragments cannot assemble in the absence of cocaine, precluding Exo III 
digestion, and the intact short fragments prevent AuNP aggregation such that the solution 
remains red.  
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Figure 4-10. A colorimetric CBSA-based EATR-amplified assay for naked-eye detection of 
cocaine. (A) AuNPs are coupled to the short fragment (COC-SF), creating steric repulsion 
between AuNPs that produces a visible red color. Upon addition of long fragment (COC-LF) and 
cocaine, (B) the CBSA assembles, and the resulting duplexed abasic site can then (C) be digested 
by Exo III. (D) This cleaves off COC-SF while recycling COC-LF and cocaine for another round 
of assembly and digestion, until (E) all short fragments have been sheared from the AuNP. (F) 
These sheared AuNPs can now aggregate, producing a visible red-to-blue color change.  
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Figure 4-11. Cocaine-binding CBSA with a poly(A)5-protected long fragment and different 
derivatives of the short fragment. Arrows indicate suitable digestion sites for Exo III.  
4.3.6 EATR of CBSA mediated by AP endonuclease of Exo III instead of its 3’-5’ 
exonuclease activity  
We first investigated the contribution of Exo III’s 3’-5’ exonuclease activity to the 
digestion of CBSA-cocaine complexes relative to its endonucleolytic activity by 
engineering three derivatives of COC-SF. The first derivative (COC-SF-5’A) included a 
poly(A)5 extension at the 5’ end that allows digestion of both the abasic site and the 3’ 
terminus (Figure 4-11A). For the second derivative, the poly(A)5 protection was added at 
the 3’ instead of 5’ end (COC-SF-3’A), allowing cleavage only at the abasic site (Figure 
4-11B). For the third derivative (COC-SF-T), we replaced the abasic site with a thymine, 
allowing digestion only from the 3’ terminus (Figure 4-11C). We also added a poly(A)5 
extension at the 5’ end of COC-SF-T to match the length of COC-SF-3’A. We performed 
Exo III digestion of a mixture of COC-LF with a 3’ poly(A)5 modification combined with 
each of the three different short fragment derivatives in the presence or absence of 250 
µM cocaine, and characterized the digestion products using PAGE. For the COC-SF-5’A, 
we observed that 61% and 5% of the short fragment was cleaved with and without 250 
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μM cocaine, respectively, after a five-minute enzyme reaction (Figure 4-12). After 60 
minutes, the amount of cleaved COC-SF-5’A increased to 97% and 21%, respectively. 
We obtained a similar digestion profile for COC-SF-3’A, where Exo III cleavage occurs 
only at the abasic site. 61% and 8% of the COC-SF-3’A were respectively cleaved with 
and without addition of cocaine after five minutes of digestion, which increased to 95% 
and 17%, respectively, after 60 minutes (Figure 4-13). These results demonstrated that 
the apurinic endonuclease activity of Exo III is efficient enough to mediate the digestion 
of CBSA-cocaine complexes. Our control experiment with COC-SF-T demonstrated that 
Exo III was able to remove only one nucleotide from the short fragment. Only 5% of the 
COC-SF-T was digested both with and without cocaine after a five-minute Exo III 
reaction, and only 15% of the COC-SF-T was digested in the presence of cocaine versus 
20% without cocaine after 60 minutes (Figure 4-14). It is clear that the CBSA-cocaine 
complex inhibits the 3’-to-5’ exonuclease activity of Exo III. Thus, we concluded that the 
abasic site is sufficient to enable robust EATR signal amplification, and poly(A)5 
protection at the 3’ end of the short fragment is unnecessary. 
 
Figure 4-12. Time-course of CBSA digestion with COC-SF-5’A. (A) PAGE analysis of digestion 
products of CBSA consisting of 1 μM COC-SF-5’A and 1 μM poly(A)5 protected COC-LF after 
treatment with 0.01 U/μL Exo III in the presence or absence of 250 μM cocaine for 5, 10, 15, 30 
or 60 min of digestion. Digestion of (B) COC-SF-5’A and (C) COC-LF-5’A was quantified by 
(Int0-Int)/Int0 × 100%, where Int is the band intensity after addition of Exo III and Int0 is the band 
intensity before addition of Exo III.  
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Figure 4-13. Time-course of CBSA digestion with COC-SF-3’A. (A) PAGE analysis of digestion 
products of CBSA consisting of 1 μM COC-SF-3’A and 1 μM poly(A)5 protected COC-LF after 
treatment with 0.01 U/μL Exo III in the presence or absence of 250 μM cocaine for 5, 10, 15, 30 
or 60 min of digestion. Digestion of (B) COC-SF-3’A and (C) COC-LF-5’A was quantified by 
(Int0-Int)/Int0 × 100%, where Int is the band intensity after addition of Exo III and Int0 is the band 
intensity before addition of Exo III.  
 
Figure 4-14. Time-course of CBSA digestion with COC-SF-T. (A) PAGE analysis of digestion 
products of CBSA consisting of 1 μM COC-SF-T and 1 μM poly(A)5 protected COC-LF after 
treatment with 0.01 U/μL Exo III in the presence or absence of 250 μM cocaine for 5, 10, 15, 30 
or 60 min of digestion. Digestion of (B) COC-SF-T and (C) COC-LF-5’A was quantified by 
(Int0-Int)/Int0 × 100%, where Int is the band intensity after addition of Exo III and Int0 is the band 
intensity before addition of Exo III.  
 
Figure 4-15. Time-course of Exo III digestion of cocaine-binding CBSA. (A) Digestion of a 
mixture of 1 μM COC-LF and 8 μM COC-SF by 0.1 U/μL Exo III in the presence or absence of 
250 μM cocaine after 5, 10, 15, 30, or 60 minutes of digestion. (B) Digestion was quantified by 
(Int0-Int)/Int0 × 100%, where Int is the band intensity after addition of Exo III and Int0 is the band 
intensity before addition of Exo III.   
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We then demonstrated that we could perform EATR with our cocaine-binding CBSA 
in solution. We performed a time-course of Exo III digestion using poly(A)5 protected 
COC-LF and unprotected COC-SF, with a 1:8 ratio of COC-LF:COC-SF, either with or 
without 250 μM cocaine. PAGE analysis of the digestion products showed rapid and 
specific Exo III digestion, with more than 60% of the short fragment cleaved in the 
presence of cocaine after only 10 minutes (Figure 4-15). In contrast, less than 5% of the 
short fragment was cleaved in the absence of cocaine. After a 30-minute reaction, COC-
SF was almost completely digested (92%) in the presence of cocaine, while only 14% 
was digested in the absence of cocaine, demonstrating the specificity of EATR 
amplification in solution.  
4.3.7 DNA surface coverage and the length of COC-SF affect EATR-mediated 
AuNP aggregation  
We employed our CBSA-based EATR-amplified assay to achieve naked-eye detection 
of cocaine. We conjugated a thiolated version of COC-SF (Table 4-1, SH-COC-SF-1X) 
onto AuNPs as described previously.143 Since DNA surface coverage has a critical 
influence on EATR-mediated AuNP aggregation, we developed a simple strategy for 
generating AuNPs displaying different quantities of short fragment. We did this by 
incubating short fragment-saturated AuNPs with various micromolar concentrations of 
DTT to displace different quantities of immobilized short fragment from the particle 
surface. We then measured the surface coverage resulting from treatment with various 
DTT concentrations by mixing each of these batches of AuNPs with an equal volume of 
1.0 M DTT128 and incubating overnight to remove all remaining DNA strands from the 
particle surface. We subsequently quantified these by centrifuging the samples and 
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measured the DNA concentration in the collected supernatant with OliGreen, a DNA 
binding dye.141 A calibration curve (Figure 4-16A) determined that treatment with DTT 
concentrations of 0, 100, 200, 300, and 400 µM produced AuNPs that respectively 
displayed 102±1, 41±1, 34±1, 25±1, and 22±1strands/particle (Figure 4-16B). This 
demonstrates that DTT treatment can effectively regulate DNA surface coverage on 
AuNPs in a concentration-dependent manner. AuNPs treated with 500 μM DTT yielded a 
surface coverage of 20±1strands/particle; the resulting particles were unstable, and 
spontaneously aggregated in the reaction buffer (data not shown). Thus, these AuNPs 
were omitted from following experiments.  
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Figure 4-16. Characterizing surface coverage of SH-COC-SF-1X-modified AuNPs treated with 
different concentrations of DTT. (A) A standard calibration curve established with known 
concentrations of SH-COC-SF-1X was used to calculate the DNA surface coverage of the DTT-
treated AuNPs. (B) Surface coverage decreased with increasing amounts of DTT employed 
during the treatment procedure. Error bars show standard deviations obtained from three 
measurements.  
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Figure 4-17. Effect of SH-COC-SF-1X surface coverage. Time-dependence of Exo III digestion 
of AuNPs displaying SH-COC-SF-1X at (A) 102±1, (B) 41±1, (C) 34±1, (D) 25±1, or (E) 22±1 
strands/particle in the absence or presence of 250 μM cocaine are shown. The detection window, 
during which the drug-containing sample is blue while the drug-free sample remains red, is 
marked as a vertical line. (F) Summary of detection time and detection window obtained using 
AuNPs with different surface coverages. 25 strands/particle was identified as the optimal surface 
coverage.  
We then assessed how differing levels of surface coverage affect CBSA-cocaine 
assembly, exonuclease cleavage, and AuNP aggregation. Since the CBSA will be 
assembled on the particle, Exo III will have minimal accessibility to the 3’ end of the 
long fragment. We incubated our various batches of 5 nM SH-COC-SF-1X-modified 
AuNPs with 100 nM unprotected COC-LF in the presence or absence of 250 µM cocaine 
for 30 minutes, and then added 0.2 U/µL Exo III. We tracked the signal response by 
performing time-dependent measurements of UV-vis absorbance. Well-dispersed AuNPs 
have an absorbance peak at 520 nm; as AuNPs start to aggregate, this peak decreases and 
a new peak appears at 650 nm.217 Therefore, we used the ratio of A650/A520 to evaluate 
EATR-mediated AuNP aggregation. When the value of A650/A520 is below 0.4, the 
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AuNPs are well separated and the solution appears red. When the value of A650/A520 is 
0.6, the AuNPs begin to aggregate and the solution appears purple. A value of A650/A520 ≥ 
0.8 indicates complete aggregation, and the solution appears dark blue. We found that 
SH-COC-SF-1X-modified AuNPs with relatively low surface coverage (25 
strands/particle) demonstrated much faster aggregation than AuNPs with high surface 
coverage (102 strands/particle) (Figure 4-17). We observed no aggregation for these 102 
strands/particle AuNPs, even 70 minutes after the addition of Exo III (Figure 4-17A). 
Likewise, we did not observe a visible color change at a surface density of 41 
strands/particle (Figure 4-17B). However, further reductions in surface coverage 
produced a clear increase in the rate of AuNP aggregation, and AuNPs with surface 
coverages of 34, 25 and 22 strands/particle produced a dark blue color (A650/A520 ≥ 0.8) 
within 72, 52, and 38 minutes of Exo III digestion, respectively. This indicates both 
specific CBSA-cocaine assembly and successful EATR amplification. In the meantime, 
the AuNPs remained well-dispersed at all levels of surface coverage and all target-free 
samples remained red (A650/A520 = 0.4) (Figure 4-17, C-E). Notably, both target- and 
non-target-mediated Exo III digestion and AuNP aggregation are more pronounced for 
AuNPs with lower surface coverages. We identified 25 strands/particle as the optimal 
level of surface coverage for our assay due to the existence of detection window during 
which the drug-containing sample is blue while the drug-free sample remains red (Figure 
4-17F). Although the ratio between COC-LF and AuNP-conjugated SH-COC-SF-1X 
under this optimal surface coverage was close to 1:1, we believe that Exo III-mediated 
recycling of LF and target was taking place on the particle surface since DNA 
hybridization efficiency on AuNPs is usually below 20%.129,136 We believe that our DTT-
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based strategy for regulating DNA surface coverage plays multiple roles in facilitating 
exonuclease digestion of AuNP-conjugated short fragments for rapid cocaine detection. 
First, it prevents non-specific binding of DNA bases218 by occupying vacant areas on the 
particle surface with DTT, lifting the covalently-bound aptamer fragments into an upright 
orientation that increases CBSA-target assembly and enzyme accessibility.219 Second, it 
adjusts the surface density by replacing some of the chemically-bound aptamer 
fragments. This significantly reduces the steric and electrostatic repulsion caused by 
neighboring DNA strands, enabling optimized CBSA-cocaine complex assembly.220 
Finally, by reducing DNA surface coverage, the treatment decreases local salt 
concentration at the surface,133 which prevents the salt-induced inhibition of Exo III.216  
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Figure 4-18. Alternative version of our colorimetric cocaine sensor using SH-COC-SF-2X-
modified AuNPs.  
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Figure 4-19. Surface coverage of SH-COC-SF-2X-modified AuNPs treated with 
different concentrations of DTT. (A) A calibration curve established with known 
concentrations of SH-COC-SF-2X was used to calculate the DNA surface coverage of the 
DTT-treated AuNPs. (B) The surface coverage decreased with increasing amounts of 
DTT employed during the treatment procedure. Error bars show standard deviations 
obtained from three measurements. 
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Figure 4-20. Effect of SH-COC-SF-2X surface coverage. Time-dependence of Exo III digestion 
of AuNPs displaying SH-COC-SF-2X at (A) 83±2, (B) 23±1, (C) 20±1, (D) 18±1, or (E) 16±1 
strands/particle in the absence or presence of 250 μM cocaine are shown. The detection window, 
during which the drug-containing sample is blue while the drug-free sample remains red, is 
marked as a shaded box. (F) Summary of detection time and detection window obtained using 
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AuNPs with different surface coverages. 20 strands/particle was identified as the optimal surface 
coverage.  
We predicted that a longer version of COC-SF should further increase the stability of 
our modified AuNPs by suppressing nonspecific digestion-mediated aggregation. Thus, 
we designed a new construct (Table 4-1, SH-COC-SF-2X) comprising of two tandem 
abasic-site-incorporated short fragment repeats with a (T)6 linker. Our reasoning was that 
the assay’s specificity should be enhanced by this change, since Exo III will have to 
cleave both abasic sites in order to trigger cocaine recycling and AuNP aggregation 
(Figure 4-18). We modified 13-nm AuNPs with SH-COC-SF-2X, used our DTT 
regulation strategy to adjust the surface coverage of AuNPs, and tested the effects of 
DNA surface coverage on EATR performance. A calibration curve (Figure 4-19A) 
determined that treatment with DTT concentrations of 0, 200, 300, 400, and 500 µM 
produced AuNPs that respectively displayed 83±2, 23±1, 20±1, 18±1, and 16±1 strands 
per particle (Figure 4-19B). As expected, increasing concentrations of DTT produced 
AuNPs with lower levels of surface coverage (Figure 4-19). Compared to SH-COC-SF-
1X modified-AuNPs, SH-COC-SF-2X modified-AuNPs are stable even with surface 
coverages as low as 16 strands/particle. This is most likely due to the increased number 
of negatively charged DNA-phosphate groups located on the AuNP surface, providing 
more repulsion among particles. Lower-coverage AuNPs underwent EATR-mediated 
AuNP aggregation at a much faster rate than those with saturating coverage (Figure 4-20, 
A-E). The surface coverage of 20±1 strands/particle was selected for a combination of 
short reaction time and long detection window (Figure 4-20F).  
 
104 
 
4.3.8 Visual detection of cocaine using CBSA-based EATR-amplified colorimetric 
assay 
Finally, we compared the assay’s performance with SH-COC-SF-1X versus SH-COC-
SF-2X at optimized surface coverage. SH-COC-SF-2X-modified AuNPs aggregated 
more rapidly than those modified with SH-COC-SF-1X (Figure 4-21). We then used SH-
COC-SF-2X-modified AuNPs to test the sensitivity of our assay. The particles remained 
stable in the reaction buffer, and the color of the sample was not affected by cocaine 
concentrations of up to 500 µM in the absence of Exo III (Figure 4-22A, 0 min). Upon 
addition of Exo III, samples containing cocaine demonstrated different levels of particle 
aggregration, resulting in a distinctive color readout that shifted from light purple, dark 
purple, to dark blue at increasing drug concentrations over the course of 20 minutes 
(Figure 4-22A, 20 min), with A650/A520 varying from 0.39 (0.2–1 µM) to 0.90 (500 µM). 
The color of the cocaine-free sample remained unchanged. We could observe a clear blue 
color in samples containg as little as 10 µM cocaine with the naked eye after 20 minutes 
(Figure 4-22A). Using UV-vis spectroscopy measurements, we obtained a measurable 
limit of detection of 2 µM (Figure 4-22B). We determined the target-specificty of the 
CBSA-based EATR-amplified colorimetric assay by challenging it with cocaine along 
with common cutting agents observed in street samples221 such as lidocaine, caffeine, 
levamisole, and benzocaine at a concentration of 50 μM. We observed a red-to-blue color 
change only in the cocaine sample within 20 minutes (Figure 4-23). These results show 
that our EATR colormietric assay can be used for the specific and sensitive naked-eye 
detection of cocaine in seized samples.  
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Figure 4-21. Comparison of different SF in the CBSA-based EATR-amplified colorimetric assay. 
Time-dependence of Exo III digestion of AuNPs modified with SH-COC-SF-1X (25 
strands/particle, black) or SH-COC-SF-2X (20 strands/particle, red) in the absence (open circles 
and squares) or presence (solid circles and squares) of 250 μM cocaine are shown.  
 
 
 
 
 
Figure 4-22. CBSA assay for cocaine detection with SH-COC-SF-2X-conjugated AuNPs. (A) 
After 20 minutes, samples containing cocaine at concentrations ≥ 10 µM produced a clearly 
visible red to blue color change. Cocaine-free samples without cocaine remained red. (B) 
Calibration curve of our colorimetic CBSA-based cocaine assay; inset shows the calibration curve 
at low cocaine concentrations.  
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Figure 4-23. Specificity of the EATR-amplified CBSA-based colorimetric assay for 50 μM 
cocaine versus various interferents. A red-to-blue color change was observed in the cocaine 
sample, whereas lidocaine, caffeine, levamisole, and benzocaine samples remained red after 20 
minutes of digestion.  
4.4. Conclusions 
We have demonstrated a general and simple approach for developing a variety of 
CBSA-based EATR-amplified assays for the sensitive detection of small-molecule 
targets. The 3’-5’ exonuclease activity of Exo III has been used extensively in DNA-
based EATR assays,159 but our results demonstrated that Exo III’s 3’-5’ exonuclease 
activity is greatly inhibited by the tertiary structure of target-CBSA complexes. To 
achieve rapid CBSA-based EATR, we therefore incorporated a C3 spacer abasic site 
between the two target-binding domains on our CBSA short fragment, creating a 
recognition site for Exo III’s apurinic endonuclease activity. We have previously 
demonstrated that the apurinic endonuclease activity of Exo III can effectively enable 
EATR-mediated AuNP aggregation for rapid and sensitive detection of single-base 
mismatched DNA.154 Here, we showed that Exo III’s apurinic endonuclease activity 
could mediate CBSA-based EATR in solution as well as on particle surface. We thus 
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believe that the highly active and robust apurinic endonuclease activity of Exo III should 
allow many DNA-based EATR sensor platforms to be applied to our CBSA-based EATR 
assays for detection of various small-molecule targets. 
As an initial demonstration, we engineered a DIS-binding CBSA with a duplexed C3 
spacer abasic site incorporated between the two target-binding domains. This allowed us 
to exploit EATR signal amplification, which enhanced the sensitivity of our CBSA-based 
fluorescence assay by 100-fold relative to an unamplified assay. The detection limit of 
our CBSA-based EATR-amplified fluorescence assay is 100 and 50 times lower than 
previously reported DIS assays based on a split aptamer92 and a structure-switching 
aptamer,222 respectively. This assay also allowed us to detect DIS at concentrations as 
low as 1 μM in 50% urine within 30 minutes. We then demonstrated that this strategy 
could be adopted for rapid colorimetric detection of cocaine, based on EATR-mediated 
aggregation of AuNPs—a useful strategy for instrument-free detection. This assay 
enabled us to achieve rapid, naked-eye detection of cocaine at low micromolar 
concentrations within 20 minutes and is more sensitive, robust, or simple compared to 
previously reported methods for the visual detection of cocaine (Table 4-2). 
Recent work has described SELEX approaches for isolating small molecule-binding 
aptamers with a three-way junction structure using a partially-structured library.33 These 
aptamers can be readily engineered into CBSAs using the strategy demonstrated in this 
work and, as also shown here, these CBSAs can then be readily adapted for use in EATR-
amplified assays. Based on the generality of our CBSA engineering procedure and 
excellent performance of EATR assays in complex samples, we believe that the strategy 
described here will accelerate the development of sensitive and accurate sensors for 
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detecting small-molecule targets in fields including environmental monitoring, food 
safety, law enforcement, medical diagnostics, and public health. 
Table 4-2. Comparison of assays for the visual detection of  cocaine. 
 
Detection strategy 
Visual 
Detection 
limit 
Detection 
Time 
Existing problems Ref 
CBSA-based EATR-amplified 
assay 10 µM 20 min Requires enzyme reaction 
This 
work 
Dissociation of aptamer-
hybridized DNA-conjugated 
AuNP-assemblies 
500 µM 1 min 
Preparation of AuNP 
assemblies is laborious 
144 
Dye-displacement assay 500 µM Overnight Long reaction time 101 
Aggregation of split aptamer-
protected unmodified AuNPs 50 µM 3 min 
Unmodified AuNPs are 
unstable 
145 
AuNP and conjugated 
polyelectrolyte 
50 μM 2 min 
Unmodified AuNPs are 
unstable 
146 
Target-induced dissociation of 
aptamer-linked hydrogels 
2 µM 10 min Enzyme-embedded hydrogel 
is hard to preserve 
207 
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CHAPTER 5: In Vitro Isolation of Small-Molecule-Binding Aptamers with Intrinsic 
Dye-Displacement Functionality  
5.1. Introduction 
Aptamers are nucleic acid-based molecules that can be isolated in vitro through 
SELEX techniques to bind various targets with high specificity and affinity.1,5 They are 
increasingly being used as recognition elements in biosensing platforms due to their low 
cost of production, ease of modification, chemical stability, and long shelf life.5,76,77 The 
generation of a sensor readout typically requires an aptamer to undergo some manner of 
binding-induced change, and most aptamer-based sensors utilize structure-switching 
aptamers that undergo a major conformational rearrangement upon target binding. 
However, most aptamers do not innately undergo a measurable binding-induced 
conformational change, and the development of a structure-switching aptamer typically 
entails a multi-stage process of sequence analysis and chemical modification.75–77  
SELEX methods have been developed that make it possible to isolate aptamers with 
inherent structure-switching functionality. For example, Ellington98 and Li32 have utilized 
a ‘strand-displacement’ strategy to directly isolate structure-switching aptamers. Their 
approach begins with the hybridization of library molecules with an immobilized 
complementary strand. Library strands that bind to the target undergo a conformational 
change, dissociate from the complementary strand, and are collected in the supernatant. 
After several rounds of isolation and enrichment, these aptamers are sequenced, 
chemically modified with a fluorophore, and can then be directly employed in strand-
displacement assays with a quencher-modified complementary strand. This approach 
eliminates the need for sequence engineering, but there is an inherent conflict between 
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the requirements for aptamer isolation and sensor development. This is because the 
isolation of high-affinity aptamers requires strong hybridization of the complementary 
strand with the library molecules in order to create an energetic barrier for stringent 
selection. Nevertheless, since competitive strands have high binding affinity for the 
aptamer, they inadvertently inhibit target binding and consequently yielding low assay 
sensitivity.32,33,97,99,100 Moreover, strand-displacement assays typically require a lengthy 
heating-and-cooling process to hybridize the complementary strand with the aptamer, 
which greatly hinders the use of these assays for rapid on-site detection. Nonetheless, the 
strand-displacement assay is presently the only generally applicable method for 
developing aptamer-based small-molecule sensors directly from isolated aptamers 
without further engineering.  
Dye-displacement strategies offer an appealing alternative in this regard.101–104 In such 
assays, a small-molecule dye competes with the target to bind with the aptamer. 
Displacement of the dye from the aptamer’s target-binding domain results in a change of 
the dye absorbance or fluorescence. Such assays not only require no chemical 
modification of the aptamer but also yield high sensitivity, since displacement of a small-
molecule dye is more thermodynamically feasible compare to a tightly-bound 
complementary strand. However, this assay strategy has not been generalized, as there is 
currently no technology to generate aptamers with dye-displacement functionality.  
Herein, we for the first time have developed a new library-immobilized SELEX 
strategy for the isolation of small-molecule-binding aptamers with inherent dye-
displacement functionality. The isolated aptamers can rapidly report binding events 
through target-induced dye-displacement, which can then be employed in a generalized 
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sensor platform for the detection of small-molecule targets. Previous research has 
demonstrated that diethylthiatricarbocyanine (Cy7) can bind to a cocaine-binding 
aptamer via its three-way junction (TWJ) binding domain,101 and we have now 
demonstrated that such Cy7 binding is a general and sequence-independent feature of 
DNA TWJ structures. This interaction produces a distinctive change in absorbance at 670 
nm and 760 nm, which allowed us to isolate aptamers that undergo target binding-
induced dye-displacement from a TWJ-containing structured library. These aptamers can 
then be directly employed to optically report the presence of their respective target 
through displacement of Cy7. As a demonstration, we isolated an aptamer for 3,4-
methylenedioxypyrovalerone (MDPV), a synthetic cathinone designer drug. The isolated 
aptamer retains a TWJ-structured binding domain and has a KD of 6.1 µM. The addition 
of MDPV displaced Cy7 from the TWJ domain, resulting in a change in the absorbance 
of the dye. Using this label-free assay, we were able to detect MDPV at a concentration 
as low as 300 nM – 20-fold lower than the KD of the aptamer – within seconds. Our Cy7-
displacement assay was more sensitive and rapid than an equivalent strand-displacement 
fluorescence assay, which used a fluorophore-modified version of the same aptamer 
along with a quencher-modified complementary strand. Importantly, our isolated aptamer 
is also cross-reactive to other synthetic cathinones, which represent a diverse emerging 
class of drugs of abuse, while remaining non-responsive to other structurally-similar non-
cathinone molecules and commonly-used cutting agents. Our method should be generally 
applicable as a means to enable the rapid and sensitive detection of a variety of small-
molecule targets that bind to three-way junction–derived receptors. 
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5.2. Experimental section  
5.2.1 Materials 
Table 5-1. The sequences of DNA oligonucleotides employed in Chapter 5. 
Sequence ID Sequence (5’ – 3’) 
DISS.1 CTCGGGACGTGGATTTTCCGCATACGAAGTTGTCCCGAG 
DOGS.1 TCGGGACGTGGATTTTCCACAAACCAGAATGGTGTCCCGA 
TWJ pool CTTACGACNNNGGCATTTTGCCNNNNAACGAAGTTNNNGTCGTAAG 
Library 
CGAGCATAGGCAGAACTTACGACNNNGGNATTTTNCCNNNNANCG
AAGNTNNNGTCGTAAGAGCGAGTCATTC 
S1 stem-loop CTTACGACTTTGTCGTAAG 
S2 stem-loop GGCATTTTGCC 
S3 stem-loop AACGAAGTT 
cDNA-bio TTTTTGTCGTAAGTTCTGCCATTTT/Bio/ 
FP GCAGCATAGGCAGAACTTAC 
RP GAATGACTCGCTCTTACGAC 
RP-bio /Bio/GAATGACTCGCTCTTACGAC 
MA  CTTACGACTCAGGCATTTTGCCGGGTAACGAAGTTACTGTCGTAAG 
MA-L  
CAGAACTTACGACTCAGGCATTTTGCCGGGTAACGAAGTTACTGTC
GTAAG 
MA-F /5Cy5/GGCAGAACTTACGACTCAGGCATTTTGCCGGGTAACGAAGTT
ACTGTCGTAAG 
cDNA GTCGTAAGTTCTGCC 
cDNA-Q GTCGTAAGTTCTGCC/3IAbRQsp/ 
d. N represents random base  
e. /Bio/ represents biotin modification  
f. /5Cy5/ represents Cy5 fluorophore modification 
g. /3IAbRQsp/ represents Iowa Black RQ quencher modification 
 
All oligonucleotides were ordered from Integrated DNA Technologies (IDT), purified 
with HPLC, and dissolved in PCR quality water (Invitrogen). DNA concentrations were 
measured using a NanoDrop 2000 spectrophotometer (Thermo Scientific). Cy7, 
dehydroisoandrosterone-3-sulfate (DIS) sodium salt dihydrate, deoxycorticosterone-21 
glucoside (DOG) and all other chemicals were purchased from Sigma-Aldrich unless 
otherwise noted. Drug standards, including MDPV, mephedrone, methylone, naphyrone, 
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and pentylone were purchased from Cayman Chemicals. Tween 20 and formamide were 
purchased from Fisher Scientific. Streptavidin-coated agarose resin (1−3 mg biotinylated 
BSA/ml resin), One Shot Chemically Competent E. coli, and SYBR Gold were purchased 
from Thermo Scientific. 500 μL micro-gravity columns were purchased from BioRad. 
5.2.2 SELEX procedure 
The isolation of MDPV-binding aptamers follows a previously-reported SELEX 
method33 with some modifications. Briefly, during each round of SELEX, 100 pmole of 
either the TWJ-containing library or the enriched pool from a given round was mixed 
with 500 pmole of biotinylated complementary strand (cDNA-bio) in 250 μL selection 
buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, pH 7.4). The mixture was heated 
at 95 °C for 5 min, slowly cooled to room temperature over 30 min, and then loaded into 
a micro-gravity column containing 250 μL of streptavidin-coated agarose resin for library 
immobilization. Unconjugated library and complementary strands were removed by 
flowing 250 μL of selection buffer through the library-immobilized column at least 10 
times. Target-bound aptamers were then eluted at room temperature with 250 μL of 
selection buffer containing either 100 μM (Rounds 1-5) or 50 μM (Rounds 6-10) MDPV. 
Each elution was completed in two minutes. The elution was repeated two more times to 
increase the yield. The combined eluted aptamers were concentrated using a 3K 
molecular weight cut-off spin filter (Millipore) and mixed with 1 μM forward primer 
(Table 5-1, FP) and 1 μM biotinylated reverse primer (Table 5-1, RP-bio) in 1 mL GoTaq 
Hot Start Master Mix (Promega). Polymerase chain reaction (PCR) was then performed 
using a BioRad C1000 thermal cycler. Amplification conditions were as follows: 1 cycle 
of 95 °C for 2 min; 13 cycles of 95 °C for 15 s, 58 °C for 30 s, and 72 °C for 45 s; and 1 
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cycle of 72 °C for 2 min. The double-stranded PCR product was immobilized on a micro-
gravity column containing 200 μL of streptavidin-coated agarose resin. The column was 
washed five times with 200 μL of 10 mM Tris-HCl buffer (pH 7.4) containing 20 mM 
NaCl to remove unconjugated strands, and then incubated with 300 μL of 0.2 M NaOH 
for 10 min. Finally, the eluent was collected and neutralized with 0.2 M HCl in a 1.5 mL 
microcentrifugation tube and concentrated using a 3K molecular weight cut-off spin 
filter. The enriched pool was used for the next round of SELEX after measuring its 
concentration with a NanoDrop 2000. 
Counter-SELEX was performed against methamphetamine (Rounds 4-5), 
amphetamine (Rounds 6-7) and dopamine (Rounds 8-10). Specifically, the library-
immobilized column was washed 10 times with 250 μL of 100 μM counter-SELEX target 
in selection buffer, followed by 20 times with 250 μL of selection buffer prior to target 
elution.  
5.2.3 Cloning and sequencing  
After 10 rounds of SELEX, the final enriched pool was PCR amplified with unlabeled 
forward and reverse primers (Table 5-1, FP and RP) under the conditions described 
above, with a prolonged 30-min extension step at 72 °C to add an A-tail. The PCR 
product was cloned into E. coli using the TOPO TA cloning kit (Invitrogen). 50 colonies 
were randomly picked and sequenced at the Florida International University DNA Core 
Facility. Multiple sequence alignments were carried out using BioEdit software, and the 
sequence logo was generated using WebLogo.223 
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5.2.4 Characterization of target displacement of Cy7 from TWJ-structured 
aptamers 
5 µL of DISS.1 aptamer or DOGS.1 aptamer (1) (final concentration: 7 μM), 5 µL of 
Cy7 (final concentration: 3 μM), 5 µL of DIS or DOG (final concentration: 0 or 250 μM), 
and 35 µL selection buffer (1) (20 mM Tris-HCl, 10 mM MgCl2, 1 M NaCl, 0.01% 
Tween 20, 1% DMSO, pH 7.4) were mixed in wells of a 384-well plate. UV-vis spectra 
were immediately recorded from 450–900 nm using a Tecan Infinite M1000 PRO at 
room temperature.  
5.2.5 Characterization of binding of Cy7 to TWJ pool 
5 µL of different concentrations of TWJ pool, 5 µL of 20 µM Cy7, and 40 µL of 
reaction buffer (final concentration 10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, 
0.01% Tween 20, and 1% DMSO, pH 7.4) were mixed in wells of a 384-well plate. UV-
vis spectra were immediately recorded from 450 nm to 900 nm at room temperature. The 
absorbance value at 760 nm was plotted against the concentration of added TWJ pool. 
The KD was estimated by non-linear fitting using the Langmuir equation. 
5.2.6 Continuous variation experiment (Job plot) 
10 µM Cy7 and 10 µM TWJ pool were separately prepared in reaction buffer. 
Different ratios of Cy7 and TWJ pool were then mixed, with the concentration of both 
species totaling 10 µM. 50 µL of each mixture was loaded into a 384-well plate, and UV-
vis spectra were immediately recorded from 450–900 nm at room temperature. The 
absorbance at 760 nm was plotted versus the mole fraction of Cy7.   
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5.2.7 Development of a target elution assay to assess pool affinity and target 
specificity 
After each round of SELEX, 50 pmole of the enriched pool was mixed with 250 
pmole of biotinylated complementary strand (Table 5-1, cDNA-bio) in 125 μL binding 
buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, 0.01% Tween 20%, pH 7.4). The 
mixture was heated to 95 °C for 5 min, slowly cooled down to room temperature over 30 
min, and loaded into a micro-gravity column containing 125 μL of streptavidin-coated 
agarose resin for library immobilization. The library-immobilized resin was collected into 
a microcentrifugation tube and washed five times with 625 µL binding buffer on an end-
to-end rotator to remove unconjugated library and complementary stands. After washing, 
the library-conjugated resin was re-suspended in 150 μL binding buffer and aliquoted 
into six PCR tubes (20 μL each). 50 μL binding buffer containing different amounts of 
MDPV was added to these tubes to reach final target concentrations of 0, 10, 50, 100, 
250, and 500 μM. After a 60-min incubation on an end-over-end rotator, the agarose resin 
was precipitated by centrifugation. 3 μL of supernatant was collected and mixed with 6 
µL of gel loading buffer (75% formamide, 10% glycerol, 0.125% SDS, 10 mM EDTA, 
and 0.15% (w/v) xylene cyanol). 5 µL of each collected sample was then loaded into the 
wells of a 15% denaturing polyacrylamide gel. A control sample (40 nM initial random 
library) was also loaded into the gel to evaluate the concentration of target-eluted library 
in each sample. Separation was carried out at 20 V/cm for 1 hour in 0.5× TBE running 
buffer. The gel was stained with 1× SYBR Gold solution for 25 min and imaged using a 
ChemiDoc MP Image System (Bio-Rad). The percentages of elution were calculated 
from the concentration of target-eluted library and the initial amount of library used in 
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immobilization, which were then plotted versus the concentration of MDPV. KD of the 
library pool was estimated with non-linear curve fitting using the Langmuir equation. The 
target specificity for the enriched pool was tested using the method described above, by 
eluting library-immobilized agarose resin with binding buffer, 500 μM MDPV, 500 μM 
methamphetamine, 500 μM amphetamine and 500 μM dopamine.  
5.2.8 Isothermal titration calorimetry (ITC)  
All ITC experiments were performed at 23 °C in reaction buffer with a MicroCal 
iTC200 instrument (Malvern). The sample cell contained 20 µM MA, 20 µM MA-L, 20 
µM Cy7-MA complex (1:1), 20 µM Cy7:MA-L complex (1:1), or 20 µM cDNA:MA-L 
complex (1:1). The syringe contained 1 mM MDPV in reaction buffer. Each experiment 
consisted of 19 successive 2 μL injections after a 0.4 μL purge injection with spacing of 
180 seconds to a final molar ratio of 11:1 (MDPV:Aptamer). The raw data were first 
corrected based on the heat of dilution of target, and then analyzed with the MicroCal 
analysis kit integrated into Origin 7 software with a single-site binding model. 
5.2.9 Strand-displacement fluorescence assay for detection of MDPV 
First, the molar ratio between the fluorophore-labeled aptamer strand (Table 5-1, MA-
F) and the quencher-labeled complementary strand (Table 5-1, cDNA-Q) was optimized. 
Specifically, 8 µL of MA-F (final concentration 50 nM) and 8 µL of different 
concentrations of cDNA-Q were mixed with reaction buffer to a total volume of 80 µL. 
The samples were then heated at 95 °C for 5 min and slowly cooled down to room 
temperature over 30 min. 75 µL of samples were loaded into a 384-well plate, and the 
fluorescence spectra were recorded from 655–850 nm with excitation at 648 nm at room 
temperature. To perform the strand-displacement fluorescence assay, reaction buffer 
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containing 50 nM MA-F and 50 nM cDNA-Q (final concentration) was heated at 95 °C 
for 5 min and slowly cooled down to room temperature over 30 min. 8 µL of different 
concentrations of MDPV were then mixed with 72 µL of the cDNA-Q:MA-F complex in 
the wells of a 384-well plate. After 10 min of incubation, fluorescence spectra were 
recorded from 655–850 nm with excitation at 648 nm at room temperature. The signal 
gain was calculated by (F−F0)/F0, where F0 and F are the fluorescence intensity at 668 nm 
without and with MDPV, respectively.  
5.2.10 Cy7 displacement assay for detection of MDPV 
5 µL of MDPV-binding aptamer (Table 5-1, MA) (final concentration: 7 μM), 5 µL of 
Cy7 (final concentration = 3 μM), 5 µL of varying concentrations of MDPV, and 35 µL 
of reaction buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, 0.01% Tween 20, 1% 
DMSO, pH 7.4) were mixed in wells of a 384-well plate. UV-vis spectra were 
immediately recorded from 450–900 nm using a Tecan Infinite M1000 PRO at room 
temperature. Signal gain was calculated by (R–R0)/R0, where R0 and R are the 670/760 
nm absorbance ratio without and with MDPV, respectively. The same assay was 
performed with 50 µM and 250 µM of naphyrone, methylone, pentylone and mephedrone 
to evaluate the cross-reactivity of the assay. Additionally, we tested the specificity of the 
assay using 50 µM and 250 µM of interfering agents such as amphetamine, 
methamphetamine, dopamine, lidocaine, benzocaine, and caffeine.  
5.3. Results and discussion 
5.3.1 Binding mechanism of Cy7 to TWJs 
Stojanovic et al. have previously reported that Cy7 (Figure 5-1A) specifically binds to 
the TWJ-structured binding domain of a cocaine-binding aptamer via hydrophobic 
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interactions.101 Cocaine displaces Cy7 from the TWJ, resulting in a significant reduction 
in the absorbance of the dye at 760 nm. We demonstrated the generality of this Cy7-
displacement mechanism using another two reported TWJ-structured aptamers which 
bind to DIS and DOG.33 Cy7 was immediately displaced from both aptamers upon the 
addition of their respective targets, yielding a significant decrease in the absorbance of 
the dye at 760 nm (Figure 5-2). Based on these results, we hypothesized that Cy7 binds to 
our TWJs in a sequence-independent manner, a principle that could guide the SELEX-
based isolation of new small-molecule binding aptamers with intrinsic Cy7-displacement 
functionality.  
To confirm our hypothesis, we chemically synthesized a 46-nt TWJ-structured DNA 
library, in which each strand contains three fully complementary stems (S1, S2, and S3) 
and 10 randomized nucleotides within the junction itself (Figure 5-1A and Table 5-1, 
TWJ pool). After mixing 2 μM Cy7 with 10 μM TWJ pool, we observed an increase in 
the absorbance of the dye at 760 nm and 670 nm, which respectively corresponds to 
binding of the Cy7 monomer and dimer (Figure 5-1B).224,225 To assess the binding of Cy7 
to various domains within the TWJ pool, we synthesized the isolated S1 stem with an 
added terminal TTT loop (termed the S1 stem-loop), the S2 stem-loop, and the S3 stem-
loop (Table 5-1 and Figure 5-3A) and characterized the binding of Cy7 to each of them. 
We observed that none of the stem-loops bound to the monomer (Figure 5-3B), and the 
dimer only bound to the S1 stem-loop—most likely within its minor groove.225 When we 
incubated Cy7 with a 1:1:1 mixture of the three isolated stem-loops, only dimer binding 
was observed (Figure 5-1B). These results clearly indicated that the Cy7 monomer can 
only bind to the fully-assembled TWJ domain of the aptamer. 
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Figure 5-1. Cy7 binding to a TWJ-containing structured DNA pool in a sequence-independent 
manner. (A) Chemical structure of Cy7 and the sequence of the randomized TWJ pool. (B) When 
combined with the TWJ pool, the absorbance of Cy7 monomer (760 nm) and dimer (670 nm) is 
enhanced. In contrast, when combined with a 1:1:1 mixture of isolated S1, S2, and S3 stem-loops, 
only the absorbance of the dimer is enhanced. (C) Binding stoichiometry of Cy7 monomer to the 
TWJ pool as characterized by a Job plot.  
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Figure 5-2. Generality of target-induced displacement of Cy7 from aptamers with a TWJ-
structured binding domain. (A) Structure of DIS and DOG and their respective aptamers, DISS.1 
and DOGS.1. Both aptamers contain a TWJ-structured binding domain. Absorbance spectra for a 
mixture of 3 μM Cy7 and 7 μM (B) DISS.1 or (C) DOGS.1 in the absence (black line) or 
presence (red line) of 250 μM DIS or DOGS, respectively. The greatly reduced Cy7 absorbance 
at 760 nm indicates successful displacement of Cy7 from the aptamer TWJ domain.  
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Figure 5-3. Characterization of Cy7 binding to the isolated stems from the TWJ pool. (A) 
Sequences of the TWJ pool and isolated S1, S2, and S3 stem-loops. (B) Binding of Cy7 to each 
isolated stem-loop. When 2 μM Cy7 was combined with 10 μM S1 stem-loop, only the 
absorbance of the dimer (670 nm) increased. Combination with either 10 μM S2 stem-loop or S3 
stem-loop did not significantly enhance the absorbance of either the monomer or the dimer. The 
dashed line represents the spectrum of Cy7 alone.  
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Figure 5-4. Characterization of Cy7 binding to the TWJ pool. (A) Titration of increasing amounts 
of the TWJ pool (2–10 μM) into 2 μM Cy7 resulted in enhanced absorbance of Cy7 at 760 nm, 
indicating interaction between the TWJ pool and the Cy7 monomer. The dashed line represents 
the spectrum of Cy7 alone. (B) Cy7 binding affinity for the TWJ pool was estimated from 
absorbance at 760 nm in the absence and presence of different concentrations of TWJ pool.  
We then obtained the binding affinity of Cy7 monomer for the TWJ pool by titrating 
different concentrations of the pool into 2 μM Cy7. As the concentration of the TWJ pool 
increased, we observed an increase in absorbance at 760 nm and a slight decrease in 
absorbance at 670 nm (Figure 5-4A). This provided further evidence that the TWJ 
domain preferentially binds to the Cy7 monomer. The decreased absorbance of the Cy7 
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dimer at higher DNA concentrations implies an equilibrium shift from dimer to monomer 
that favors Cy7 binding to the TWJ pool. Based on the absorbance at 760 nm, we 
obtained a KD of 6.4 ± 0.8 μM (Figure 5-4B). We further characterized the binding 
stoichiometry of the Cy7 monomer to the TWJ pool using a Job plot 226. We measured 
the absorbance at 760 nm at various Cy7:DNA ratios, with a constant total concentration 
of 5 μM. The maximum absorbance was observed at a mole fraction (XCy7) of 0.5, 
indicating that the TWJ pool binds to Cy7 in a 1:1 ratio. Since the Cy7 monomer 
exclusively binds to the TWJ domain, each randomized TWJ in the pool should bind to a 
single Cy7 monomer (Figure 5-1C). These results confirmed our initial hypothesis that 
the binding of Cy7 to TWJs is sequence-independent and indicated that it should 
therefore be feasible to isolate new small-molecule-binding aptamers with intrinsic dye-
displacement functionality from TWJ-structured libraries.   
5.3.2 Library design and isolation process 
We designed a structured library in which we extended both termini of the TWJ pool 
by 12 nucleotides, creating partial PCR primer binding sites (Figure 5-5 and Table 5-1, 
library). We have previously demonstrated that changes in the sequence adjacent to the 
TWJ binding domain greatly affected the affinity of a cocaine-binding aptamer 86,102. 
With this in mind, we randomized one base-pair in stems 2 and 3 to further enhance the 
potential target-binding affinity of our aptamer. The resulting library is designed to 
primarily form TWJ-structured target-binding domains. Although there is a small 
possibility of isolating non-TWJ-structured aptamers in the final enriched pool, these 
sequences can be identified and removed after sequencing. It should be noted that the 
randomness of this library (414 sequences) is considerably lower than many reported 
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SELEX libraries.31,32,100 However, this should not be of concern, as small-molecule 
targets can only interact with a limited number of nucleotides within an aptamer’s 
binding domain. In fact, several small-molecule-binding aptamers have been successfully 
isolated using a TWJ-structured library representing no more than 48 different sequences 
33. Increasing the number of random nucleotides in the TWJ binding domain could also 
lead to the isolation of aptamers with non-TWJ structures, which lack dye-displacement 
functionality.  
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Figure 5-5. Isolation of TWJ-structured aptamers for a Cy7-displacement small-molecule 
detection assay. A TWJ-containing structured DNA library is immobilized onto a streptavidin-
coated bead surface using a biotinylated cDNA strand (left). Target-binding strands are eluted due 
to a conformational change in the aptamer (right). 
We then used this TWJ-containing library along with a previously reported library-
immobilized SELEX strategy33 to isolate aptamers for MDPV, an emerging drug of abuse 
in the synthetic cathinone family. Since there is currently no reliable presumptive test for 
any synthetic cathinone, the development of such an assay would be highly valuable. We 
performed SELEX in a low ionic strength buffer (10 mM Tris-HCl, 20 mM NaCl, 0.5 
mM MgCl2, pH 7.4), as an excessive amount of ions can induce non-specific 
hydrophobic interactions227 between the target and the TWJ binding domain, which 
disfavors the isolation of highly target-specific aptamers. We immobilized our library 
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onto streptavidin-coated agarose beads through hybridization to a biotinylated 
complementary DNA (cDNA) strand (Table 5-1, cDNA-bio) that disrupts the TWJ 
structure (Figure 5-5A, left). In the presence of MDPV, library molecules that recognized 
this target underwent a conformational change and refolded into a TWJ structure, thereby 
detaching themselves from the biotinylated cDNA (Figure 5-5A, right). These aptamers 
were collected, PCR amplified, and used for the next round of selection. To further 
improve aptamer specificity, we sequentially performed counter-SELEX at various 
rounds against three molecules that are structurally similar to MDPV: amphetamine, 
methamphetamine, and dopamine.  
 
Figure 5-6. Estimation of target affinity and specificity of the enriched pools during SELEX 
using a target elution assay. (A) Target elution profile of the initial library and enriched pools 
after selection rounds 3, 5, 7, and 10 was analyzed by PAGE. Lanes 1-6 represent samples of the 
initial library and enriched pools eluted with 0, 10, 50, 100, 250, and 500 μM MDPV. Control 
samples (lane 7) containing 40 nM synthesized library were used to measure the concentration of 
eluted strands and percent elution of each sample. (B) The MDPV binding affinity of the library 
and enriched pools were calculated based on the percent elution of each sample. (C) The target 
specificity of the enriched pool after 10 rounds of SELEX was also assessed by the target elution 
assay. Inset shows the enriched pool eluted with binding buffer (lane 1), 500 μM MDPV (lane 2), 
500 μM methamphetamine (lane 3), 500 μM amphetamine (lane 4), and 500 μM dopamine 
(lane5). 
After each round of SELEX, we estimated the target affinity and specificity of the 
enriched pool with a target elution assay. After 10 rounds of selection, the enriched pool 
achieved saturated target affinity and low cross-reactivity to the counter-SELEX targets 
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(Figure 5-6). The isolated aptamers were then cloned and sequenced. We observed that 
all sequences retained the TWJ structure present in the original library. The 10 random 
nucleotides (Figure 5-7, positions 9–11, 23–26, 36–38) in the TWJ binding domain 
exhibited a high level of consensus, with 41 out of 50 clones sharing an identical 
sequence at these sites. The four random nucleotide positions within the stems were more 
varied (Figure 5-7, positions 14, 20, 28 and 34), but predominantly retained standard 
Watson-Crick base-pairing. We selected the most highly-represented sequence and 
truncated the 12-nucleotide partial primer-binding sites at both termini to generate the 
MDPV-binding aptamer MA (Table 5-1).  
 
Figure 5-7. Sequence logo for 50 clones isolated after 10 rounds of SELEX, showing the relative 
frequency of every nucleotide at each position. Nucleotides at pre-determined positions are 
marked grey, while positions with randomized nucleotides are color-coded to show the 
distribution of different nucleotides. Higher frequency nucleotides appear in a larger font-size. 
5.3.3 Aptamer characterization and development of the label-free Cy7-
displacement assay 
We determined the binding affinity of MA using ITC, titrating 1 mM MDPV into a 20 
μM solution of the aptamer. We found that MA binds MDPV with a KD of 6.1± 0.2 μM 
(Figure 5-8A). Binding is driven by a negative enthalpy change (∆H = -11.0 ± 0.2 kcal 
mol-1) but with a moderate entropy cost (∆S = -13.1 ± 0.2 cal mol-1K-1) due to the fact 
that MDPV is constrained within the TWJ binding domain. Based on our prior findings, 
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we anticipated that Cy7 would also bind to the TWJ domain of MA but could be 
displaced by MDPV. This was confirmed by performing an ITC experiment in which we 
titrated 1 mM MDPV into 20 μM Cy7-MA complex (1:1). The presence of Cy7 did not 
significantly reduce the MDPV-binding affinity of MA (KD = 7.0 ± 0.7 μM) (Figure 
5-8B). However, the binding heat (∆H = -6.3 ± 0.2 kcal/mol) was notably lower than in 
the absence of Cy7 (∆H = -11.0 ± 0.2 kcal mol-1), indicating that a certain amount of 
energy was required for target-induced displacement of the dye. Additionally, the higher 
binding entropy obtained with Cy7 (∆S = 0.5 ± 0.7 cal mol-1K-1) suggested positive 
entropy associated with the MDPV-mediated release of the dye from the aptamer. These 
results indicate that both Cy7 and MDPV can bind to the TWJ-structured binding 
domain, and that MDPV can efficiently displace Cy7. 
A B
KD= 6.1 ± 0.2 µM
∆H= -11.0 ± 0.1 kcal mol-1
∆S= -13.1 ± 0.2 cal mol-1K-1
KD= 7.0 ± 0.7 µM
∆H= -6.3 ± 0.2 kcal mol-1
∆S= 0.5 ± 0.7 cal mol-1K-1
 
Figure 5-8. Binding affinity of MDPV to MA and MA-Cy7 complex. ITC characterization of 
MA binding to MDPV in the (A) absence or (B) presence of Cy7 are shown. The top panels 
display raw data, showing the heat generated from each titration of MDPV. The bottom panels 
show the integrated heat of each titration after correcting for dilution heat of the titrant. 
We then employed MA in a label-free colorimetric assay for the detection of MDPV, 
where target-induced displacement of Cy7 from the aptamer TWJ binding domain 
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produces a change in dye absorbance (Figure 5-9A). Specifically, we added different 
concentrations of MDPV (0.1–640 μM) to a solution containing Cy7-MA complexes, and 
then immediately began recording the absorption spectra. Within seconds, we observed a 
progressive reduction of absorbance at 760 nm and enhancement of absorbance at 670 
nm (Figure 5-9B). Using the absorbance ratio at 670/760 nm as an indicator, we obtained 
a linear range from 0–40 μM, with a low detection limit of 300 nM (Figure 5-9C). 
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Figure 5-9. Detection of MDPV with a label-free Cy7-displacement colorimetric assay. (A) Cy7 
binds within the TWJ domain of MA (left). MDPV displaces Cy7 from the binding domain 
(right) to generate a change in the absorbance spectra of Cy7. (B) UV-vis spectra of 3 μM Cy7 
premixed with 7 μM MA in the presence of varying concentrations of MDPV (0, 0.16, 0.31, 0.63, 
1.25, 2.5, 5, 10, 20, 40, 80, 160, 320, 640 µM). The increasing concentrations (shown as 
blackred curves) resulted in decreased absorbance at 760 nm and increased absorbance at 670 
nm. (C) A calibration curve based on the absorbance ratio at 670/760 nm. Inset shows assay 
performance at a low concentration range. Error bars show standard deviation from three 
measurements at each concentration. 
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Figure 5-10. High cross-reactivity of MA to synthetic cathinone drugs and high specificity 
against other structurally–similar or –dissimilar interfering agents. (A) Chemical core structure 
and structures of synthetic cathinones. (B) Signal gain measurements from the Cy7-displacement 
assay with 50 μM MDPV, other synthetic cathinones, or interfering agents (structures shown in 
panel C). Error bars show standard deviations from three measurements of each compound.  
 
 
 
Figure 5-11. Cross-reactivity and specificity of our Cy7-displacement assay with 250 μM 
MDPV, other synthetic cathinones, or structurally-similar non-cathinone compounds and 
common cutting agents. Signal gain was calculated by (R–R0)/R0, where R and R0 are the 
absorbance ratio at 670/760 nm with and without target/interfering agent, respectively. Error bars 
show standard deviation from three measurements of each compound tested.  
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Notably, MA was highly cross-reactive to other synthetic cathinones (methylone, 
pentylone, naphyrone and mephedrone) that share the same beta-keto phenethylamine 
core structure as MDPV but with different side-chains (Figure 5-10A). We tested MA 
cross-reactivity to these four synthetic cathinones at concentrations of 50 μM and 250 μM 
in the Cy7-displacement assay. We observed cross-reactivity greater than 65% and 80% 
for all four molecules at both concentrations (Figure 5-10B and Figure 5-11). This 
suggests that MA specifically recognizes the core structure of synthetic cathinones rather 
than their side chain substituents. Interestingly, naphyrone showed exceptionally high 
cross-reactivity compared to other synthetic cathinones, possibly due to the 
hydrophobicity of its naphthalene moiety. The high cross-reactivity of MA is desirable 
for onsite detection of the synthetic cathinone family, a class of designer drugs for which 
new derivatives are continually being developed. In contrast, MA was not responsive to 
non-synthetic cathinone interfering agents. No specific signal was observed from any of 
our three counter-SELEX targets (Figure 5-10C) in our Cy7-displacement assay at 
concentrations of 50 μM (Figure 5-10B) or 250 μM (Figure 5-11), despite their structural 
similarity to MDPV. We further tested the specificity of the assay against lidocaine, 
benzocaine, and caffeine, which are cutting agents commonly found in seized substances 
(Figure 5-10C), and likewise observed little cross-reactivity at either concentration 
(Figure 5-10B and Figure 5-11). It should be noted that the counter-SELEX targets and 
cutting agents either do not contain all the moieties present in MDPV (a phenyl ring, a 
ketone, and an amine group), or have all of these moieties but arranged in different 
positions. These results indicate that MA recognizes targets based on multiple specific 
interactions in a certain arrangement. We found that MA was somewhat cross-reactive to 
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the structurally dissimilar compounds cocaine, DIS, and DOG at a concentration of 50 
μM, with cross-reactivities of 50%, 18%, and 40% respectively relative to MDPV (Figure 
5-12) in the Cy7-displacement assay. We believe this cross-reactivity occurs because 
counter-SELEX was not performed against these particular compounds, but it should be 
feasible to eliminate this unintended cross-reactivity with well-designed counter-SELEX 
procedures against additional structurally dissimilar compounds.  
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Figure 5-12. Cross-reactivity of our Cy7-displacement assay with 50 μM MDPV, cocaine, DIS 
and DOG. Error bars show standard deviation from three measurements of each compound.  
5.3.4 Comparison of Cy7-displacement and strand-displacement assays 
Finally, we compared the sensitivity of our Cy7-displacement colorimetric assay with a 
strand-displacement fluorescence assay (Figure 5-13) based on the same MDPV-binding 
aptamer. We generated a fluorophore-modified version of MA (Table 5-1, MA-F) and a 
quencher-modified complementary strand (Table 5-1, cDNA-Q). In the absence of 
MDPV, MA-F forms a 15-bp duplex with cDNA-Q that situates the fluorophore in close 
proximity to the quencher (Figure 5-13A). The fluorescence of 50 nM MA-F was almost 
completely quenched in the presence of 50 nM cDNA-Q (Figure 5-14A). We 
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subsequently titrated different concentrations of cDNA-Q into 50 nM MA-F and obtained 
a KD of 0.5 ± 0.2 nM (Figure 5-14A, inset). In the presence of MDPV, the target induced 
a conformational change in MA-F, forming a TWJ structure that resulted in dissociation 
of cDNA-Q, generating a measurable fluorescence signal (Figure 5-13B). We observed 
less than 50% fluorescence recovery upon adding various concentrations of MDPV up to 
640 μM (Figure 5-14B). We obtained a linear range of 0–20 µM, with a detection limit of 
2.5 μM (Figure 5-14C), eight-fold poorer than the Cy7-displacement assay. This is 
primarily because cDNA-Q has a much higher affinity for the aptamer than Cy7, which 
makes target-induced displacement of the complementary strand less energetically 
favorable. To further illustrate this point, we synthesized unmodified versions of MA-F 
and cDNA-Q (Table 5-1, MA-L and cDNA) and performed ITC experiments in which we 
titrated 1 mM MDPV into 20 μM of MA-L either with or without 20 μM cDNA. We 
found that MA-L has an affinity for MDPV almost identical to that of MA (Figure 5-15A, 
KD = 6.2 μM) in the absence of cDNA. However, in the presence of 20 μM cDNA, no 
MDPV binding was observed (Figure 5-15B), confirming that MDPV could not 
efficiently displace the cDNA from the aptamer. It should be noted that strand-
displacement efficiency was lower in the ITC experiment due to the higher concentration 
of aptamer-cDNA complex employed (20 µM), which greatly reduces the level of 
dissociation of this complex. As a control, we titrated 1 mM MDPV into 20 µM Cy7-
MA-L (1:1), and found that the presence of Cy7 does not attenuate MDPV binding by 
MA-L (Figure 5-15C, KD = 7.0 μM). These results clearly demonstrate that the Cy7-
displacement assay is more sensitive than an equivalent strand-displacement assay for the 
detection of small-molecule targets.   
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Figure 5-13. Working principle of a conventional strand-displacement fluorescence assay. (A) In 
the absence of MDPV, MA-F forms a 15-bp duplex with cDNA-Q, which situates the fluorophore 
in close proximity to the quencher, thus quenching fluorescence. (B) MDPV induces a target-
induced conformational change in MA-F, forming a TWJ structure that results in dissociation of 
cDNA-Q, generating a measurable fluorescence signal.  
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KD= 0.5 nM
C
Figure 5-14. Strand-displacement fluorescence assay based on the MA aptamer. (A) 
Fluorescence spectra obtained from titration of cDNA-Q into a solution of MA-F at different 
molar ratios (0–2×). Inset shows binding affinity of cDNA-Q to MA-F as estimated from the 
fluorescence intensity at 668 nm in the absence and presence of different concentrations of 
cDNA-Q. (B) Fluorescence spectra obtained from titration of different concentrations of MDPV 
into 50 nM MA-F and 50 nM cDNA-Q. (C) Calibration curves for the strand-displacement 
fluorescence assay. Inset shows assay performance at a low concentration range. Error bars show 
standard deviation from three measurements at each concentration.  
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Figure 5-15. Affinity of MDPV to MA-L, cDNA-MA-L complex, and Cy7-MA-L complex. 
MDPV binding affinity to (A) MA-L alone, (B) cDNA-MA-L complex (1:1), and (C) Cy7-MA-L 
complex (1:1) are characterized by ITC. The top panels display raw data showing the heat 
generated from each titration of MDPV. The bottom panels show the integrated heat of each 
titration after correcting for dilution heat of the titrant.  
5.4. Conclusions 
In this report, we describe a general approach for the isolation of small-molecule-
binding aptamers with intrinsic dye-displacement functionality that can be directly 
implemented in a label-free colorimetric assay. We first determined that Cy7 can bind to 
a randomized TWJ-structured DNA library pool in a sequence-independent manner. We 
then used a TWJ-structured library to isolate a DNA aptamer against MDPV, an 
emerging designer drug, and directly employed the isolated aptamer in a Cy7-
displacement colorimetric assay without any further engineering. The assay showed high 
target sensitivity, detecting MDPV at concentrations as low as 300 nM, 20-fold lower 
than the KD of the aptamer, within seconds at room temperature. Our aptamer showed 
high specificity in terms of discriminating against structurally-similar non-synthetic 
cathinone compounds such as amphetamine, methamphetamine, and dopamine as well as 
common cutting agents such as lidocaine, benzocaine, and caffeine. At the same time, the 
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isolated aptamer was highly cross-reactive to other synthetic cathinones such as 
naphyrone, methylone, pentylone, and mephedrone, indicating that it could offer a 
broadly applicable yet specific assay for this particular class of designer drugs, based on 
recognition of shared core structural features.  
Our determination that Cy7 can generally bind our DNA TWJs in a sequence-
independent manner means that such dye-displacement assays can be generalized for the 
detection of other small-molecule targets using existing or future isolated TWJ-structured 
aptamers. Since we have previously demonstrated that the fluorescent dye ATMND can 
bind to the TWJ domain of a cocaine-binding aptamer,102 we anticipate that other 
hydrophobic small-molecule dyes may also serve as signal reporters in such dye-
displacement assays. Our assay is simple, rapid, sensitive, and cost efficient, as it can be 
performed by simply mixing the sample, Cy7, and unmodified aptamer. The Cy7 
absorbance read-out can be quantified in seconds by a microplate-reader or portable 
photometer, allowing for high-throughput or on-site detection, respectively. Importantly, 
the absorbance of Cy7 at 670 nm and 760 nm exhibits minimal overlap with other small 
molecules 228 or sample matrices,229 potentially allowing for interference-free detection in 
complex specimens. Finally, our assay is eight-fold more sensitive than an equivalent 
strand-displacement fluorescence assay, because Cy7 is more efficiently displaced by 
small-molecule targets than a hybridized cDNA strand. Therefore, we believe that our 
SELEX strategy using our TWJ-structured library could offer a broad foundation for the 
development of sensitive and simple Cy7-displacement colorimetric assays for the 
detection of a wide variety of small-molecule targets.  
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CHAPTER 6: In Vitro Isolation of Class-Specific Oligonucleotide-Based Small-
Molecule Receptors 
6.1. Introduction 
It is highly advantageous to be able to sensitively detect multiple different members of 
a particular molecular family or class in many analytical contexts—for example, 
detecting illicit drugs and their metabolites for forensic investigations, antibiotics for food 
safety, or pesticides for environmental monitoring.67–69 Cross-reactive assays that can 
broadly detect small molecules based on a shared molecular framework offer a more 
efficient and cost-effective solution to this problem than the tandem use of multiple 
highly specific assays that each detects an individual analyte. Antibody-based 
immunoassays have dominated the field of small-molecule detection,230 and while assays 
have been developed for a wide variety of individual targets, the development of class-
specific immunoassays has proven difficult.231,232 This is in part because the process of 
antibody generation, which is performed in vivo, provides no control over the target-
binding affinity and spectrum of the resulting antibody. Nucleic-acid-based affinity 
reagents known as aptamers hold much promise in circumventing many of the 
shortcomings associated with antibodies.76 Aptamers are isolated through SELEX to bind 
targets of interest with high affinity and specificity. Unlike antibodies, aptamers can be 
isolated relatively quickly and chemically synthesized in an inexpensive manner with no 
batch-to-batch variation. Moreover, aptamers are thermostable and have shelf lives of a 
few years at room temperature.15 
Theoretically, since SELEX is an in vitro process, the selection strategy and 
conditions can be precisely controlled to isolate class-specific aptamers that can broadly 
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bind to small molecules sharing the same core structure. However, little work has been 
done to demonstrate the capability of SELEX to achieve such a goal. Aptamers isolated 
for a given small-molecule target often have innate cross-reactivity to analogs of that 
molecule, but the target-binding spectra of these aptamers are often either insufficient 
and/or unpredictable. For example, one heavily studied cocaine-binding aptamer21 can 
also bind to metabolites such as norcocaine and cocaethylene, but does not respond to the 
major metabolite benzoylecgonine, which only differs from cocaine by a single methyl 
group.88,233 Toggle-SELEX was developed as a solution to isolate cross-reactive 
aptamers.26 In this strategy, a library pool is challenged with two different targets sharing 
the same core structure, which are alternated every round to select for an aptamer that can 
cross-react to both targets—and ideally, target analogs sharing the same core structure. 
This method has led to the isolation of cross-reactive aptamers for a few structurally-
related small molecules.36,39,73 However, these aptamers typically exhibit only limited 
cross-reactivity,39,73 and the overall success rate of such approaches has been low.36 For 
example, Derbyshire et al. successfully isolated an aptamer that can bind to eight 
aminoglycoside antibiotics using Toggle-SELEX. Out of four independent selections 
with four different target pairs, and only one yielded the final aptamer.36 The limitations 
of Toggle-SELEX could be attributed to two reasons. First, in previously reported 
approaches, only a fraction of possible substituent positions was varied between the two 
targets, yielding aptamers with narrow target-binding spectra. Second, since only a small 
portion of the aptamers in the initial pool are cross-reactive compared to those that bind 
to at least one target, those cross-reactive aptamers could be lost during Toggle-SELEX. 
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To overcome these problems, we have developed a new ‘parallel-and-serial’ selection 
strategy for SELEX to isolate class-specific aptamers for small molecule families. Our 
strategy has three steps that are crucial for its success. First, a set of structurally-related 
targets are selected to define the core structure that is to be recognized by the isolated 
aptamer. The use of these targets creates selection pressure for aptamers that recognize 
generic molecular features common to all targets while remaining insensitive to 
peripheral substituents. Accordingly, it is important to choose as many targets as needed 
to represent variations at all desired substituent sites while preserving the core molecular 
framework of the target family. Next, these various targets are employed in a parallel 
selection process, in which multiple aptamer pools are enriched using each individual 
target. As a result, cross-reactive aptamers recognizing the shared core structure are 
enriched in all of the resulting pools after a few rounds of selection. When all these 
parallel pools are combined, the population of such aptamers should be relatively high. 
Finally, this combined pool is subjected to serial selection with each target sequentially, a 
process that ultimately retains only those aptamers that bind to the core structure shared 
by these targets. Importantly, this selection strategy is supplemented with a well-designed 
counter-SELEX procedure25 to further define the targeted core structure and to prevent 
the aptamer from binding to structurally-similar non-target molecules.  
As a demonstration of this strategy, we isolated a class-specific aptamer for synthetic 
cathinones, a large family of dangerous designer drugs173 that are associated with many 
severe psychological and physiological health consequences.174,175 The isolated aptamer 
demonstrated low nanomolar binding affinity to 12 synthetic cathinones while having no 
response to 11 structurally-similar non-cathinone molecules. Analysis of the aptamer 
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isolation process via high throughput sequencing revealed that cross-reactive sequences 
were enriched during parallel selection, and that exponential enrichment of such aptamers 
occurred during serial selection. The target-binding spectrum of the aptamer was further 
evaluated via a dye-displacement sensing platform. Impressively, the aptamer enabled 
instantaneous colorimetric detection of several synthetic cathinones at nanomolar 
concentrations in biological samples, rivaling the performance of any currently-available 
immunoassays which can only detect a few members of this family. To our knowledge, 
this is the first demonstration of using a rationally-designed strategy to isolate high-
affinity aptamers that are truly class-specific, having both broad target-binding spectrum 
as well as excellent specificity. Such success shows that the customizable nature of 
SELEX makes it well-suited for sourcing receptors with specific, yet broad molecular 
recognition capabilities, and that the approach described herein can be generally 
employed to directly isolate class-specific aptamers for any small-molecule family.  
6.2. Experimental section 
6.2.1 Materials  
All DNA oligonucleotides were purchased from Integrated DNA Technologies 
(HPLC-purified) and dissolved in PCR water. The names and sequences of the DNA 
oligonucleotides are listed in  
 
Table 6-1. The concentrations of dissolved DNA were measured using a NanoDrop 
2000 spectrophotometer (Thermo Fisher Scientific). Synthetic cathinone standands (all 
hydrochloride salts and racemic unless specified), including 3,4-methylenedioxy-α-
pyrrolidinobutiophenone (MDPBP), 3,4-methylenedioxypyrovalerone (MDPV), 3-
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fluoromethcathinone (3-FMC), 4-fluoromethcathinone (4-FMC), 4-methyl-
αpyrrolidinobutiophenone (MePBP), 4'-methyl-α-pyrrolidinohexiophenone (MPHP), 4-
methylmethcathinone (4-MMC), alpha-pyrrolidinopentiophenone (α-PVP), butylone, 
cathinone, ethylone, methcathinone, methedrone, methylone, naphyrone, pentylone, 
pyrovalerone, and pure enantiomers (-)-MDPV and (+)-MDPV were purchased from 
Cayman Chemicals. Acetaminophen, (±)-amphetamine hemisulfate, benzocaine, caffeine, 
cocaine HCl, diethylthiatricarbocyanine iodide (Cy7), (-)-ephedrine HCl, lidocaine HCl, 
(+)-methamphetamine HCl, procaine HCl, promazine HCl, (+)-pseudoephedrine HCl, 
sucrose and all other chemicals were purchased from Sigma-Aldrich unless otherwise 
noted.  Tween 20, formamide, SYBR Gold, streptavidin-coated agarose resin (capacity: 
1-3 mg biotinylated BSA/ml resin), One Shot Chemically Competent E. coli, TOPO TA 
cloning kit, PureLink Quick Plasmid Miniprep Kit, and ExoSAP-IT Express PCR 
Purification Kit were purchased from ThermoFisher Scientific. 500 μL micro-gravity 
columns were purchased from Bio-Rad. GoTaq Hot Start Colorless Master Mix was 
purchased from Promega. 3 kDa cut-off spin filters were purchased from Millipore.  
 
Table 6-1. Sequences of DNA oligonucleotides employed in Chapter 6. 
 
Sequence ID Sequence (5’ – 3’) 
DNA Library CGAGCATAGGCAGAACTTACGAC(N30) 
GTCGTAAGAGCGAGTCATTC 
cDNA-bio TTTTTGTCGTAAGTTCTGCCATTTT/Bio/ 
FP CGAGCATAGGCAGAACTTAC 
RP-bio /Bio/GAATGACTCGCTCTTACGAC 
RP GAATGACTCGCTCTTACGAC 
SCA2.1 CTTACGACCTTAAGTGGGGTTCGGGTGGAGTTTATGGGGTCGTAAG 
N represents random base; /Bio/ represents biotin modification 
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6.2.2 SELEX strategy 
The isolation of aptamers was carried out via a parallel-and-serial selection strategy. 
The whole aptamer isolation process consisted of five (ethylone and butylone) or nine (α-
PVP) rounds of parallel selection and two cycles of serial selection. Detailed information 
regarding the conditions for each round of selection are listed in Table 6-2. Since each 
sequence has a low copy number at the beginning of SELEX, high target concentrations 
were used during the first few rounds to ensure retention of all possible target binders. 
Moreover, counter-target concentrations were initially kept low to remove high-affinity 
interferent binders while avoiding loss of target binders. In later rounds of SELEX, 
selection stringency was increased by decreasing the target concentration and increasing 
the counter-target concentration; this would yield aptamers with high target affinity and 
specificity. The counter-SELEX protocol was rationally designed to encompass known 
and commonly-observed interferents found in seized drug samples, including cutting 
agents (e.g., caffeine and acetaminophen), adulterants (e.g., procaine, lidocaine, and 
promazine), other illicit drugs (e.g., cocaine and methamphetamine), or structurally-
related non-cathinone molecules (e.g., amphetamine, pseudoephedrine and ephedrine) to 
ensure that the isolated aptamer did not bind to them.  
6.2.3 Parallel selection  
Parallel selection began with three initial pools consisting of 1 nmole DNA library 
(Table 6-1) for each of the three different selection targets (α-PVP, ethylone, butylone). 
From Round P2 to P9, ~ 300 pmole of enriched library pool for each target from the 
previous round were employed in the subsequent round. Positive selection was performed 
with progressively decreasing target concentrations (Round P1: 1 mM, Rounds P2–P3: 
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500 µM, Rounds P4–P5: 250 µM for α-PVP, ethylone and butylone; Rounds P6–P9: 100 
µM for α-PVP only) to increase selection stringency for the enrichment of strong binders. 
For every round after the first, counter-selection was performed prior to positive selection 
in order to eliminate non-specific binders. The number of counter-targets and their 
concentrations were progressively increased during the selection process to increase 
selection stringency. Specifically, from Rounds P2–P5 for the ethylone and butylone 
pools and Rounds P2–P8 for the α-PVP pool, we used the following counter-selection 
strategy: 100 µM cocaine for Round P2, a mixture of 100 µM cocaine and 100 µM 
procaine for Round P3, and a mixture of 100 µM cocaine, 100 µM procaine, and 100 µM 
lidocaine for Rounds P4–P8. For Round P9 for the α-PVP pool, 300 µM each of cocaine, 
procaine, and lidocaine was employed consecutively for counter selection (Table 6-2). 
6.2.4 Serial selection 
We combined 100 pmole each from the P5 parallel pools for ethylone and butylone 
and the P9 parallel pool for α-PVP to generate the initial pool for serial selection. Two 
cycles of serial selection (Cycle 1 comprising Rounds S1–S3, Cycle 2 comprising 
Rounds S4–S6) were performed to specifically isolate cross-reactive aptamers. For each 
cycle, positive selection was performed by alternating the selection target (Rounds S1 & 
S4: butylone, Rounds S2 & S5: ethylone, and Rounds S3 & S6: α-PVP). Target 
concentration was maintained at 100 µM for each round of serial selection for maximum 
stringency. In the first cycle of serial selection, counter-SELEX was performed prior to 
each round of positive selection by consecutively challenging the pool with 500 µM each 
of cocaine, procaine, and lidocaine, while in the second cycle of serial selection, counter-
SELEX was performed by sequentially challenging with a mixture of 500 µM each of 
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ephedrine, pseudoephedrine, acetaminophen, methamphetamine, amphetamine; then with 
a mixture of 1 mM each of cocaine, procaine, and lidocaine; and finally with 500 µM 
promazine (Table 6-2).  
Table 6-2. Detailed information regarding the conditions for each round of SELEX. 
 
 Round 
# 
Pool size 
(pmole) Counter-targets 
Targets 
(µM) 
Pa
ra
lle
l s
el
ec
tio
n 
P1 
1000 
N/A 
Butylone (1000) 
1000 Ethylone (1000) 
1000 α-PVP    (1000) 
P2 
358 
COC (100 µM) 
Butylone (500) 
346 Ethylone (500) 
368 α-PVP    (500) 
P3 
321 
Mixture of COC & PRC (100 µM each) 
Butylone (500) 
362 Ethylone (500) 
345 α-PVP    (500) 
P4 
319 
Mixture of COC, PRC, & LDC (100 µM each) 
Butylone (250) 
367 Ethylone (250) 
292 α-PVP    (250) 
P5 
300 
Mixture of COC, PRC, & LDC (100 µM each) 
Butylone (250) 
300 Ethylone (250) 
300 α-PVP    (250) 
P6 300 Mixture of COC, PRC, & LDC (100 µM each) α-PVP    (100) 
P7 300 Mixture of COC, PRC, & LDC (100 µM each) α-PVP    (100) 
P8 300 Mixture of COC, PRC, & LDC (100 µM each) α-PVP    (100) 
P9 300 COC 
(300 µM) 
PRC 
(300 µM) 
LDC 
(300 µM) 
α-PVP    (100) 
Se
ria
l s
el
ec
tio
n 
S1 300* 
COC 
(500 µM) 
PRC 
(500 µM) 
LDC 
(500 µM) 
Butylone (100) 
S2 300 Ethylone (100) 
S3 300 α-PVP    (100) 
S4 300 Mixture of EPH, 
PSE, ACM, 
METH, & AMP 
(500µM each) 
Mixture of COC, 
PRC, & LDC                      
(1000 µM  each) 
Promazine 
(500µM) 
Butylone (100) 
S5 300 Ethylone (100) 
S6 300 α-PVP    (100) 
  
* Consists of 100 pmole each of pool enriched with butylone (Round P5), ethylone (Round P5) 
and α-PVP (Round P9). 
Acetaminophen (ACM), amphetamine (AMP), cocaine (COC), ephedrine (EPH), lidocaine (LDC), 
methamphetamine (METH), procaine (PRC), pseudoephedrine (PSE).  
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6.2.5 SELEX procedure 
The isolation of aptamers was carried out following a previously-reported library-
immobilized SELEX protocol.61 The initial single-stranded DNA library used for SELEX 
consisted of approximately 6×1014 oligonucleotides. Each library strand is stem-loop 
structured and 73 nucleotides in length, with a randomized 30 nucleotide loop flanked in 
turn by a pair of 8-nt stem-forming sequences and two primer-binding regions (Table 
6-1, DNA library). For each round of SELEX, the library/pool was mixed with 
biotinylated capture strands (Table 6-1, cDNA-bio) at a molar ratio of 1:5 in selection 
buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, pH 7.4), heated at 95 °C for 10 
min, and cooled at room temperature for over 30 min to ensure hybridization between 
library and capture strands. A micro-gravity column was prepared by adding 250 μL of 
streptavidin-coated agarose beads followed by three washes with 250 µL of selection 
buffer. 250 µL of library solution was then flowed through the micro-gravity column 
three times in order to conjugate the library to the agarose beads (Figure 6-1A). The 
column was subsequently washed 10 times with selection buffer. Then, 250 µL of target 
(α-PVP, ethylone or butylone) dissolved in selection buffer was added to the column. 
Library molecules that bound to the target underwent a conformational change, which 
caused them to detach themselves from the biotinylated cDNA into solution (Figure 
6-1B). The eluent containing these strands was collected. This process was repeated 
twice, and all eluents were combined (750 µL total). The resulting pool was concentrated 
via centrifugation using a 3 kDa cut-off spin filter. The concentrated pool (100 µL) was 
then mixed with 1 mL of GoTaq Hot Start Colorless Master Mix with 1 µM forward 
primer (Table 6-1, FP) and 1 µM biotinylated reverse primer (Table 6-1, RP-bio) to 
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amplify the pool via PCR. Amplification was performed using a BioRad C1000 thermal 
cycler with conditions as follows: 2 min at 95 °C; 13 cycles of 95 °C for 15 s, 58 °C for 
30 s, and 72 °C for 45 s; and 5 min at 72 °C. The optimal number of amplification cycles 
was determined by performing pilot PCR to ensure sufficient amplification of enriched 
sequences without generating PCR-related artifacts. Amplification of the enriched pool 
and the absence of byproducts was confirmed using 3% agarose gel electrophoresis. If 
byproducts with differing lengths from the original library strands were observed, the 
pool was purified with a 4% agarose gel and the 73-nt products were recovered by silica 
column as reported previously.61 To generate single-stranded DNA from the resulting 
double-stranded PCR products, a fresh micro-gravity column was prepared containing 
250 µL streptavidin-coated agarose beads. The amplified pool was then flowed through 
the column three times to conjugate the pool to the beads. Afterwards, the column was 
washed six times with 250 µL of separation buffer (10 mM Tris-HCl, 20 mM NaCl, pH 
7.4). The column was then capped, and 300 µL of a 0.2 M NaOH solution was added to 
the column and incubated for 10 min to generate single-stranded DNA, after which the 
eluent was collected. An additional 100 µL of 0.2 M NaOH was added to elute residual 
library strands from the column. Both eluents were combined and neutralized with 0.2 M 
HCl, and the pool was then concentrated via centrifugation with a 3 kDa cut-off spin 
filter. For every round after the first, counter-SELEX was performed before the positive 
selection step. Specifically, the library-immobilized column was washed with 250 µL of 
counter-target(s) in selection buffer to remove non-specific DNA strands. This process 
was repeated three times for Rounds P1–P3 and S1–S6, and ten times for Rounds P4–P5 
and, in the case of α-PVP, Rounds P6–P9. Afterwards, the column was washed 30 times 
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with selection buffer to wash away non-specific binders in preparation for positive 
selection. 
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Figure 6-1. Scheme for library-immobilized SELEX. (A) Library molecules are immobilized on 
streptavidin-coated agarose beads via a biotinylated complementary DNA (cDNA) strand. (B) 
Strands that bind to the target are released into solution via target-induced strand displacement.  
6.2.6 Gel elution assay 
The enrichment, target affinity, specificity, and cross-reactivity of the pools collected 
after Rounds P5 (for α-PVP, ethylone, and butylone), P9 (for α-PVP only), S3, and S6 
were evaluated using a modified version of a previously reported gel elution assay 
(Figure 6-2).34 Specifically, 50 pmole of enriched library (Figure 6-2A) was incubated 
with 250 pmole of biotinylated cDNA in 125 μL of selection buffer, heated at 95°C for 
10 min, and cooled at room temperature over 30 min to anneal both strands and form 
cDNA-library complex (Figure 6-2B). Afterwards, a microcentrifugation column was 
prepared by adding 125 μL of streptavidin-coated agarose beads. The cDNA-library 
complex was then added to the column and immobilized on the beads (Figure 6-2C), and 
the eluent was collected and recycled through the column twice more. The library-
immobilized agarose beads were transferred into a microcentrifugation tube and washed 
five times by adding 625 µL of selection buffer, incubating on an end-over-end rotator 
for 5 min, followed by centrifugation and removal of the supernatant. The volume of the 
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library-immobilized bead solution was adjusted to 150 µL with selection buffer and 
aliquoted into 7 tubes (20 μL/tube). Afterwards, 50 μL of target at a variety of final 
concentrations (0, 10, 50, 100, 250, 500, or 1,000 μM) was added into each tube (Figure 
6-2D). After rotating for 60 min on an end-over-end rotator at room temperature, the 
beads were settled by centrifugation and 40 µL of the supernatant, which contained the 
target-eluted strands, was collected and set aside (Figure 6-2E). Meanwhile the leftover 
solution (30 µL) (Figure 6-2F) was mixed with 50 μL of a 95% formamide solution 
containing 10 mM EDTA and incubated at 90 °C for 10 min to completely release all 
DNA strands from the beads (Figure 6-2G). The resulting solution contained both 
leftover target-eluted strands and non-target-eluted strands. We analyzed the target-eluted 
aptamer solution and formamide-treated library solution via 15% denaturing 
polyacrylamide gel electrophoresis (PAGE) and determined the concentrations of the 
strands based on standardized concentrations of ladder loaded in the gel. The elution 
percentage was calculated using the equation:   
where θ is the fraction of target-eluted strands, cs is the concentration of target-eluted 
strands, cb is the concentration of strands in the formamide solution, V1 is the volume of 
solution before supernatant collection (estimated as 62 μL, with ~8 μL occupied by 
agarose beads), V2 is the volume of the collected supernatant containing target-eluted 
strands (40 μL), and V3 is the volume of solution after addition of formamide (80 μL). A 
calibration curve was created by plotting the fraction of eluted strands against the 
employed target concentration. The resulting curve was fitted with the Langmuir equation 
to determine the dissociation constant (KD) of the enriched pool. The same protocol was 
147 
 
used to determine the target cross-reactivity and specificity of the enriched pool for other 
synthetic cathinones (4-MMC, 4-FMC, MDPBP, MDPV, MePBP, methedrone, 
methylone, MPHP, naphyrone, pentylone, and pyrovalerone) or interferents 
(acetaminophen, amphetamine, caffeine, cocaine, ephedrine, lidocaine, 
methamphetamine, procaine, promazine, pseudoephedrine, and sucrose).  
 
Figure 6-2. Scheme of the gel elution assay. (A) Library strands are hybridized with biotinylated 
cDNA to form (B) library-cDNA complex. (C) The resulting complex is immobilized on 
streptavidin-coated agarose beads. (D) The target is added the solution and (E) the supernatant 
containing the target-bound strands is collected and added to a separate tube. (F) The leftover 
beads are treated with formamide-EDTA and heat to (G) release remaining non-binding strands 
from the beads. The quantity of DNA in the solutions obtained from E and G is determined via 
PAGE; the number of eluted strands is used to calculate the pool binding affinity and specificity 
using the boxed equation.  
6.2.7 High throughput sequencing (HTS) analysis of the aptamer isolation process  
HTS of the three final parallel pools and two serial pools was performed using Ion 
Torrent Sequencing. To prepare samples for sequencing, 1 µM pool was mixed with 
GoTaq® Hot Start Colorless Master Mix, 1 µM forward primer, and 1 µM reverse primer 
with a final volume of 100 µL. PCR was then performed with the same PCR conditions 
as described in ‘SELEX Procedure’. Then 40 µL of PCR product was added into 16 µL 
of ExoSAP-IT™ reagent in an ice bath. The mixture was then incubated at 37 ℃ for 15 
min to degrade remaining primers and nucleotides, followed by incubation at 80 ℃ for 15 
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min to inactivate ExoSAP-IT reagent. HTS was performed at FIU DNA Core Facility 
using an Ion Personal Genome Machine System with an Ion 318 v2 chip (ThermoFisher 
Scientific). Upon obtaining the sequencing data, the primer sequences were trimmed by 
cutadapt234 and the population of sequences from each pool were calculated using 
FASTAptamer.235 Members of the SCA2.1 family are defined as sequences containing 
“AGTGGGGTTCGGGTGGAGTT” in any position in the 30-nt random region.  
6.2.8 Cloning and sequencing 
Cloning and sequencing of the final enriched pool was performed using a previously 
reported protocol.61 Briefly, the enriched sequences from the final pool (Round S6) were 
amplified by PCR with unlabeled forward and reverse primers (Table 6-1, FP and RP) 
using the same program as described above in ‘SELEX procedure’. At the end of the 
amplification protocol, an additional 30 min extension step was performed at 72 °C to 
add a poly-A tail. Amplicons were cloned into a plasmid vector and transformed into E. 
coli cells using the TOPO TA cloning kit (Invitrogen) according to the supplier 
recommendations. The plasmids from 50 randomly picked colonies were extracted using 
a PureLink Quick Plasmid Miniprep Kit (Invitrogen) and sequenced via Sanger 
Sequencing at the Florida International University DNA Core Facility. After removing 
the sequences of the plasmid and primers, the aptamer sequences were aligned with 
BioEdit software to determine the consensus sequence. 
6.2.9 Isothermal titration calorimetry (ITC) 
ITC was performed using a MicroCal ITC200 instrument (Malvern). All ITC 
experiments were carried out using the following protocol at 23 °C. A solution containing 
the aptamer (final concentration 20 µM) was prepared in selection buffer (10 mM Tris-
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HCl, 0.5 mM MgCl2, 20 mM NaCl, pH 7.4) and loaded into the ITC sample cell. We then 
loaded different concentrations of synthetic cathinone (350 µM (±)-α-PVP, 300 µM (±)-
ethylone, 400 µM (±)-butylone, 300 µM (±)-MDPV, 225 µM (-)-MDPV, or 400 µM (+)-
MDPV) or interferent (1 mM (±)-amphetamine, (+)-methamphetamine, cocaine, 
procaine, or (+)-ephedrine) in the same buffer into the syringe and titrated it into the cell, 
with an initial 0.4 μL purge injection followed by 19 successive 2 μL injections. A 
spacing of 180 seconds was used between each titration. The heat generated from each 
titration was recorded, and the binding stoichiometry (N), enthalpy (ΔH), and KD were 
obtained by fitting the resulting titration curve with a single-site binding model (wherein 
the aptamer and synthetic cathinone are considered to be the receptor and ligand, 
respectively) using the MicroCal analysis kit integrated into Origin 7 software. All 
titrations involving racemic synthetic cathinone mixtures were also fitted with a modified 
two-site binding model to determine the binding parameters for each enantiomer. This 
model assumes that a receptor with two ligand-binding sites independently interacts with 
a ligand. Unlike the single-site binding model, the aptamer in the sample cell is 
considered as the ligand and the pair of synthetic cathinone enantiomers is considered as 
a receptor with two discrete binding sites. For example, titration of 300 µM (±)-MDPV – 
containing 150 µM each of (-)-MDPV and (+)-MDPV – into 20 µM SCA2.1 is treated as 
titration of 150 µM of a receptor with two independent ‘binding sites’ into 20 µM of 
ligand. The binding parameters of the first site (i.e. N1, KD1, ΔH1) reflect the binding of 
one of the enantiomers to the aptamer, while those for the second site (i.e. N2, KD2, ΔH2) 
reflect the binding of the other. 
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6.2.10 Characterization of Cy7 binding to SCA2.1 
8 µL of different concentrations of SCA2.1, 8 µL of 20 µM Cy7, and 64 µL of 
reaction buffer (final concentration 10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, 
0.01% Tween 20, and 1% DMSO, pH 7.4) were mixed in the wells of a transparent flat-
bottomed 384-well plate. UV-vis spectra were immediately recorded from 450–900 nm 
using a Tecan Infinite M1000 PRO microplate reader at room temperature. The 
absorbance value at 775 nm (λmax of Cy7 monomer) was plotted against the concentration 
of added aptamer. KD was estimated by non-linear fitting using the Langmuir equation. 
6.2.11 Cy7-displacement assay for colorimetric detection of synthetic cathinones  
8 µL of SCA2.1 (final concentration: 3 μM), 8 µL of Cy7 (final concentration 2 μM), 
8 µL of varying concentrations of target (α-PVP, butylone, or ethylone), and 56 µL of 
reaction buffer (final concentration 10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, 
0.01% Tween 20, 1% DMSO, pH 7.4) were mixed in the wells of a transparent flat-
bottomed 384-well plate. UV-vis spectra were immediately recorded from 450–900 nm 
using a Tecan microplate reader at room temperature. The absorbance ratio between 670 
nm and 775 nm (A670/A775) was calculated for each sample, and signal gain was 
calculated by (R–R0)/R0, where R0 and R represent A670/A775 without and with target, 
respectively. Using the same protocol, the cross-reactivity and specificity of the assay 
were tested with other synthetic cathinones (naphyrone, MDPV, pentylone, methylone, 4-
MMC, 4-FMC, 3-FMC, methcathinone and cathinone) and interferents (amphetamine, 
methamphetamine, cocaine, pseudoephedrine, ephedrine, procaine, lidocaine, 
benzocaine, caffeine, acetaminophen, and sucrose) at a concentration of 50 µM. Cross-
reactivity was calculated using the signal gain of 50 µM ethylone as 100%. For visual 
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synthetic cathinone detection, the assay was performed using the same protocol but with 
higher concentrations of SCA2.1 (5 μM) and Cy7 (3.5 μM) with 50 μM of the 
aformentioned synthetic cathinones or interferents.  Samples were loaded into a white 
flat-bottomed 384-well plate. Photographs of the samples were taken using a digital 
camera immediately after mixing all reaction components. 
6.3. Results and discussion 
6.3.1 Choosing targets for selection 
Synthetic cathinones share the same β-keto phenethylamine chemical core structure 
and typically differ at four substituent sites (Figure 6-3A, core structure). Performing 
selection directly against this ‘bare core’ (i.e. 2-amino-propiophenone, also known as 
cathinone) may yield aptamers with high affinity towards cathinone, but there is no 
guarantee that such aptamers will bind other synthetic cathinones that have different 
substituents on the core structure. This is supported by previous studies which showed 
that small-molecule-binding aptamers isolated for a single target often have lower or no 
affinity for compounds with additional/differing substituents.25,110 We rationalized that 
performing SELEX with a set of structurally-similar, yet sufficiently diverse, targets 
would create selection pressure for isolating aptamers that tolerate variations at all such 
sites, greatly increasing the likelihood that the isolated aptamer will have high cross-
reactivity to this family as a whole. Thus, to isolate class-specific synthetic cathinone-
binding aptamers, we selected three targets that share the same core structure but have 
variations at all of the substitution sites that are typically modified in this family: α-
pyrrolidinovalerophenone (α-PVP), ethylone, and butylone (Figure 6-3A).  
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Figure 6-3. Isolation of a class-specific aptamer using a parallel-and-serial SELEX strategy. (A) 
The core structure of synthetic cathinones and the three targets chosen for parallel-and-serial 
SELEX, with substituent moieties shaded in red. (B) Schematic diagram of parallel-and-serial 
SELEX. Each of the three targets was subjected to parallel SELEX to enrich for broadly synthetic 
cathinone-specific aptamers (top), after which the resulting pools were combined and subjected to 
serial SELEX screening (bottom) to eliminate target-specific binders while retaining those 
aptamers with broad cross-reactivity for this drug class. 
6.3.2 Parallel selection 
Parallel selection was performed using three different initial library pools, with one 
pool being challenged with α-PVP, one with ethylone, and one with butylone (Figure 
6-3B, top). Presumably, challenging the parallel pools with individual targets enriches all 
sequences binding to the target, including those that are also cross-reactive to other 
synthetic cathinones. In contrast, challenging a single pool with a mixture of targets may 
lead to loss cross-reactive aptamers. This is evidenced by a previous study which 
demonstrated that performing SELEX with a mixture of four targets yielded aptamers 
that specifically bind to just one of the four.37 This may be attributable to competitive 
binding among these targets.  
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Figure 6-4. Determination of the target-binding affinity, cross-reactivity, and specificity of the 
round P5 ethylone pool via gel-elution assay. (A) Polyacrylamide gel electrophoresis (PAGE) 
results depict the target elution profile, with lanes representing samples of the pool eluted with 0, 
50, 100, 250, 500, or 1,000 µM ethylone (left to right). The percent of target-eluted pool was 
plotted against the concentration of ethylone employed for elution to determine the binding 
affinity of the enriched pool. (B) PAGE analysis (top) of elution with 500 µM synthetic 
cathinones (α-PVP, ethylone, butylone) or interferents (cocaine, procaine, lidocaine) was used to 
measure cross-reactivity and specificity of the enriched P5 pool. 
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Figure 6-5. Determination of the target-binding affinity, cross-reactivity, and specificity of the 
round P5 butylone pool via gel-elution assay. (A) PAGE results depict the target elution profile, 
with lanes representing samples of the pool eluted with 0, 50, 100, 250, 500, or 1,000 µM 
butylone (left to right). The percent of target-eluted pool was plotted against the concentration of 
butylone employed for elution to determine the binding affinity of the enriched pool. (B) PAGE 
analysis (top) of elution with 500 µM synthetic cathinones (α-PVP, ethylone, butylone) or 
interferents (cocaine, procaine, lidocaine) was used to measure cross-reactivity and specificity of 
the enriched P5 pool.  
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Figure 6-6. Determination of the target-binding affinity, cross-reactivity, and specificity of the 
round P5 α-PVP pool via gel-elution assay. (A) PAGE results depict the target elution profile, 
with lanes representing samples of the pool eluted with 0, 50, 100, 250, 500, or 1,000 µM α-PVP 
(left to right). The percent of target-eluted pool was plotted against the concentration of α-PVP 
employed for elution to determine the binding affinity of the enriched pool. (B) PAGE analysis 
(top) of elution with 500 µM synthetic cathinones (α-PVP, ethylone, butylone) or interferents 
(cocaine, procaine, lidocaine) was used to measure target-cross-reactivity and specificity of the 
enriched P5 pool. 
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Figure 6-7. Determination of the target-binding affinity, cross-reactivity, and specificity of the 
round P9 α-PVP pool via gel-elution assay. (A) PAGE results depict the target elution profile, 
with lanes representing samples of the pool eluted with 0, 50, 100, 250, 500, or 1,000 µM α-PVP 
(left to right). The percent of target-eluted pool was plotted against the concentration of α-PVP 
employed for elution to determine the binding affinity of the enriched pool. (B) PAGE analysis 
(top) of elution with 500 µM synthetic cathinones (α-PVP, ethylone, butylone) or interferents 
(cocaine, procaine, lidocaine) was used to measure target-cross-reactivity and specificity of the 
enriched P9 pool.  
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To perform parallel selection, we employed a library pool consisting of ~6×1014 
unique oligonucleotide sequences, which form an 8-bp stem and a 30-nt random loop as 
the putative target-binding domain (Figure 6-1A). During the first round, each initial 
library pool was challenged with 1 mM target, and eluted strands were collected and 
amplified for the next round of selection. To further establish class-specificity, from the 
second round onward we performed counter-SELEX prior to the positive selection step to 
remove aptamers binding to structurally-similar interferents (e.g. cocaine, procaine, 
lidocaine) that have the same functional groups or partial structural features as our 
targets. In round two, counter-SELEX was first performed for each pool against 100 µM 
cocaine, followed by positive selection with 500 µM target, as reducing target 
concentration increases selection stringency.62–64 In the third round, a mixture of 100 µM 
cocaine and 100 µM procaine was used for counter-SELEX, with the same target 
concentration for positive selection. In rounds four and five, counter-SELEX was 
performed against cocaine, procaine, and lidocaine (each at a concentration of 100 µM) 
in a mixture, with 250 µM target used for the positive selection step.  
After the fifth round, a gel-elution assay (see methods) was performed to determine 
the target-binding affinity of each pool for its respective target. We observed that the 
fraction of eluted library increased with increasing target concentrations for the ethylone 
and butylone pools (Figure 6-4A and Figure 6-5A), showing that aptamers binding to 
these targets had been enriched through parallel selection. In contrast, target elution 
remained low for the α-PVP pool (Figure 6-6A) regardless of the employed concentration 
of target, which indicated that the pool was not yet enriched. We further determined the 
cross-reactivity and specificity of the three pools via the gel-elution assay. The enriched 
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ethylone and butylone pools were able to bind to both ethylone and butylone, but not to 
α-PVP, which indicated that the population of cross-reactive aptamers was relatively low. 
These pools also showed some affinity to procaine, with the ethylone pool also binding to 
cocaine. Neither pool displayed any affinity for lidocaine (Figure 6-4B and Figure 6-5B). 
In contrast, the α-PVP pool showed no affinity for any of the targets or counter-targets 
(Figure 6-6B).  
Given that the α-PVP pool was not yet enriched, we performed additional rounds of 
selection. From rounds six to eight, we used the same counter-target mixture of 100 µM 
cocaine, procaine, and lidocaine from round 5 with a further-reduced α-PVP 
concentration of 100 µM for positive selection. For the ninth round, we used the same α-
PVP concentration but with counter-selection performed with 300 µM of each of the 
three counter-targets in a consecutive manner. After the ninth round, we performed the 
gel-elution assay with the enriched pool and observed a clear target concentration-
dependent elution profile for α-PVP, with an estimated dissociation constant (KD) of 28 
µM (Figure 6-7A). Notably, only 30% of the library was eluted, even in the presence of 1 
mM α-PVP, which implied that there was just a small population of binders in the pool. 
We also determined that this pool displayed affinity to ethylone and butylone but was less 
responsive towards the various interferents (Figure 6-7B), which can be attributed to the 
fact that more rounds of counter-SELEX were performed. Given that the pools enriched 
with individual targets also cross-reacted to other targets, it seemed likely that those pools 
contained cross-reactive aptamers. We believed that if parallel selection was continued, 
highly target-specific aptamers would have begun to dominate the pool, therefore we 
terminated parallel selection before this could occur.  
157 
 
TargetA B
α-PVP
Ethylone
Butylone
KD
 (µM)
34
77
82
 
Figure 6-8. Determination of the target-binding affinity, cross-reactivity and specificity of the 
round S3 pool via a gel elution assay. (A) PAGE results depict the target elution profile with 
lanes representing samples of the pool eluted with 0, 10 50, 100, 250, 500, or 1,000 µM (left to 
right) of α-PVP, ethylone, or butylone. The percent of target-eluted pool was plotted against the 
concentration of target used for elution to determine the binding affinity of the enriched pool. (B) 
PAGE analysis of enriched pool eluted with 500 µM synthetic cathinones (α-PVP, ethylone, 
butylone) or interferents (cocaine, procaine, lidocaine) was used to measure target-cross-
reactivity and specificity of the enriched S3 pool.  
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Figure 6-9. Characterization of the affinity and specificity of the final enriched pool via a gel-
elution assay. (A) PAGE results depict the target elution profile, with lanes representing samples 
of the pool eluted with 0, 10, 50, 100, 250, 500, or 1,000 µM (from left to right) α-PVP, ethylone, 
or butylone. The percent of target-eluted pool was plotted against the concentration of target to 
determine the binding affinity of the enriched pool. (B) Percent elution values for 14 synthetic 
cathinones and 11 interferents at a concentration of 50 µM and buffer alone.  
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6.3.3 Serial selection  
We then performed serial selection to enrich cross-reactive aptamers and exclude 
those specific to individual targets (Figure 6-3B, bottom). We combined all three 
enriched parallel pool as a starting library. For each cycle of serial selection, we 
challenged the combined pool with each target sequentially for a total of three rounds of 
selection using butylone (first round), ethylone (second round), and α-PVP (third round). 
In each round, we first performed counter-SELEX with 500 µM cocaine, procaine, and 
lidocaine sequentially followed by positive selection with 100 µM target. After the first 
cycle of serial selection against all three targets, we performed the gel-elution assay to 
determine the cross-reactivity and specificity of the resulting pool. We observed that the 
cross-reactivity towards ethylone and butylone had substantially increased (KD = 82 µM 
and 77 µM, respectively) relative to the individual pools obtained for these targets at the 
end of parallel selection, while affinity towards α-PVP was essentially unchanged (KD = 
34 µM) (Figure 6-8A). Importantly, this pool exhibited greatly improved specificity, with 
minimal affinity for cocaine and lidocaine and only a moderate response to procaine 
(Figure 6-8B). We then performed a second cycle of serial selection with an identical 
selection procedure but with a three-stage counter-SELEX process entailing sequential 
screening against a mixture of 500 µM each of ephedrine, pseudoephedrine, 
acetaminophen, methamphetamine, amphetamine, then a mixture of 1 mM each of 
cocaine, procaine, and lidocaine, and finally with 500 µM promazine. We believe that the 
inclusion of these additional counter-targets, which are similar in structure to synthetic 
cathinones and commonly encountered in seized substances, further enhance the 
specificity of the enriched pool. After this cycle, we again evaluated the pool binding 
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affinity via the gel-elution assay (Figure 6-9A). Each individual target (at a concentration 
of 500 µM) eluted more than 70% of the pool. The pool affinity towards ethylone and 
butylone had increased by ~10-fold (KD = 6.9 µM and 9.5 µM, respectively), whereas the 
affinity towards α-PVP only marginally increased (KD = 21 µM).  
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Figure 6-10. Chemical structures. The chemical structures of the (A) synthetic cathinones and 
(B) interferent compounds used in this work are shown. Note that racemic MDPV was also used 
in this work. 
 
6.3.4 Characterization and sequencing of the final serial pool 
We concluded that at this stage, the enriched pool largely comprised of cross-reactive 
synthetic-cathinone-binding aptamers. To confirm this, we used the gel-elution assay to 
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test the cross-reactivity of this pool by challenging it with the three targets as well as 11 
other synthetic cathinones (Figure 6-10A). All of them demonstrated >60% target elution 
at a concentration of 50 µM (Figure 6-9B). This shows that the aptamer could recognize 
the core structure of synthetic cathinones, while being tolerant even to side-chain 
substituents that were not encountered during SELEX. To evaluate the specificity of the 
enriched pool, we challenged the pool with 50 µM of the counter targets and other 
potential interferents (Figure 6-10B) and found that none of them showed increased 
elution compared with buffer alone (Figure 6-9B). We therefore cloned and sequenced 
this final enriched pool. The pool was revealed to have low diversity, with 30 of the 50 
clones having an identical sequence, which we named SCA2.1 (Table 6-3). Mfold82 
predicts that SCA2.1 has a stem-loop structure with a 9-bp stem and a 28-nt loop in our 
selection buffer at room temperature (Figure 6-11).  
∆G = -6.89 kcal mol-1  
Figure 6-11. Secondary structure of SCA2.1 as predicted by Mfold at selection buffer ion 
concentrations (20 mM Na+ and 0.5 mM Mg2+) at 23 ºC. Estimated free energy of formation (ΔG) 
is also shown.  
161 
 
Table 6-3. The sequences of the N30 random domain of the oligonucleotides from the final 
enriched pool. The prevalence of each oligonucleotide is ranked from highest to lowest based on 
the number of counts. 
No. Sequences (5’ – 3’) Counts (total 50) 
1 (SCA2.1) CTTAAGTGGGGTTCGGGTGGAGTTTATGGG 30 
2 TGAGAAGTGTGATTCAGTATGTTTTCCGAA 7 
3 CGAGAAGTGTGTTCAGTGAGTTTTCCGAGG 4 
4 CGCGGGGGTGGCTGGGGGTGTCTAGCAGAG 2 
5 ATTAAGTGGGGTTCGGGTGGAGTTTATGGG 1 
6 CCTTGGGTAGGTCAGTGTGGGGTTAGGGA 1 
7 CTTAAGTGGGGTTCGGGCGGAGTTTATGGG 1 
8 GGGAAGTGGGGTTCGGGTGGTGTTTTCCCA 1 
9 GGGATGGGGTGCTCGGTCGGGGGTTGTGAG 1 
10 GGTAAGAGTGGTTCCAGTTGAGTTTATGCC 1 
11 GGTCAGCACCTGTCGTGGTGGAGGGGTACT 1 
 
6.3.5 HTS analysis of the selection process 
We performed a thorough investigation of the parallel-and-serial selection process 
using HTS. Specifically, we sequenced our three final parallel pools (butylone P5, 
ethylone P5, and α-PVP P9) and two serial pools (S3 and S6) (Figure 6-12). Analysis of 
the parallel pools showed that the most prevalent sequence represented 0.0079% 
(butylone P5), 0.0012% (ethylone P5), and 4.6% (α-PVP P9) of their respective pool. The 
greater enrichment observed in the α-PVP P9 pool is probably due to the additional four 
rounds of parallel selection. Nevertheless, no particular sequence dominated any of these 
parallel pools, which indicated that they were not yet highly enriched. Meanwhile, the 
SCA2.1 family (see methods) comprised 0.011% of the butylone P5 pool and 0.00095% 
of the α-PVP P9 pool, which is notably higher than the median sequence abundance in 
each pool (0.00019% for butylone P5 and 0.00032% for α-PVP P9), showing that parallel 
selection enriches cross-reactive aptamers. We noted that ethylone P5 pool did not show 
any signs of enrichment. To determine if cross-reactive aptamers were present or lost in 
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the ethylone pool, we performed an additional three rounds of parallel selection for this 
pool and then performed high-throughput sequencing with the resulting ethylone P8 pool. 
We found that the SCA2.1 family represented 0.1% of this pool, which implies that these 
sequences were originally present in the ethylone P5 pool, but at an amount below the 
detection capability of the HTS method we employed. 
 
Figure 6-12. Box and whisker plots of the population distribution of sequences. Population 
distribution of sequences after parallel selection (butylone P5, ethylone P5, ethylone P8, and α-
PVP P9) and each round of serial selection (S3 and S6) are shown. The longest horizontal line 
indicates the 50th percentile, with the boundaries of the box indicating the 5th- and 95th -
percentile, and the whiskers indicate the highest and lowest values of the results. Sequences with 
population above 95th percentile are plotted as grey dots. The SCA2.1 family is plotted as a red 
dot in each pool, except for the ethylone P5 pool where no such sequences were detected. Inset 
shows the pool population distribution after eight rounds of parallel selection using ethylone as 
target. Given the high diversity of the parallel pools, the lowest value, 5th, 50th, and 95th percentile 
all overlap, thus the box and lowest whisker cannot be seen. For the serial pools, the lowest value, 
5th and 50th percentile overlap, thus the bottom portion of the box and the lowest whisker is 
likewise not apparent.   
Upon combining the three parallel pools, the SCA2.1 family consisted of 0.0041% of 
the combined pool (median population: 0.000086%) based on our sequencing data. Such 
enrichment allowed for exponential enrichment of cross-reactive aptamers during serial 
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selection, wherein the population of the SCA2.1 family increased to 0.39% of the S3 pool 
and 29% of the S6 pool. Indeed, parallel selection made serial selection highly efficient. 
It is likely that performing serial selection without parallel selection would result in loss 
of cross-reactive aptamers, given the generally low copy number of such sequences in 
initial rounds.  
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Figure 6-13. Characterization of the target-binding affinity of SCA2.1 using ITC. Top panels 
present raw data showing the heat generated from each titration of (A) α-PVP, (B) ethylone and 
(C) butylone to SCA2.1, while bottom panels show the integrated heat of each titration after 
correcting for dilution heat of the titrant. ITC data were fitted using a single-site model and the 
binding parameters are shown in Table 6-4.  
 
Table 6-4. Binding parameters of SCA2.1 to α-PVP, ethylone and butylone, as characterized by 
fitting ITC data with a one-site or modified two-site binding model. 
 
Targets α-PVP Ethylone Butylone 
Binding model One-site Two-site One-site Two-site One-site Two-site 
N1 (target/aptamer) 1.66±0.05 1.10±0.01 1.09±0.01 1.06±0.06 1.20±0.01 1.06±0.09 
KD1 / µM 2.36±0.55 0.09±0.02 1.62±0.06 0.10±0.03 1.81±0.13 0.16±0.05 
∆H1 / kcal mol-1 -10.8±0.5 -16.5±0.1 -21.5±0.1 -23.1±0.2 -19.9±0.3 -25.9±0.6 
N2 (target/aptamer)  0.91±0.16  0.90±0.03  0.98±0.04 
KD2 / µM  18.5±7.7  2.22±0.09  1.59±0.14 
∆H2 / kcal mol-1  -12.2±4.4  -19.2±0.6  -12.9±2.7 
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6.3.6 Characterization of the affinity and specificity of the isolated aptamer 
We then characterized the affinity of SCA2.1 for the selection targets and specificity 
against interferents using isothermal titration calorimetry (ITC). We titrated a 300–400 
µM solution of target into a 20 µM solution of the aptamer, recorded the heat released by 
each titration, and integrated these data to generate a binding curve. Curve fitting with a 
one-site binding model resulted in atypical binding stoichiometries (N) and less-than-
optimal fitting, especially for α-PVP which has a non-sigmoidal curve (Figure 6-13 and  
Table 6-4). Given that synthetic cathinones are chiral molecules and a racemic mixture 
of the targets was employed for SELEX, we hypothesized that the aptamer may have 
differential binding affinity for each enantiomer. The pure enantiomers of the three 
selection targets were not commercially available, but the high cross-reactivity of the 
aptamer allowed us to use enantiomers for another synthetic cathinone, (-)- and (+)-
MDPV, to confirm our hypothesis. ITC data indicated that the aptamer binds to one target 
molecule, with N = 0.92 and 0.95 for (-)- and (+)-MDPV, respectively, and exhibits 100-
fold greater affinity for the (-) enantiomer (KD = 46.5±7.5 nM) relative to the (+) 
enantiomer (KD = 3.61±0.12 µM) (Figure 6-14, A and B, and Table 6-5). We also 
performed ITC by titrating racemic MDPV into a solution of SCA2.1 and observed a 
binding curve similar in appearance to that of α-PVP. Using a modified two-set-of-sites 
model (see methods for detail) to fit the result (Figure 6-14C), we obtained similar 
binding parameters to those produced by the titration of each enantiomer alone (Table 
6-5, (±)-MDPV). This confirmed that the modified model is appropriate to describe such 
binding phenomenon.  
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Figure 6-14. Characterization of the synthetic-cathinone-binding affinity of SCA2.1 using ITC. 
Top panels present raw data showing the heat generated from each titration of (A) (-)-MDPV, (B) 
(+)-MDPV and (C) (±)-MDPV to SCA2.1, while bottom panels show the integrated heat of each 
titration after correcting for dilution heat of the titrant. ITC data obtained with (-)-MDPV and (+)-
MDPV were fitted using a single-site model, and ITC data obtained with (±)-MDPV were fitted 
with a modified two-site binding model. All binding parameters are shown in Table 6-4.  
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Figure 6-15. Characterization of the target-binding affinity of SCA2.1 using ITC. Top panels 
present raw data showing the heat generated from each titration of (A) α-PVP, (B) ethylone and 
(C) butylone to SCA2.1, while bottom panels show the integrated heat of each titration after 
correcting for dilution heat of the titrant. ITC data were fitted with a modified two-site binding 
model and the binding parameters are shown in Table 6-4.  
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Table 6-5. Binding parameters of SCA2.1 to (-)-MDPV, (+)-MDPV, (±)-MDPV, as characterized 
by fitting ITC data with a one-site (for (-)- or (+)-MDPV) or modified two-site binding model 
(for (±)-MDPV).  
 
Binding parameters (-)-MDPV (+)-MDPV (±)-MDPV 
N1 (target/aptamer) 0.92±0.01 
 
1.04±0.06 
KD1 / nM 46.5±7.5 
 
17.5±16.4 
∆H1 / kcal mol-1 -24.7±0.2 
 
-22.3±0.4 
N2 (target/aptamer) 
 
0.95±0.01 0.91±0.08 
KD2 / µM 
 
3.61±0.12 3.77±1.34 
∆H2 / kcal mol-1 
 
-17.2±0.2 -17.8±3.5 
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Figure 6-16. Characterization of the interferent-binding affinity of SCA2.1 using ITC. Top 
panels present raw data showing the heat generated from each titration of (A) amphetamine, (B) 
methamphetamine, (C) ephedrine, (D) cocaine, and (E) procaine to SCA2.1, while bottom panels 
show the integrated heat of each titration after correcting for dilution heat of the titrant. ITC data 
were fitted with a one-site binding model and KDs are shown in the figures.  
167 
 
We then used this modified two-set-of-sites model to fit the ethylone, butylone, and α-
PVP binding curves and obtained improved fitting and normal N values (0.9–1.1), with 
nanomolar affinity towards one enantiomer and micromolar affinity for the other (Figure 
6-15 and Table 6-4). Opposing intuition, these results suggest that SCA2.1 can achieve 
not only high target-cross-reactivity, but also superior binding affinity. To determine the 
specificity of SCA2.1, we performed ITC with interferents that are most structurally-
similar to synthetic cathinones including amphetamine, methamphetamine, ephedrine, 
cocaine, and procaine. All such compounds had very low binding affinity for SCA2.1 
(Figure 6-16).  
6.3.7 Evaluating the target-binding spectrum and specificity of the isolated 
aptamer  
We then demonstrated the analytical utility of SCA2.1 in a colorimetric dye-
displacement assay. Cy7 is a small-molecule dye that exists in equilibrium between 
monomer and dimer forms, which have absorbance peaks at 760 and 670 nm, 
respectively. Previous studies have shown that Cy7 monomers can bind to hydrophobic 
target-binding domains of aptamers, which results in strong enhancement of absorbance 
at 760 nm.34,101 However, the binding of target to the aptamer can displace Cy7 monomer 
from the binding domain within seconds, which causes the dye to dimerize in aqueous 
solution, resulting in the reduction of absorbance at 760 nm and enhancement of 
absorbance at 670 nm (Figure 6-17). This approach can thus be used as a colorimetric 
indicator for small molecule detection. We first examined if such an assay can be 
employed to detect synthetic cathinones using SCA2.1. We determined the binding 
affinity of Cy7 to SCA2.1 by titrating different concentrations of the aptamer into a 
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solution of 2 µM Cy7 (Figure 6-18A). Increasing the amount of aptamer progressively 
enhanced the absorbance of Cy7 monomer at ~ 760 nm, indicating binding to the 
aptamer. A gradual peak shift from 760 to 775 nm was also observed, which is consistent 
with previous studies34,101 showing that absorbance of the monomer can change in 
different microenvironments, such as when the dye binds to the aptamer. Based on Cy7 
absorbance at 775 nm, we obtained a KD of 1.6 µM (Figure 6-18B). We then investigated 
whether the synthetic cathinone targets can efficiently displace Cy7 from SCA2.1. We 
first titrated different concentrations of butylone into a mixture of 2 µM Cy7 and 3 µM 
SCA2.1, and found that increasing concentrations of butylone progressively reduced the 
absorbance of Cy7 at 775 nm while enhancing absorbance at 670 nm (Figure 6-19A). 
This change can be attributed to dimerization of the Cy7 monomer when displaced from 
the aptamer into solution.34,101 We used the absorbance ratio between 670 nm and 775 nm 
(A670/A775) to calculate the signal gain and generate a calibration curve, which displayed 
a linear range of 0–10 µM and a measurable detection limit of 250 nM (Figure 6-20). We 
obtained equivalent results with both ethylone and α-PVP (Figure 6-19, B and C, and 
Figure 6-20), again confirming the high cross-reactivity of SCA2.1. Our Cy7-
displacement assay is also compatible with biosamples such as urine and saliva, since the 
absorbance range of Cy7 is well outside the background absorbance exhibited by these 
matrices.34 We obtained calibration curves with ethylone spiked into 50% urine (Figure 
6-21) and 50% saliva (Figure 6-22) with a linear range of 0–10 µM and a measurable 
detection limit of 80 and 120 nM, respectively. The enhanced sensitivity of the assay in 
these biomatrices can be possibly attributed to the higher ionic strength of the media, 
which may enhance target-binding to the aptamer or Cy7 dimerization.  
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Figure 6-17. Colorimetric detection of synthetic cathinones using a Cy7-displacement assay. 
Schematic of the Cy7-displacement assay, wherein binding of a synthetic cathinone molecule 
displaces the Cy7 monomer from the binding domain of SCA2.1, inducing formation of Cy7 
dimers that produce a change in the absorbance of the dye.  
A B
 
Figure 6-18. Determination of the binding affinity of Cy7 to SCA2.1 via a colorimetric assay. 
(A) Absorbance spectra of 2 µM Cy7 in the presence of 0.2, 0.4, 0.8, 1.6, 3.1, 6.3, 12.5, or 25 µM 
SCA2.1, with the black-to-red color gradient representing increasing concentrations. (B) Plot of 
the absorbance of Cy7 monomer at its peak wavelength (775 nm) versus concentration of 
SCA2.1, fitted with the Langmuir equation to determine the binding affinity of Cy7 to SCA2.1. 
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Figure 6-19. Cy7-displacement colorimetric assay for the detection of synthetic cathinones using 
SCA2.1. Absorbance spectra of Cy7 (2 µM) in the presence of 0, 0.1, 0.3, 0.5, 1.1, 2.3, 4.9, 10.3, 
21.6, 45.4, 95.2, or 200 µM (A) butylone, (B) ethylone, (C) α-PVP, with the black-to-red color 
gradient representing increasing concentrations of target. [SCA2.1] = 3 µM.  
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Figure 6-20. Calibration curves based on the absorbance ratio at 670/775 nm in the presence of 
different concentrations of α-PVP, ethylone or butylone in buffer. The inset represents the linear 
range at 0 to 10 µM target. Error bars show standard deviation from three measurements at each 
concentration. [SCA2.1] = 3 µM, [Cy7] = 2 µM.  
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Figure 6-21. Detection of ethylone in 50% urine using an SCA2.1-based Cy7-displacement 
colorimetric assay. (A) Absorbance spectra of Cy7 (2 µM) in the presence of 0, 0.03, 0.06, 0.12, 
0.25, 0.53, 1.11, 2.33, 4.90, 10.28, 21.60, 45.35, 95.24, or 200 µM ethylone, with the black-to-red 
color gradient representing increasing concentrations of target. (B) Assay calibration curve 
generated using 0-200 µM ethylone, with the inset representing the range of target concentrations 
from 0 to 1.1 µM. [SCA2.1] = 3 µM.  
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Figure 6-22. Detection of ethylone in 50% saliva using the SCA2.1-based Cy7-displacement 
colorimetric assay. (A) Absorbance spectra of Cy7 (2 µM) in the presence of 0, 0.03, 0.06, 0.12, 
0.25, 0.53, 1.11, 2.33, 4.90, 10.28, 21.60, 45.35, 95.24, or 200 µM ethylone, with the black-to-red 
color gradient representing increasing concentrations of target. (B) Assay calibration curve 
generated using 0-200 µM ethylone, with the inset representing the range of target concentrations 
from 0 to 1.1 µM. [SCA2.1] = 3 µM.  
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We tested the cross-reactivity of this assay for nine other synthetic cathinones, 
including naphyrone, MDPV, pentylone, methylone, 4-MMC, 4-FMC, 3-FMC, 
methcathinone and cathinone at a concentration of 50 µM. As expected, despite the 
diversity of the side chains substituents, all synthetic cathinones induced a significant 
change in A670/A775, producing a signal gain ranging from 45% to 130% relative to 
ethylone (Figure 6-23A). This implies that SCA2.1 mainly recognizes the β-keto 
phenethylamine core structure, and variations in the side chains do not significantly affect 
target-binding affinity. Notably, the aptamer is more cross-reactive to a broad range of 
synthetic cathinones than antibodies used in existing immunoassays, which 
achieve >20% cross-reactivity for only five synthetic cathinones.236 SCA2.1 shows a 
moderate bias towards bulkier synthetic cathinones such as MDPV, naphyrone, and 
pentylone. Such ligands may fit better in the binding pocket compared to smaller 
synthetic cathinones like methcathinone or 4-FMC, achieving high binding affinity 
through greater interaction with the aptamer. This supports the higher signal gain 
observed in the assay. Importantly, our assay has excellent specificity, as the aptamer 
does not cross-react to non-synthetic cathinone interferents. We tested our assay with 12 
different interferent compounds, including common illicit drugs (amphetamine, 
methamphetamine and cocaine) and cutting agents found in street samples 
(pseudoephedrine, ephedrine, procaine, lidocaine, benzocaine, caffeine, acetaminophen 
and sucrose) at a concentration of 50 µM. The assay yielded no response to any of these 
interferents (Figure 6-23A), even though many contained a partial β-keto phenethylamine 
structure, demonstrating that aptamer specificity can be precisely controlled through a 
well-designed selection approach.  
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We finally determined the limit of detection for our Cy7-displacement assay for 12 
synthetic cathinones and observed detection limits that varied from 40–80 nM in 50% 
urine (Figure 6-24). Clearly, the high affinity of this aptamer as well as its 
unresponsiveness towards endogenous compounds enables sensitive screening of 
synthetic cathinones in biological samples. Given that the concentration of these drugs in 
urine typically ranges between high nanomolar to <100 µM within a few hours after 
consumption,237 we believe that our assay will be useful for label-free detection of 
synthetic cathinones in these matrices. 
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Figure 6-23. Colorimetric detection of synthetic cathinones using a Cy7-displacement assay. (A) 
Signal gain measured via a plate reader from the Cy7-displacement assay with 12 synthetic 
cathinones (gray, with the three selection targets shaded) and 11 interferents (white) at a 
concentration of 50 μM with 3 µM SCA2.1 and 2 µM Cy7. Cross-reactivity is defined as the ratio 
of signal gain between the reference target ethylone and another synthetic cathinone or interferent 
multiplied by 100%. Error bars show standard deviations from three measurements. (B) Naked-
eye detection of synthetic cathinones using a mixture of 5 μM SCA2.1 and 3.5 µM Cy7. The 
color of the solution changes to bright blue within seconds upon addition of 50 µM synthetic 
cathinones (a-l). However, the color appears as a faint blue color in the absence of target (-) or 50 
μM of a wide range of interferents (m-w).  
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Figure 6-24. Calibration curves and linear ranges for the SCA2.1-based Cy7-displcaement assay 
in 50% urine based on the absorbance ratio at 670/775 nm in the presence of different 
concentrations of various synthetic cathinones. Error bars show standard deviation from three 
measurements at each concentration. [SCA2.1] = 3 µM, [Cy7] = 2 µM. 
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Figure 6-25. Naked-eye detection of ethylone in the concentration range of 0.4 µM to 200 µM. 
(A) Photograph of the assay. The blue color change can be clearly observed at concentrations 
≥6.3 µM target. (B) A calibration curve based on the photograph was made using Image-J 
software. [Cy7] = 3.5 µM. [SCA2.1] = 5 µM.  
We further fine-tuned our Cy7-displacement assay by using a higher concentration of 
the dye and aptamer in order to intensify the target-induced color change and thereby 
enable naked-eye detection. We challenged this assay with the aforementioned 12 
synthetic cathinones and 11 interferent compounds at a concentration of 50 µM with 3.5 
µM Cy7 and 5 µM SCA2.1. In the absence of target, the aptamer-bound Cy7 monomer 
has an absorption peak at 775 nm, which is not in the visible range, and thus the sample is 
practically colorless. However, when Cy7 is displaced by the target, the resulting 
dimerization-associated absorption peak at 670 nm causes the solution to produce a 
bright, clearly visible blue color. We observed that all 12 synthetic cathinones 
immediately induced a clear-to-blue color change in the solution, while no color change 
was identified upon addition of any of the interferent compounds (Figure 6-23B). Using 
ethylone as a target, we determined that 6.3 μM is the lowest concentration that can 
develop a color distinguishable from the blank with the naked eye (Figure 6-25). These 
results demonstrate the feasibility of the Cy7-displacement assay for instrument-free on-
site drug screening applications.  
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6.4. Conclusions 
Class-specificity implies a degree of both receptor promiscuity towards targets within 
a designated molecular family and specificity against molecules outside of the family. 
The development of class-specific antibodies and aptamers has proven challenging due to 
the lack of viable methods to precisely control receptor binding profiles and specificity. 
In this work, we sought to develop a new aptamer isolation strategy, parallel-and-serial 
selection, as an effective way to select for class-specific aptamers recognizing small 
molecules based on a familial molecular core structure. The parallel-and-serial selection 
strategy increases the likelihood of isolating broadly-cross reactive aptamers by enriching 
oligonucleotide pools in parallel against diversely-structured members of the designated 
target family and then combining and challenging the pools serially with these targets to 
fine tune specificity towards a particular class of targets. Here, we chose three synthetic 
cathinones that vary at all major substituent sites of the targeted family to ensure that 
broadly cross-reactive aptamers are isolated. Other target triplets could yield equally 
cross-reactive aptamers if they are sufficiently diverse. More targets can be employed to 
create broader cross-reactivity, although this will increase labor and cost requirements. 
By supplementing our strategy with counter-SELEX, the binding spectrum can be 
narrowed down to the target family, thereby avoiding unwanted cross-reactivity to 
structurally-similar non-target molecules.  
As a demonstration, we isolated a single class-specific DNA aptamer that can bind to 
12 diverse synthetic cathinones. This aptamer is insensitive to variations at all substituent 
sites on the core structure, and even tolerates many substituents that do not appear in our 
selection targets. Importantly, our aptamer does not respond to 11 structurally-similar 
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compounds, some of which only differ from our targets by a single atom. We 
subsequently demonstrated the superior class-specificity and affinity of our aptamer in a 
single-step, colorimetric Cy7-displacement assay, which can detect clinically-relevant 
concentrations of synthetic cathinones in biomatrices237–239 and presents greater target-
cross-reactivity than existing antibodies. Advantageously, this assay can also achieve 
naked-eye detection of synthetic cathinones at concentrations at low micromolar 
concentrations, which is valuable for on-site screening of seized substances.  
The aptamer isolated herein displays binding characteristics that confound intuition. 
This aptamer has great molecular promiscuity, binding to several molecules sharing a 
common, defined core structure. All the while, the aptamer retains the ability to 
discriminate against non-target molecules that are closely related in structure to members 
of the designated target family, even by a single atom difference in certain instances. 
Impressively, the aptamer also can bind to its targets with nanomolar affinity. This was 
not as expected, as broad cross-reactivity and high affinity is, on the surface, counter-
intuitive.  
Our findings significantly expand the capability of aptamers as class-specific 
biorecognition elements and demonstrate an unprecedented level of control over aptamer 
binding profiles through this new parallel-and-serial selection strategy. We believe that 
our approach can be used to isolate class-specific aptamers for other families of small 
molecules for applications relevant to medical diagnostics, environmental monitoring, 
food safety, and forensic science.  
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CHAPTER 7: Summary and Future Work 
7.1. Summary 
Aptamer-based sensors have recently gained considerable attention for diverse sensing 
applications such as drug detection, medical diagnostics, and environmental monitor. 
However, the detection of small molecules using aptamers has been challenging. This 
dissertation aims to remedy this problem by generating functionalized signal-reporting 
aptamers via several generally applicable aptamer engineering and isolation strategies. 
Split aptamers that reassemble in the presence of a target ligand have excellent target-
specificity and are compatible with various sensing platforms. However, the splitting of 
an aptamer is typically accompanied with reduction in target-binding affinity, which 
mitigates any overall gains in sensitivity. In Chapter 3, we for the first time present a 
simple approach to greatly enhance the target-response of split aptamers utilizing a 
cooperative binding mechanism. We experimentally demonstrate that the resulting 
CBSAs exhibit higher target binding affinity and are far more responsive in terms of 
target-induced aptamer assembly compared to parent split aptamers containing a single 
binding domain. Using a fluorescence assay developed from a cocaine-binding CBSA, 
we were able to detect cocaine at concentrations as low as 50 nM within 15 minutes in 
10% saliva without signal amplification. This limit of detection is 200-fold better than a 
similar previously reported fluorescence assay utilizing a split aptamer with a single 
binding domain. Given the simplicity of engineering a CBSA from a given aptamer, we 
were able to develop CBSA-based assays for other small molecules such as DIS and 
MDPV from aptamers with three-way-junction (TWJ) structured binding domains. 
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In Chapter 4, we further describe a general and simple approach for the development 
of rapid and sensitive CBSA-based EATR-amplified sensor platforms for the detection of 
small-molecule targets. As a demonstration, we developed a CBSA-based EATR-
amplified fluorescence assay to detect DIS, a potential cancer biomarker, in urine 
samples. This assay had 100-fold greater sensitivity relative to the same CBSA-based 
assay without EATR amplification, with a detection limit of 1 μM in 50% urine and a 
turnaround time of 30 minutes. To further demonstrate the generality of our assay, we 
utilized a cocaine-binding CBSA to develop rapid instrument-free colorimetric assays 
that report target-binding events through EATR-mediated aggregation of CBSA-modified 
gold nanoparticles. We achieved naked-eye detection of low micromolar concentrations 
of cocaine within 20 minutes.  
Most aptamer-based sensors, including CBSA-based assays, utilize structure-
switching functionalized aptamers that undergo a major conformational change upon 
target binding. However, aptamers usually do not innately undergo target-binding-
induced conformational changes, and the development of these so-called ‘structure-
switching aptamers’ typically entails a multi-stage process of sequence engineering and 
chemical modification. To simplify the process of aptamer-based sensor development, in 
Chapter 5, we for the first time report a simple SELEX strategy for directly isolating 
small-molecule-binding aptamers with intrinsic dye-displacement signal-reporting 
functionality. These aptamers can transduce target-binding events into a change of dye 
absorbance. Specifically, we first demonstrated that the small-molecule dye 
diethylthiatricarbocyanine (Cy7), can bind within the central cavities of DNA TWJs in a 
sequence-independent manner, and this interaction significantly changes the dye’s 
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absorbance spectra. We then designed a TWJ-structured DNA library and employed it to 
isolate an aptamer against MDPV, a synthetic cathinone that is an emerging drug of 
abuse. This aptamer intrinsically binds Cy7 within its TWJ-structured target-binding 
domain, but the presence of MDPV efficiently displaces the dye into solution, resulting in 
a significant change in absorption spectra of the dye within seconds. The Cy7-
displacement assay is label-free, rapid, sensitive, simple, and does not require sequence 
engineering or modification of the aptamer. The assay detects MDPV at concentrations as 
low as 300 nM with strong cross-reactivity to other synthetic cathinone analogs, while 
remaining minimally cross-reactive to structurally-similar non-cathinone compounds and 
common cutting agents. Importantly, such dye-displacement assay can be generalized for 
any small-molecule target isolated from the same TWJ-structured library.  
To further control the target-binding spectra of isolated aptamers, in Chapter 6, we 
describe a novel parallel-and-serial SELEX strategy employing multiple structurally-
related targets for isolating class-specific DNA aptamers. Such aptamers display both 
familial promiscuity and specificity towards a designated molecular family and are highly 
desirable for various applications, in particular, for the recognition and sensing of 
structurally-similar small molecules. As a demonstration, we isolated an aptamer cross-
reactive to the synthetic cathinone family. The aptamer displays binding characteristics 
that confound intuition, having high molecular promiscuity and nanomolar affinity for 12 
synthetic cathinones, while retaining the ability to discriminate against 11 non-target 
compounds that are closely related in structure, even by a single atom difference in 
certain instances. Leveraging the qualities of this aptamer, instantaneous colorimetric 
detection of synthetic cathinones at nanomolar concentrations in biological samples is 
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achieved. This assay exemplifies the true potential of class-specific aptamers and 
generally represents a highly efficient means of screening specific small-molecule 
families. As a whole, this work shows that nucleic-acid-based aptamers can exhibit a 
combination of broad target-cross-reactivity, high affinity, and remarkable specificity. 
Such feat has yet to be achieved by any existing antibodies or other bioreceptors in 
general for small molecules. 
7.2. Future work 
This dissertation demonstrates that CBSAs are highly target-responsive and adaptable 
with different sensing platforms for sensitive detection of small-molecule targets. Since 
many other optical and electrochemical sensing strategies have been developed that 
employ target-induced split aptamer assembly, it should be feasible to integrate our 
CBSA into these platforms. For example, split G-quadruplex-structured DNAzymes with 
peroxidase activity have been employed as label-free, colorimetric reporters for DNA 
detection. Such split DNAzymes can be grafted onto CBSAs for label-free visual 
detection of small-molecule targets within minutes. Alternatively, CBSAs can be 
incorporated into the well-established electrochemical aptamer-based sensor for rapid 
detection of small molecules in complex matrices such as blood. In this work, we have 
developed a straightforward strategy to engineer CBSAs from aptamers with TWJ 
structures. In the future, new methods can be developed to engineer CBSAs from 
aptamers with other secondary structures, for example, stem-loop structured aptamers. 
The dye-displacement aptamer-based assay has been demonstrated to be a rapid, 
sensitive and label-free method for small molecule detection. In this work, we have 
generalized this method to the aptamers with TWJ-structured target-binding domains. 
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Inspired by this success, small-molecule dyes binding to other secondary structures such 
as stem-loop and G-quadruplex can be screened and employed to develop generally 
applicable dye-displacement assays for aptamers with such secondary structures. 
Finally, our works have shown that the binding spectra of aptamers can be precisely 
manipulated using rationally designed aptamer isolation strategies. In the future, such 
selection strategies can be further refined to isolate aptamers with even higher specificity 
and affinity. Moreover, the multi-step washing/elution processes can be performed using 
an automatic syringe pump, significantly reducing the labor of SELEX and expediting 
aptamer isolation. 
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